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Numbering of the Pteridine Ring.
Tlie numbering of the pteridine ring in this thesis 
accords with t .e international rules of nomenclature.
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(I)
decent studies, usin physical methods, indicate that 
hydroxypteridines exist (in the cases studied) in the lactam 
form, for example (II).
0 OH
HO
(id
OH
However, for ease in reference, in this thesis 
hydroxypteridines are named, in accordance with tradition, 
i.e. as if they have the Lactim form (III). Thus (III) is 
named 2,4,7-trihydroxypteridine, and not 1,2,3,4,7,8- 
hexahydro-2,4,7-trioxopteridine.
Summa r;y
Reduction: The fifteen possible hydroxy- and polyhydroxy- 
pteridines were reduced, chemically and catalytically. 
Potassium borohydride, sodium dithionite, and potassium (or 
sodium) amalgam were used as the chemical reducing agents. 
Hydrogenation over palladium, platinum, and Raney-nickel were 
used for catalytic reductions. Except 2,4,7-trihydroxy- 
pteridine all these were successfully reduced by at least one 
of the above methods. Hyuroxypteridines lacking a hydroxy 
group in the pyrazine ring gave tetrahydropteridines and, in 
some cases, a dihydro-compound as well. Thus 2-hydroxy- 
pteridine gave 5,6,7, -tetraliydro-2-hydroxypteridine and also 
3,4-dihydro-2-hydroxypteridine. The latter is the first 
example of the reduction of a pteridine in the pyrimidine 
ring.
On the other hand, hydroxypteridines having a hydroxy 
group in the pyrazine ring gave only dihydro-compounds on 
reduction. Thus 6-hydroxypteridines gave 7,8-dihydro-6~ 
hydroxypteridines, and 7-hydroxypteridines gave their 5,6- 
dihydro-derivatives.
Synthesis: The structures of the products, often indicated 
by ionization constants and ultraviolet spectra, were 
confirmed by synthesis in most cases.
A synthetic route to the hitherto inaccessible 5,6- 
dihydro pteridines was discovered. This involved reduction
. .
of the Schiff s base of a 4,5-diaminopyrimidine. In 
addition a method was devised for preparing 5,6,7,8-tetrahydro- 
-4-hydroxyi:>t eri dine which could not be synthesized by Lister 
and Ramage’s method (cyclization of a 5-amino-4-(benzyl-ß- 
hydroxyethylamino)-pyrimidine). It is a well-known defect 
of this method that it cannot be used to make tetrahydro- 
hydroxypteridines, for, if a hydroxy-group is present in the 
pyrimidine ring before the cyclization, an alternative 
reaction occurs and gives a glyoxalinopyrimidine in jjlace of 
the desired tetrahydropteridine. The alternative reaction 
succeeds because of the tautomeric possibilities of the 
hydroxy-group. Hence the problem was solved by 
introducing an ethoxy group at the pyrimidine stage. The 
ethoxy-group, under the conditions of cyclization, was 
hydrolysed to a hydroxy-group and gave the desired tetrahyd.ro- 
hydroxypteridine.
substituent in the 6-position. But no method for producing 
such substances has been recorded. However it seemed that 
7,8-dihydropteridines, lacking a substituent in the 6- 
position, could be prepared by condensing aminoacetal and a 
4-chloro-5-nitropyrimidine. In practice, a difficulty arose 
in the last step (cyclization), but this was solved by 
hydrolysis of the acetal group before the reduction of the
Some 7,8-dihyuropteridines were required lacking a
nitro-group. 7,8-Dihydro-2-hydroxypteridine was prepared in 
this way.
In all tl: irty six new compounds were prepared and are 
listed at the end of this summary.
Ioni5ation conr-1ants : Ionization constants were measured in 
order to record precise spectra of single ionic species. 
Sometimes these constants gave useful clues to structure, e.g. 
t. e significant rise of basic strength in 7,8-dihydro- 
pteridines compared to the parent xrfceridines. This rise is 
undoubtedly caused by extra resonance in the cation exactly 
as in simple nitrogen heterocyclic compounds having an amino- 
group in the Tf-position (e.g. 4-aminopyridine).
Spectra: Close similarity of the ultraviolet spectra of 
5,6,7,8-tetrahydropteridines and of the corresponding 
4,5-diaminopyrimidines furnished a convenient confirmation of 
the structure of tetrahydro-2-hydroxypteridine. A similar 
relationship confirmed the structure of the alkaline 
hydrolysis product of dihydro-7-hydroxypteridine, as 4- 
amino-5-carboxymethylaminopyrimidine. The similarity in 
ultraviolet spectra of x,y-dihydro-2-hydroxypteridine and 
of 2-hydroxypteridine (known to be covalently hydrated 
across the 3,4-bond) confirmed the structure of the former 
as 3,4-dihydro-2-hydroxypteridine.
New »Substances (All analysed)
Pteriuine
2-Hydroxy-6-met hylpt eridine 
I) i hydro pt e r i dines
7.8- Di hydro-4,6-dime thy lpt er i dine 
3,4-Dihydro-2-hydroxypteridine
7.3- Dihydro-2-hydroxypteridine
3.4- Dihydro-2-hydroxy-6-methylpteridine
7.8- Dihydro-2-hydroxy-6-methylpteridine 
x , y-Dihydro-4-hydroxypt eridine
5.6- Dihydro-4-hydroxypt eridine 
x,y-Dihydro-2,7-dihydroxypteridine
5.6- Dihydro-4,7-dihydroxypteridine
1et rahydropt eridine s
8-Benzyl-4-chloro-5,6,7,8-tetrahydropteridine 
8-Denzyl-5,6,7,8-tetrahydro-4-hydroxypteridine
5.6.7.8- Tetrahydro-2-hydroxypteridine
5.6.7.8- Tetrahydro-4-hydroxypteridine
5.6.7.8- letrahydro-2,4-dihydroxypteridine 
Pormyltetrahydro-2,4-dihydroxypteridine
Sulphur Containing; Products
Sodium tetrahydro-2,4-dihydroxypteridine sulphonate 
Sodium tetrahydro-2,7-dihydropteridine sulphonate 
Sodium dihydro-2,7-dihydroxypteridine sulphonate 
Sodium dihydro-2-hydroxypteridine sulphonate
lyrimi dines
4-Acetonylamino-2-hydroxy-5-nitropyrimidine
4- Acetonylamino-6-hydroxy-5-nitropyrimidine
5- Amino-4-(benzyl-ß-hydroxyethylamino)-6-benzyloxypyrimidine 
hydrochloride
5-Amino-4-(benzyl-ß-hydroxyethylamino)-6-chloropyrimidine 
hydrochloride
5-Amino-4- (benzyl-ß-hydroxyethylamino )-6-hydroxypyrimidine 
4-Amino-5-cyanomethyla ninopyrimidine
4-Amino-5-ethoxycarbonylmethylamino-6-hydroxypyrimidine 
4-Amin o-5-ß-diet hoxyet hy1amino-2-hydroxypyrimidine
4- Amino-5~P-diethoxyethylamino-6-hydroxypyrimidine 
5“Amino-4-ß-diethoxyethylamino-2-hydroxypyrimidine
5- Bromo-4-phthaloylglycylaminopyrimidine 
4-ß-Diethoxyethylamino-2-hydroxy-5-nitropyrimidine 
4-ß-Diethoxyethylamino-6-hydroxy-5-nitropyrimidine 
2,4-Bis-ß-diethoxyethylamino-5-nitropyrimidine 
4-Bormylmethylamino-2-hydroxy-5-nitropyrimidine
Pyrazine
2-Amino-3-hydroxymethylpyrazine.
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1SECTION 1.
INTRODUCTION, 
a. Opening Remarks,
Many pteridine derivatives such as xanthopterin, 
leucopterin, isoxanthopterin, erythropterin, chrysopterin, 
ichthyopterin, hiopterin, drosopterin and the folic acid 
group have been found in nature and their structures have 
been investigated. In the course of those studies it 
was found that some of these derivatives have relatively 
low oxidation reduction potentials and a number of 
reversible reductions were demonstrated. Some of the 
reductions are now known to be of great importance for the 
reproduction of living cells.
isolated from liver and yeast (Pfiffner at al., 1943, 1947; 
Stokstad 1943; Stokstad, Hutchings and Subba Row, 1943) and
The biologically active substance "folic acid" was
its structure was shown to be a pteridine derivative (la-I)A
(Angier et al.. 1945, 1946).
2GOGH (la-I)
OH
NH-CH
The "biological function of folic acid was then investigated, 
and it was eventually found that it acted as a coenzyme after 
reduction to 5,6,7,8-tetrahydrofolic acid. In some enzyme 
systems this functioned in loose combination with formaldehyde 
giving the so-called "active formaldehyde", In other 
enzymes it is combined with formic acid ("active formate"). 
These pteridine coenzymes bring about the transfer of single 
carbon atom fragments in the biosynthesis of purines, 
pyrimidines and some amino acids. Careful work ha3 
established the metabolic route from folic acid to the
5.6.7.8- tetrahydrofolic acid via a dihydro derivative.
The same dihydrofolic acid was also prepared by chemical 
reduction (O'Dell, Vandenbelt, Bloom and Pfiffner, 1947; 
Puttermann, 1957) and it is now considered to be the
7.8- dihydro derivative from somewhat indirect chemical 
analogies (O'Dell et al,, 1947) and by enzymic evidence
3b a s e d  on l a c k  of  a  new c e n t r e  o f  asymmetry (Osborn  and 
H uennekens ,  1958)*
S im p le r  p’t e r i d i n e s  have  been  l i t t l e  i n v e s i t g a t e d  
from t h e  v ie w p o in t  o f  r e d u c t i o n .  By s t u d y i n g  t h e  r e d u c t i o n  
of  h y d r o x y p t e r i d i n e s ,  t h e  p r e s e n t  work s e e k s  p a r t l y  t o  remedy 
t h i s  s t a t e  o f  a f f a i r s .
b .  H i s t o r i c a l  O u t l i n e .
The e a r l i e s t  work on t h e  r e d u c t i o n  of  t h e  p t e r i d i n e  
r i n g  a r o s e  d u r in g  s t r u c t u r a l  i n v e s t i g a t i o n s  of  t h e  n a t u r a l  
p ig m e n t s ;  x a n t h o p t e r i n  ( l b - I ) ,  i s o x a n t h o p t e r i n  ( l b - I l ) ,  and 
l e u c o p t e r i n  ( l b - I I l ) ,  f o l i c  a c i d  ( l a - l ) ,  and o t h e r  n a t u r a l l y  
o c c u r i n g  p t e r i d i n e s .
( l b - I I l )
4Although the structure of xanthopterin was not known until 
1940, it was found to he reduced with zinc dust in acidic 
or in alkaline solution in 1927 (Wieland and Schöpf, 1925). 
Fuming hydriodic acid (Wieland, Tartter and Purrmann, 1940), 
hydrogen sulphide, sodium dithionite and sodium sulphite 
(Soschara, 1936, 1937) were all found to reduce xanthopterin 
to a leuco-compound, which was reoxidized to the starting 
material by shaking in the air. Xanthopterin was also reduced 
catalytically, and it was reported that three moles of 
hydrogen were taken up if the formula was ^po^lS^lo^o an  ^
two moles if the formula was (Koschara, 1937).
(The uncertainty arose fro 1 difficulties in micro-combustion, 
and the formula was proved later to be G^H^N^0o). 
Isoxanthopterin (lb-11) was reduced with hydriodic acid 
(Wieland, Tartter and Purrmann, 1940), but reduction was 
assumed only on the evidence of liberated iodine and no 
reduced product was isolated. Leucoirterin could not be 
reduced by these reagents. During 1940-1, the structures 
of xanthopterin (Purrmann, 1940a), isoxanthopterin (Purrmann, 
1941), and leucopterin (Purrmann, 1940b) were finally 
established. In 1944, leucopterin was reduced with sodium 
amalgam to a dihydroxanthopterin which was identical with the
r*5
product obtained by the reduction of xanthopterin with zinc, 
fuming hydr^iodic acid etc., (Totter, 1944).
About 1943, a biologically active substance,
"folic acid", was isolated, and research was concentrated on 
tie determination of its structure. In 1947, O'Dell et al., 
hydrogenated folic acid in acidic and in alkaline solution 
over palladium or Adams' catalyst. They found that folic 
acid absorbed two atoms of hydrogen in alkaline solution 
using a palladium catalyst, but four atoms of hydrogen in 
acidic solution over Adams' catalyst. The reduction of 
folic acid has since been carried out with sodium dithionite, 
and dihydrofolic acid was obtained (Futtermann, 1957;
Blakley, I960).
Some other hydrogenated pteridines were made by 
reduction, and some synthetic work was attempted (as in 
Besson's synthesis, described below). However, it was 
not until 1950 that any method was discovered v/hich gave 
hydropteridines in which the positions of the hydrogen atoms 
were known beyond doubt. Besson (194°) condensed 
4,5-diamino-2-ethylthio-6-hydroxypyrimidine (lb-IV) with 
benzoin and obtained two isomeric dihydro compounds (X and Y), 
which were oxidized to the same pteridine (lb-V).
6OH OH
( l b - I V )
SEt
A g e n e r a l  s y n t h e t i c  r o u t e  from  c h lo r o p y r im id in e s  t o
7 . 8 -  d i h y d r o p t e r i d i n e s  was d e v e lo p e d  by Boon, Ramage and t h e i r  
c o l l a b o r a t o r s  and in d e p e n d e n t ly  by P o lo n o v s k i  and h i s  
c o l l a b o r a t o r s .  T h is  was a  n o t a b l e  advance  b e ca u se  i t
gave r i s e  t o  d i h y d r o p t e r i d i n e s  w hich  were i n d u b i t a b l y
7 . 8 -  d i h y d r o - d e r i v a t i v e s .  Up t o  t h e  i n c e p t i o n  o f  t h e  work 
d e s c r ib e d  i n  t h e  p r e s e n t  t h e s i s ,  no s i m i l a r  method f o r  
p ro d u c in g  d i h y d r o p t e r i d i n e s  w i th  t h e  hy d ro g en  atom s i n  o t h e r  
p o s i t i o n s h a d  been  fo u n d .
Thus 7 , 8 - d i h y d r o - 6 - h y d r o x y p t e r i d i n e s  ( l b - V I I I a )
(Boon, Jo n e s  and Ramage, 1951.-5 P o lo n o v s k i  and Je rom e, 1950) 
and 7 , 8 - d i h y d r o - 6 - a l k y l p t e r i d i n e s  ( l b - V I I I b )  (Boon and 
J o n e s ,  1951 ; P o lo n o v s k i ,  P esso n  and P u i s t e r ,  1950) were 
unam biguously  s y n t h e s i z e d  by t h e  r o u t e  ( lb - V I  ---- » l b - V I I l ) .
7(lb-VT) (lb-VTI) (lb-VIII)
a , R^ = OH
b, R^ = alkyl
or aryl
a , R = OH
b, R. = alkyl
or aryl
A number of 7 ,8-dihydro-hydroxypteridines were 
synthesized by this method. For example, 7,8-dihydro-o- 
hydroxypteridine (lb-XIb) was synthesized from 2,4-dichloro- 
5-nitropyrimidine (lb-IXa) (Boon, Jones and Ramage, 1951). 
Condensation of glycine ethyl ester with 2,4-dichloro-5- 
nitropyrimidine (lb-IXa) gave 2-chloro-4- 
ethoxycarbonylmethylamino-5-nitropyrimidine (lb-Xa) which, 
on hydrogenation over Raney nickel, gave 2-chloro-7,8- 
dihydro-6-hydroxypteridine (lb-XIa). 7,8-Dihydro-6- 
hydroxypteridine (lb-XIb) was obtained by reductive removal 
of the 2-chloro-group of (lb-XIa) with hydriodic acid.
8(lb-IX) (lb-X) (lb—XI)
R 1 R2 Ri ß 2 R 1 R2
a, Cl H a, Cl H a, Cl H
b, H Cl u OH H *>, H H
c, H OH OH H
<3, H OH
7,8-Dihydro-2,S-dihydroxypteridine (lb-XIc) was synthesized 
from the same pyrimidine (lb-IXa) via (lb-Xa) and (lh-Xb) 
(Boon, Jones and Ramage, 1951). 7,8-Bihydro-4,6-
dihydroxypteridine (lb-XId) was synthesized from 4,6-dichloro- 
5-nitropyrimidine (lb-IXb) (Boon, Jones and Ramage, 1951) by 
a similar synthesis to that used for 7,S-dihydro-2,5- 
dihydroxypteridine.
97 , 8 - L i h y d r o - 2 , 4 , 6 - t r i h y d r o x y p t e r i d i n e  ( l b - X V )  
w as  s y n t h e s i z e d  a s  shown (B o o n  a n d  L e i g h ,  1 9 5 2 ) :
OH OH OH
OH
( l h - X I l ) ( l b - X I I I ) ( l b - X I V )
OH
4 - C h l o r o - 2 , 6 - d i h y d r o x y p y r i m i d i n e  ( l b - X I I )  w as  c o n d e n s e d  w i t h  
p - t o l u e n e d i a z o n i u m  s a l t  t o  g i v e  ( l b - X I I I ) ,  a n d  t h i s  was  t h e n  
c o n d e n s e d  w i t h  g l y c i n e  m e t h y l  e s t e r  t o  g i v e  ( l b - X I V )  w h i c h ,  
on r e d u c t i o n ,  g a v e  7 , 8 - d i h y d r o - 2 , 4 , 6 - t r i h y d r o x y p t e r i d i n e  
( l b - X V ) .
The s t r u c t u r e  o f  d i h y d r o x a n t h o p t e r i n  was  f i n a l l y
10
established as 2-amino-7,8-dihydro-4,6-dihydroxypteridine 
(lb-XVl) by a slight and obvious modification of this 
synthesis (Boon and Leigh, 1951, 1952).
OH
(lb-XVI)
7,8-Dihydro-2-hydroxy-4,6-dimethylpteridine (lb-XX ) was 
synthesized from 2,4-dichloro-6-methyl-5-nitropyrimidine 
(lb-XVII) by the following route (Lister and Ramage, 1953)«
NHoCHoC0CH
(lb-XVII) (lb-XIX)
(lb-XX) (lb-XXI)
USHARV %
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However, before the present work was undertaken, no 
method existed for preparing 7 ,8-dihydropteridines lacking 
a hydroxy- or alkyl-group in the 6-position.
7,8-Dihydropteridines, which have no hydroxy group in 
the 6-position, were found to be readily hydrogenated to the 
corresponding tetrahydropteridines (Polonovski, Pesson and 
Puister, 1950; lister and Ramage, 1953 J Lister, Ramage and 
Coates, 1954). (All of these had an alkyl-group in the 
6-position). Because these tetrahydropteridines had 
ultraviolet absorption spectra similar to the corresponding
4.5- diaminopyrimidines, the 5,6,7,8-tetrahydro structure was 
assigned to them. For example the 7 ,8-dihydro-2-hydroxy-4,6- 
dimethylpteridine (lb-XX) was reduced to a tetrahydro compound 
which had (similar") ultraviolet absorption spectra to those of
4.5- diamino-2-hydroxy-6-methylpyrimidine and it was therefore 
assigned the structure 5,6,7,8-tetrahydro-2-hydroxy-4,6- 
dimethylpteridine (lb-XXI) (Lister and Ramage, 1953).
Another unambiguous synthetic route to 5,6,7,8— 
tetrahydropteridines had been worked out (Brook and Ramage, 
1955, 1957), and 5,6,7,8-tetrahydropteridines with no other 
substituent in the 6-positions are also available by this 
method. However the synthesis of 5,6,7,8-tetrahydro- 
hydroxypteridines with no substituent in the 8-position could
12
not be accomplished. 8-Benzyl-5,6,7,8-tetrahydro-2- 
hydroxy-4-methylpteridine (lb-XXVT) was prepared 
unambiguously as follows, but unfortunately it resisted 
debenzylation (Brook and Ramage, 1955).
R R
(ib-XXII) (lb-ZXIII)
a, R = GH. a, R = CH3
(lb-XXIV)
a, H = CH3
b, E = H
V
(lb-XXV) (lb-XZVl)
R =
13
C o n d e n s a t i o n  o f  2 , 4 - d i c h l o r o - 6 - m e t h y l - 5 - n i t r o p y r i m i d i n e  
( l b - X X I l )  w i t h  b e n z y l - ß - h y d r o x y e t h y l a m i n e  gave ( l b -  C T I I ) .  
8 - B e n z y l - 2 - c h l o r o - 5 , 6 , 7 , 8 - t e t r a h y d r o - 4 - m e t h y l p t e r i d i n e  
( l b —XXIV) was o b t a i n e d  f rom  ( l b - X X I I l )  by r e d u c t i o n  and t h e n  
by t r e a t m e n t  w i t h  p h o sp h o ru s  t r i c h l o r i d e .  H y d r o l y s i s  o f  
(lb-XXIV) w i t h  5 N - h y d r o c h lo r i c  a c i d  gave 8 - b e n z y l - 5 , 6 , 7 , 8 -  
t e t r a h y d r o - 2 - h y d r o x y - 4 - m e t h y l p t e r i d i n e  ( lb-XXVI) bu t  a t t e m p t  
a t  r e p l a c e m e n t  o f  t h e  8 - b e n z y l - g r o u p  w i t h  hydrogen  by 
t r e a t m e n t  w i t h  sodium i n  l i q u i d  ammonia gave an u n s t a b l e  
pro  d u c t . 5 , 6 , 7 , 8 - T e t r a h y d r o p t e  r i d i n e  ( lb-XXV) was
s y n t h e s i z e d  from ( lb -X lTV) by r e d u c t i o n  w i t h  sodium i n  l i q u i d  
ammonia, a p r o c e s s  which a c h i e v e d  b o t h  d e b e n z y l a t i o n  and 
d e c h l o r i n a t i o n  s i m u l t a n e o u s l y  (Brook and Homage, 1 957 ).  The 
d i s a d v a n t a g e  o f  t h i s  method f o r  p r e p a r i n g  t e t r a h y d r o -  
p t e r i d i n e s  i s  t h a t  n a l t e r n a t i v e  c y c l i z a t i o n  t o  g l y o x a l i n o -  
p y r i m i d i n e s  o c c u r s  i f  a  t a u t o m e r i z a b l  ( e . g .  -OH o r
-NHn ) i s  p r e s e n t  a t  s t a g e  ( l b - X X I I l )  (Ramage and T rap p e ,  
1952 ).
A l i t t l e  work h a s  b e en  done on t h e  r e d u c t i o n  o f  amino-  
and e t h o x y - p t e r i d i n e s .  However,  a s  t h e  p r e s e n t  r e s e a r c h  
work i s  c o n ce rn e d  w i t h  h y d r o x y p t e r i d i n e s , t h e  r e s t  of t h i s  
h i s t o r i c a l  o u t l i n e  w i l l  be c o n f i n e d  t o  an a c c o u n t  o f  work on 
t h e  r e d u c t i o n  of  p t e r i d i n e  and h y d r o x y p t e r i d i n e s ,  and w i l l  
i n c l u d e  p r o o f s  o f  s t r u c t u r e s .
P t e r i d i n e  was f i r s t  p r e p a r e d  by t h e  c o n d e n s a t i o n  of  
4 , 5 - d i a m in o p y r i m id i n e  w i t h  g l y o x a l  ( J o n e s ,  1943) and was
14
later reduced to the tetrahydro derivative with lithium 
aluminium hydride (Taylor and Sherman, 1959). The same 
tetrahydropteridine was also prepared by catalytic hydrogenation 
of 2,4-dichloro-5,6,7,8-tetrahydropteridine (Taylor and Sherman, 
1959) and was identified as 5,6,7,8-tetrahydropteridine by 
comparison with a sample which was unambiguously prepared by 
brook and Ramage (1957), as described above.
All the possible mono- and poly- hydroxypteridines are 
known (Table 1, see p. 17) but, prior to the present work 
few had been reduced. Reduction of 6-hydroxy-, and 6,7- 
dihydroxy-, pteridines with sodium amalgam always gave the 
corresponding 7,8-dihydro-6-hydroxy derivatives. Thus for 
example, both 6-hydroxy-, and 6,7-dihydroxy-, pteridine gave
7.5- dihydro-6-hydroxypteridine (lb-XIb) identical with that 
obtained by Boon's synthesis (Albert, Brown and Cheeseman,
1952) . Similarly, 4,6,7-trihydroxypteridine gave the known
7,8-dihydro-4,6-dihydroxypteridine (lb-XId) (Albert and Brown,
1953) . 2,4,6,7-Tetraliydroxypteridine was reduced with sodium 
amalgam to what was apparently 7,3-dihydro-2,4,6-trihydroxy- 
pteridine (Albert, Lister and Pedersen, 1956) because it was 
oxidized to 2,4,6-trihydroxypteridine. The same dihydro­
compound was obtained by the reduction of 2,4-dichloro-6,7- 
dihydroxypteridine with sodium amalgam (Taylor and Sherman, 
1959). Similarly sodium amalgam reduction of 4,6,7- 
trihydroxy-N^ ^ -methyl-2-oxopteridine produced 7,8-dihydro-
4.6- dihydroxy-N^ j -methyl-2-oxopteridine (Pfleiderer, 1957).
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The use of two other reducing agents is exemplified in the 
reduction of 4-hy&roxy-6-methylpteridine by sodium 
borohydride to a tetrahydro-4-hydroxy-6-methylpteridine 
(Blakley, 1959), and in the reductive cleavage of 7-hydroxy- 
pteridine (lb-XXVIl) by sodium dithionite to give 4-amino-5- 
carboxymethylaminopyrimidine (lb-XXVTII) (Albert, Brown and 
Cheeseman, 1952). The same compound (lb-XXVIIl) was also 
obtained by a catalytic hydrogenation over Adams' catalyst 
in 0.1 N-sodium hydroxide solution (Albert, Brown and 
Cheeseman, 1952).
HO^CCHLNH
H2N OH
H
H
HO
(lb-XXVII) (lb-XXVIII) (lb-XXIX)
Evidence for the ring opening structure (lb-XXVIII) was 
obtained from analytical figures and from the presence of a 
carboxyl group. This compound gave an ester hydrochloride, 
as do amino acids, by treatment with hydrogen chloride in 
methanol, but conclusive evidence for the position of the 
introduced hydrogen was not presented. The compound
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(lb-XXVIII) easily cyclized to a dihydro-7- 
hydroxypteridine, believed to be (lb-XXIX), by refluxing 
in N-hydrochlorio acid and it was regenerated by boiling 
in !T-sodium hydroxide (Albert, Brown and Cheeseman, 1952 ).
All hydroxypteridines which had been reduced to 
products of confirmed orientation, prior to the present work 
are shown in Table 2 (see p. 18 ).
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Table 1
List of known hydroxypteridines
Reference
(Pteridine Jones 1948)
2-Hydroxypteridine Albert, Brown and Ghees email 1951
4-Hydroxypteridine Albert, Brown and Cheeseman 1951
o-IIydroxypt eridine Albert, Drown and Cheeseman 1952
7-Hydroxypteridine Albert, Brown and Cheeseman 1952
2,4-Dihydroxypteridine Kuhn and Cook 1937
2,6-Dihydroxypteridine Albert, Lister and Pedersen 1956
2,7-Dihydroxypteridine Albert, Lister and Pedersen 1956
4,6-Dihydroxypteridine Albert and Brown 1953
4,7-Dihydroxypteridine Albert and Brown 1953
6,7-Dihydroxypt eridine Albert, Brown and Cheeseman 1952
2,4,6-Trihydroxypteridine Wieland and Liebig 1944
2,4,7-Trihydroxypteridine Tsehesehe and Körte 1951
2,6,7-Trihydroxypteridine Albert, Lister and Pedersen 1956
4,6,7-Trihydroxypteridine Albert and Brown 1953
2,4,6,7-Tet rally dr oxy pteridine Schöpf, Reichert and Riefst ah 1 1941
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Talle 2.
Hydroxypteridines where the positions of the hydrogen atoms are unambiguously known.
Pteridines which have been 
reduced and the product 
unambiguously identified
Reducing
agent
Reference
(Reduction)
6-Hydroxypt eri dine Na-Hg 1)
6,7-bihyuroxypteridine Na-Hg 1)
4,6,7-Trihydroxypteridine Na-Hg 3)
2,4,6,7-Tetrahydroxypteridine Na-Hg 4)
This suhstance has been synthesized, 
but not obtained by reduction.
Product
HO
\
H
OH
OH
H
Reference
(Unambiguous
synthesis)
2)
2)
5)
2)
1) Albert, Brown and Cheeseman, 1952
2) Boon, Jones and Ramage, 1951
3) Albert and Brown, 1953
4) Albert, Lister and Pedersen, 1956
5) Boon and Leigh, 1952
20
The structures of the reduction products were mainly 
confirmed hy comparison /with samples prepared unambiguously. 
The first synthetic routes to 7 ,0-dihydro-., 5,0-dihydro-, and 
5,0,7,8-tetrallydro-, hydroxypteridines having no substituent 
in the 6-, and 7-positions, were worked out.
Ionization constants of the hydrogenated pteridines 
were determined by potentiometric titration or by 
spectroscopic methods.
The ultraviolet absorption spectra, and the infrared 
absorption spectra of the reduced pteridines were also 
determined for comparison of structure.
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SECTION 2,
METHODS.
a. Methods Available for Reduction.
As indicated in the historical outline, many methods 
have been used for the reduction of pteridine derivatives.
They include physical, chemical and biochemical procedures.
Nor systematic investigation of the reduction of the 
pteridine ring, it is important to select a proper 
combination of reducing agent and the substance to be reduced. 
Many such combinations are possible, but for simplicity and in 
order to achieve practical result, attention has been confined 
to selected variations in (a) the reducing agent and (b) the 
ionic species of the substance to be reduced.
As all hydroxypteridines have acidic and basic 
functions, the pH of the solution determines the ionic 
species of the hydroxypteridine in the reaction mixture.
It is clearly desirable, therefore to restrict each reduction 
of a hydroxypteridine to one ionic si)ecies in any one 
experiment. Nor example, 7-hydroxypteridine has three pKa 
values of 6.41 (acidic), 1.2 (basic) and -2.0 (basic).
Hence, if the 7-hydroxypteridine is reduced in a solution of 
pH 9, the reaction occurs almost entirely between the 7- 
hydroxypteridine anion and the reducing agent, but at pH 4 
the reaction occurs almost entirely between the neutral 
molecule and the reducing agent. The pICa values of 
hydroxypteridines are shown in Table 3, p. 25* In some
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c a s e s  t h e  number of  i o n i c  s p e c i e s  a v a i l a b l e  f o r  t h e  
r e d u c t i o n  was l i m i t e d  on a c c o u n t  o f  i n s o l u b i l i t y  o f  one o r  
o t h e r  o f  t h e  s p e c i e s .
The most i m p o r t a n t  v a r i a b l e  i n  t h e  r e d u c t i o n  of  
p t e r i d i n e s  i s  t h e  c h o ic e  of  a r e d u c i n g  a g e n t . C l a s s i c a l  
t h e o r y  s u g g e s t s  t h a t  r e d u c t i o n  u s i n g  c h e m ic a l  r e a g e n t s  i s  
i n i t i a t e d  by t h e  a t t a c k  o f  a  p r o t o n  t o  g iv e  an i n t e r m e d i a t e  
c a t i o n .  The c a t i o n  t h e n  t a k e s  up  two e l e c t r o n s  f rom t h e  
r e d u c i n g  a g e n t  which  c o n v e r t s  i t  i n t o  an a n io n ,  and t h e  
r e d u c t i o n  i s  t h e n  c o m p le te d  by a b s t r a c t i o n  of  a  second  
p r o t o n  from t h e  s u r r o u n d i n g  medium. However, i t  i s  now 
commonly a c c e p t e d  t h a t  o t h e r  mechanisms of  r e d u c t i o n  a r e  
evoked by x ^ a r t i c u l a r  c l a s s e s  o f  r e a g e n t s .  For  example ,  
d i s s o l v i n g  m e t a l s  r e d u c e  t h e  s u b s t a n c e  by a h y drogen  a n io n  
(2 e + H+ ) mechanism. (B a k e r ,  1952; I n g o l d ,  1 9 5 3 ) .  Complex 
m e t a l  h y d r i d e s  a l s o  r e d u c e  a  s u b s t a n c e  by a hy d ro g en  a n io n  
mechanism, i n  some c a s e s  w i t h  t h e  f o r m a t i o n  of  a t r a n s i e n t  
a d d i t i o n  complex.  The r e d u c t i o n  o f  p y r i d i n e n u c l e o t i d e s  by 
sodium d i t h i o n i t e ,  a l s o  p r o c e e d s  t h r o u g h  an a d d i t i o n  complex, 
bu t  i t  i s  of  a n o t h e r  t y p e  (Y a rm o l in sk y  and Colowick ,  1 956) .  
F i n a l l y  h y d r o g e n a t i o n s  u s i n g  m e t a l  c a t a l y s t s  a r e  c o n s i d e r e d  
t o  be r e d u c t i o n s  by f r e e  h y d ro g en  atoais  (Conant  and C u t t e r ,  
1922; L a i d l e r ,  1 9 5 1 ) .
The f o l l o w i n g  r e a g e n t s  were s e l e c t e d  f o r  t h e  p r e s e n t  
work: p o t a s s i u m  b o r o h y d r i d e  (h y d ro g en  a n io n  t y p e ) ,  sodium
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amalgam (dissolving metal type), sodium dithionite 
(reduction through an addition compound), hydrogenation over 
platinum, palladium and Raney nickel (free hydrogen atoms). 
Potassium borohydride is one of the best of the
This is a great advantage for the reduction of hydroxy- 
pteridines because most hydroxypteridines are quite 
insoluble in organic solvents. For this reason lithium 
aluminium hydride (a more active complex metal hydride than 
potassium borohydride) has been used only for the reduction 
of lipo-soluble pteridines, e.g. pteridine, a chloropteridine 
(Taylor and Sherman, 1959) and an alkylpteridine (Brook and 
Ramage, 1957). All hydroxypteridines in the present work, 
were treated with potassium borohydride.
Because potassium (or sodium) amalgam is used in 
alkaline conditions, all hydroxypteridines can be treated 
with this reagent. (Some hydroxypteridines, for example 7- 
hydroxypteridine, give an insoluble sodium salt and in such 
cases potassium amalgam is superior to sodium amalgam). 
Reduction of some 6,7-dihydroxypteridines by this reagent is 
unusual in that elimination of the 7-hydroxy group occurs, 
giving the corresponding 7,8-dihydro-6-hydroxypteridines.
Some reductions of hydroxypteridines by this reagent have 
been described in the historical outline (p.14 ).
Sodium dithionite was chosen as an example of the type
gcomplex hydride“ because it can be used in aqueous solution
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of reducing agent which makes an addition compound with the 
substance to be reduced. This compound is usually 
hydrolysed below pH 8. This reagent is used in an alkaline 
solution and when this is made less alkaline to decompose 
the addition complex, sulphur dioxide is produced. In 
practice, this restricts the application of the method, 
because sulphite ion combines with some reduced hydroxy- 
pteridines to give sulphur-containing products (as will be 
described later).
All catalytic hydrogenations in the present work 
were carried out at room temperature and atmospheric 
pressure. Because of the poor solubility of polyhydroxy- 
pteridines in alcohol only the monohydroxypteridines were 
available for the reduction over Raney-nickel which is 
deactivated if used in alcohol more dilute than 8 5 The 
reduction over palladium catalyst in O.lN-sodium (or 
potassium) hydroxide solution was employed for all hydroxy- 
pteridines, and in a number of cases platinum catalyst was 
also used. Because catalytic hydrogenation may be 
followed quantitatively, it can give information on the 
facility and the extent to which a substance is being 
reduced.
Biochemical and electrolytic reductions were not 
investigated in the present work.
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Table 3.
pK values of hydroxypteridines.ci
Hydroxypteridines
■
Reference
basic acidic
2-Hydroxypteridine 2 11.13 1
4-IIydroxypt eri dine -0.17 7.39 1, 2
6-Hydroxypteridine 3.67 6.7 3
7-Hydroxypteridine -2.0, 1.2 6.41 3
2,4-Dihydroxypt eridine 1.0 7.91 1
2,6-Dihydroxypteridine 2.7 6.7* 4
2,7-Dihydroxypt eridine 5.83, 10.07 4
4,6-Dihydroxypteridine .6.08, 9.73 5
4,7-Dihydroxypteridine 6.08, 9.62 5
6,7-Dihydroxypteridine 6.9, 10 3
2,4,6-Trihydroxypteridine 5.73, 9.41 ■ 4
2,4,7-Trihydroxypteridine 3.61 4
for anhydrous species.
l) Albert, Brown and Cheeseman, 1951
2) Brown and Mason > 1956
3) Albert, Brown and Cheeseman, 1952
4) Albert, Lister and. Pedersen, 1956
5) Albert and Brown 1953
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b .  Methods A v a i l a b l e  f o r  D ia g n o s in g  t h e  P o s i t i o n s  where 
Hydrogen Atoms have  E n t e r e d  t h e  M o l e c u l e .
C h em ica l ,  p h y s i c a l ,  b i o c h e m i c a l  methods a s  w e l l  a s  
c o m b in a t io n s  o f  t h e s e  m ethods  have  been  u se d  f o r  d e t e r m i n i n g  
t h e  p o s i t i o n s  a t  which  e x t e r n a l  h y d ro g e n s  a r e  i n t r o d u c e d  
d u r i n g  r e d u c t i o n  of  h e t e r o a r o m a t i c  s u b s t a n c e s .
The two c h e m ic a l  m ethods  f o r  d e t e r m i n i n g  m o l e c u l a r  
s t r u c t u r e s  c o n s i s t  o f  t h e  s y n t h e t i c  and t h e  d e g r a d a t i v e  
a p p r o a c h e s .  The s y n t h e t i c  method g i v e s  c o n c l u s i v e  e v id e n c e  
a s  lo n g  a s  any s h i f t  o f  a  doub le  bond i s  a v o id e d  d u r i n g  t h e  
s y n t h e s i s .  Much u se  h a s  been  made, i n  t h i s  t h e s i s ,  o f  t h e  
s y n t h e t i c  m ethod ,  and t h i s  w i l l  be d i s c u s s e d  i n  3 "b ( p . 6 7  )• 
I n  t h e  d e g r a d a t i v e  method i t  i s  l i k e w i s e  i m p o r t a n t  
t h a t  n e i t h e r  t h e  o r i g i n a l  m o le cu le  n o r  t h e  r e s u l t i n g  s m a l l e r  
m o le c u l e s  a r e  a l t e r e d  by t h e  p r o c e s s .  An example of t h i s  
method i s  se en  i n  t h e  f i s s i o n  o f  doub le  bonds by o z o n o l y s i s .  
Thus,  t h e  d e c o m p o s i t i o n  o f  3 , 5 - d i e t h o x y c a r b o n y l - 2 , 6-  
d i m e t h y l - 4 - p h e n y l d i h y d r o p y r i d i n e  by o z o n o l y s i s  y i e l d e d  
p h e n y l a c e t i c  a c i d  ( 2 b - I I ) .  S in ce  bond r e a r r a n g e m e n t s  were 
u n l i k e l y ,  t h i s  s u g g e s t e d  t h e  1 , 4 - d i h y d r o  s t r u c t u r e  ( 2 b - I )  
f o r  t h i s  p y r i d i n e  (Kuss and K a r r e r ,  1 9 5 7 ) .
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G6H5
CH,
C02H
(2b-I) (2b-XI)
This method however can not be used to determine the 
structure of reduced hydroxypteridines, because the type of 
reduced hydroxypteridines with which this thesis is concerned 
have two hydrogen atoms on the relevant carbon atom* Such 
reduced pteridines are too readily oxidized to the original 
pteridines for the ozonolysis technique to be practicable.
Providing the introduced hydrogen atoms do not 
migrate from the original positions, and providing that a 
suitable reaction for removing hydrogen atoms from definite 
positions in the reduced molecule is available, a tracer 
method may be used for the determining where the hydrogen 
atoms were originally introduced. For example, the 
structure of reduced diphosphopyridine nucleotide was 
established as a 1,4-dihydro configuration by using 
deuterium as a tracer (Pullman, San Pietro and Colowick, 1954). 
The principle of the method is shown below.
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CONH,
(28-111)
>
(28-IV)
/ z ( D+ H)
(2b-V)
/2(i>+h )
Me Me
(2b-VT) a, b.
The details are as follows:
Diphosphopyridine nucleotide (DPN) (2b-IIl), when reduced in 
heavy water with sodium dithionite, took up one atom of 
deuterium to form a "dihydro"-compound (2b-IV?). This was 
reoxidized to DPN (2b-V) which retained half an atom of 
deuterium per mole of DPN. The deuterated DPN (2b-V) was 
hydrolysed to a nicotinamide and then methylated to 
N(i)-methylnicotinamide (2b-V, R = CH^). The nicotamide was 
then oxidized with alkaline ferricyanide to a mixture of the 
corresponding 2-, and 6-, pyridones (2b-VIa and 2b-VTb).
By examining the deuterium content of (2b“V, R =
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(2 b - V I a )  and (2b-VTb) ,  t h e  p o s i t i o n  of  t h e  i n t r o d u c e d  
d e u te r iu m  c o u ld  he e s t a b l i s h e d  a s  f o l l o w s .  I f  one of  t h e  
f i n a l  p r o d u c t s  (2 b -V Ia )  c o n t a i n e d  ( t h e  e q u i v a l e n t  o f )  h a l f  
an  atom of d e u te r iu m  and t h e  o t h e r  c o n t a i n e d  none ,  t h e  
f i r s t  d ih y d r o  compound would have  t o  be t h e  1 , 6 - d i h y d r o  
d e r i v a t i v e  o f  DPN. C o n v e r s e l y ,  i f  (2b -V Ib)  c o n t a i n e d  h a l f  
an atom o f  d e u te r iu m  and (2 b -V Ia )  c o n t a i n e d  n o n e ,  t h e  f i r s t  
r e d u c t i o n  p r o d u c t  would have  t o  be a  1 , 2 - d i h y d r o  s t r u c t u r e .  
I f  (2 b -V Ia )  and (2 b -V Ib )  b o t h  c o n t a i n e d  h a l f  an atom o f  
d e u t e r iu m ,  t h e  f i r s t  d ih y d r o  compound would have  to  be a  
1 , 4 - d i h y d r o  d e r i v a t i v e  of  DPN. F i n a l l y  i f  DPN was re d u c e d  
t o  a  1 , 2 -  and a  1 , 6 - d i h y d r o  compound i n  e q u a l  amount,  t h e n  
b o t h  (2 b -V Ia )  and (2 b -V Ib )  would have  t h e  same d e u te r iu m  
c o n t e n t .  However, i n  t h i s  c a se  t h e  d e u te r iu m  c o n te n t  o f  
each  compound would be r e d u c e d  t o  h a l f  o f  t h a t  o f  (2b-V) 
a t  t h e  s t a g e  of  f e r r i c y a n i d e  o x i d a t i o n .  The s t r u c t u r e  o f  
t h e  r e d u c e d  d i p h o s p h o p y r i d in e  n u c l e o t i d e  was i n  f a c t  
c o n f i rm ed  as  t h e  1 , 4 - d i h y d r o  d e r i v a t i v e ,  f rom t h e  d e u te r iu m  
c o n t e n t s  o f  (2 b -V ) ,  (2 b -V Ia )  and ( 2 b - V I b ) .  T h is  method can 
t h e o r e t i c a l l y  be u s e d  t o  d i s t i n g u i s h  t h e  3 , 4 - d i h y d r o - 2 -  
h y d r o x y p t e r i d i n e  f rom  o t h e r  p o s s i b l e  d i h y d r o - 2 -  
h y d r o x y p t e r i d i n e s  i f  t h e  f o l l o w i n g  r e a c t i o n s  c o u ld  be done 
i n  p r a c t i c e .
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(2 b - IX ) (2To-X)
The r e d u c t i o n  of  (2 'b -V I l )  t o  a d ih y d r o  d e r i v a t i v e  ( a s  2 b - V I I I )  
i s  d e s c r i b e d  i n  t h e  p r e s e n t  work, and t h e  o x i d a t i o n  of
( 2 b - I X ) ---- >(2b-X) ( n o n - d e u t e r a t e d )  was d e s c r i b e d  by Brown
and Mason ( 1 9 5 6 ) .  U n f o r t u n a t e l y ,  a  t r i a l  e x p e r im e n t  showed 
t h a t  o x i d a t i o n  of  t h e  d i h y d r o - 2 - h y d r o x y p t e r i d i n e  ( 2 b - V I I l )  t o  
2 - h y d r o x y p t e r i d i n e  c o u ld  no t  be done s a t i s f a c t o r i l y ,  even 
w i t h  c o l d  d i l u t e  p o t a s s i u m  p e r m a n g a n a te . T h e r e f o r e ,  t h i s  
method c o u ld  n o t  be u se d  f o r  d e t e r m i n i n g  t h e  s t r u c t u r e  of  
x , y - d i h y d r o - 2 - h y d r o x y p t e r i d i n e .
I f  a  new a sy m m etr ic  c e n t r e  i s  i n t r o d u c e d  by t h e  
r e d u c t i o n  of  a  m o le c u le  a t  a  c e r t a i n  p o s i t i o n ,  i t  i s  p o s s i b l e  
t o  l i m i t  t h e  p o s s i b l e  s t r u c t u r e s  o f  t h e  p r o d u c t .  Fo r  example ,  
d i h y d r o f o l i c  a c i d  had t h r e e  p o s s i b l e  s t r u c t u r e s ,  ( 2 b - X l ) ,
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(2b-XIl) and (2b-XIIl). Structure (2b-XIIl) has an 
asymetric centre. The two dihydrofolio acids which were 
prepared respectively by biological and chemical methods, 
showed no difference in biological activity. This means 
that the dihydrofolic acid prepared by the chemical method 
had no asymmetric centre in the molecule, and the 
possibility of the structure (2b-XIIl) was therefore 
eliminated (Osborn and Huennekens, 1958).
(2b-Xl) (2b-XII) (2b-XIII)
However, since no asymmetric centre is introduced by 
reduction of simple hydroxypteridines, the method is 
inapplicable to such cases.
Physical methods are also important tools for the 
structural investigation of reduced pteridines. The 
identity of two specimens (of a single substance) which 
have been prepared by different method can readily be 
established by comparison of their physical constants.
Also, very important fundamental information about the 
structure of the molecule can be obtained from such physical 
constants as the pKa values, ultraviolet absorption spectra,
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infrared absorption spectra and nuclear magnetic resonance 
spectra. In some cases the information obtained yields 
its meaning only after comparison with results from 
substances of known constitution. In the present work 
such standards were often lacking and had to be prepared. 
Electronic absorption is caused by a transition of electrons 
from one electronic energy level to another. The main 
factors that determine the electronic absorption are the 
electronic structure and polarizability of the molecule. 
Compounds which have a similar electronic structure have 
similar ultraviolet spectra.
HpN
0,GCH2NH H2NY " V nh COpCH-NH
H2N ' \ N ^ H 2N ^ \ Ny H2N
(2'd-XIV) (2b-XV) (2h-XVI) (2b-XVII)
Thus, there is a close similarity between the ultraviolet
absorption spectra of the neutral molecule of 4,5- 
diaminopyrimidine (2b-XIV) and of the anion of 4-amino~5- 
carboxymethylaminopyrimidine (2b-XV), and also between the 
spectra of 4,5-diaminopyrimidine as cation (2b-XVT) and 
the neutral molecule of 4-amino-5-carboxymethylamino- 
pyrimidine (2b-XVIl). These facts follow from the 
principle that the main factor which contributes to the
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u l t r a v i o l e t  a b s o r p t i o n  i s  th e  n a t u r e  of  t h e  c o n j u g a t e d  sy s te m .
I n  t h e  above exam p les ,  t h e  c a r b o n y l  g ro u p s  i n  (2b-XV) and 
(2 b -X V Il )  a r e  s e p a r a t e d  from t h e  c o n ju g a t e d  sys tem  of  t h e  
p y r i m i d i n e  r i n g  by a -CH^- g ro u p  and do n o t  c o n t r i b u t e  t o  
t h e  u l t r a v i o l e t  a b s o r p t i o n .  So, (2b-XV) h a s  t h e  same 
c o n j u g a t e d  sy s te m  a s  ( 2 b - I V ) ,  and (2b-XVII)  t h e  same 
c o n j u g a t e d  sy s te m  a s  (2b -X V I) .  No c o n c l u s i v e  e v id e n c e  on 
t h e  o r i e n t a t i o n  of  h y d ro g en  atoms i n  r e d u c e d  h y d ro x y -  
p t e r i d i n e s  c o u ld  be o b t a i n e d  f rom  i n f r a r e d  s p e c t r a ,  b e c a u se  
t h e  s p e c t r a  o f  t h e s e  compounds can  o n ly  be m easured  i n  t h e  
s o l i d  s t a t e ,  where t h e r e  i s  i n t e n s e  i n t r a - m o l e c u l a r  h y d ro g en ­
b o n d in g .  I n f r a r e d  s p e c t r a  a r e ,  however ,  o f  immense v a lu e  
i n  a s c e r t a i n i n g  t h e  i d e n t i t y  o f  two sp e c im en s .
N u c l e a r  m a g n e t i c  r e s o n a n c e  (NMR) s p e c t r a  g iv e  d i r e c t  
i n f o r m a t i o n  on t h e  o r i e n t a t i o n  of  h y drogen  atoms i n  a m o le c u l e .  
C o n c lu s iv e  e v id e n c e  f o r  t h e  l o c a t i o n  o f  hydrogen  atoms can o f t e n  
be o b t a i n e d  by t h i s  method b e c a u se  t h e  s t r u c t u r e  o f  t h e  
m o le c u le  i s  e n t i r e l y  u n a l t e r e d  d u r i n g  m easu rem en t .  Thus 
any p o s s i b i l i t y  o f  m i s u n d e r s t a n d i n g  cau se d  by an u n u s u a l  
r e a c t i o n  o r  by t h e  s h i f t  o f  a p r o t o n  i s  e x c lu d e d .  The 
s t r u c t u r e s  of  d i h y d r o - N ^ - m e t h y I n i c o t i n a m i d e  (H u t to n  and 
W esthe im er ,  1958;  Hubb, S a n d e rs  and Wang, 1958) and d i h y d r o -  
3, 5 - d i e t h o x y c a r b o n y  1 - 1 ,  2 , 6 - t r i m e t h y l p y r i d i n e  (S m i th ,  1958) 
were co n f i rm ed  r e s p e c t i v e l y  a s  1 , 4 - d i h y d r o - s t r u c t u r e s ,
(2 b -X V II I )  and (2b -X IX ) ,  (These  r e s u l t s  a r e  i n  ag reem ent
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w i t h  t h e  r e s u l t s  o b t a i n e d  b y  t h e  i s o t o p e  t r a c e r  m e t h o d ) .  
H H H H
CONH
( 2 b - X V I I l )  ( 2 b - X I X )
I t  f i r s t  s e e m e d  t h a t  t h e  NMR m e t h o d  c o u l d  b e  u s e d  f o r  t h e  
d e t e r m i n a t i o n  o f  t h e  s t r u c t u r e s  o f  x y - d i h y d r o - 2 - h y d r o x y -  
p t e r i d i n e  a n d  x y - d i h y d r o - 4 - h y d r o x y p t e r i d i n e .  I t  s o o n  
a p p e a r e d ,  h o w e v e r ,  t h a t  d i f f i c u l t y  i n  t h e  a p p l i c a t i o n  o f  
t h e  m e t h o d  t o  t h e s e  d i h y d r o p t e r i d i n e s  m i g h t  b e  e n c o u n t e r e d  
t h r o u g h  t h e  i n s o l u b i l i t y  o f  t h e s e  h y d r o x y p t e r i d i n e  c o m p o u n d s ,  
a n d  i n  f a c t  t h e  n u c l e a r  m a g n e t i c  r e s o n a n c e  m e a s u r e m e n t s ,  w hen  
m a d e ,  d i d  n o t  g i v e  s u f f i c i e n t l y  i n t e n s e  s p e c t r a  f o r  t h i s  
v e r y  r e a s o n  ( T h e s e  m e a s u r e m e n t s  w e r e  k i n d l y  c a r r i e d  o u t  a t  
t h e  I n s t i t u t e  o f  t h e  A t o m i c  P o w e r  C e n t r e  o f  J a p a n  b y  K r .
II . H a y a k a w a ) .
B i o c h e m i c a l  m e t h o d s  w e r e  n o t  u s e d  d u r i n g  t h e  p r e s e n t  
w o r k  b e c a u s e  n o  s u i t a b l e  e n z y m e s  a r e  k n o w n .
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c • likely Positions of Hydrogen Atoms in Reduced 
Hydroxypteridines.
There are many possible reduced forms of the 
pteridine ring, hut the reduction of pteridines should yield 
the more stable isomers, that is to say the final products 
will retain as much conjugation as possible. Therefore, it 
is unlikely to find a reduction product with such a structure 
as (2c-I), because of the greatly reduced conjugation (it 
should be noted that (2c-l) does not contain even one fully- 
conjugated ring).
HA
H
(20-1)
On these grounds it seems reasonable that the di- and tetra- 
hydropteridines likely to be obtained by reduction will 
be represented by the following formulae only (or a 
selection of these):
TVT
% d h nN
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(Gl) (II) ( I )
I n  t h o s e  s t r u c t u r e s  t h e  two p a i r s  o f  comp u i s ,  (] ) ind (C ) ,  
and (F)  and ( G-) e ach  have  a con-ion c a t i o n  so t h a t  i n t e r c h a n g e  
t o  t h e  more s t a b l e  fo rm  o f  each  p a i r  would i n s t a n t l y  o c c u r  on 
p r o t o n a t i o n .  Which i s  t h e  more s t a b l e  fo rm  w i l l  be d e c i d e d  by 
s u b s t i t u e n t s  i n  t h e  r i n g  (an  example w i l l  be d i s c u s s e d  l a t e r  i n  
t h e  c a se  of  x , y - d i h y d r o - 4 - h y d r o x y p t e r i d i n e , sec  p .  4 8 ) .
T h is  c o n t e n t i o n  i s  s u p p o r t e d  by t h e  f a c t  t h a t  a l l  a t t e m p t s  
t o  s y n t h e s i s e  a r e l a t e d  s u b s t a n c e ,  1 , 4 - d i h y d r o q u i n a z o l i n e  ( 2c—I I ) f 
gave 3 , 4 - d i h y d r o q u i n a z o l i n e  ) 2 c - I I I )  (D r .  W.L.F. A t
p e r s o n a l  c o m m u n ic a t io n ) .
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A / "  ■'
H
( 2 c - I I ) ( 2 C - I I I )
A f u r t h e r  e x c l u s i o n  of some of  t h e  r e m a in i n g  e i g h t  r e d u c e d  
s t r u c t u r e s  (A ,0 ,D ,3 ,F ,G- ,H  and I )  can  he made on t h e  
f o 1lo w in g  g r o u n d s .
P r e v i o u s  work had i n d i c a t e d  t h a t  h y d r o x y p t e r i d i n e s  
h a v in g  a hydroxy  g ro u p  i n  t h e  6-  and 7 - p o s i t i o n  were a lw ays  
r e d u c e d  i n  t h e  p y r a z i n e  r i n g  (no e x c e p t i o n s  were found  t o  
t h i s  r u l e  i n  t h e  p r e s e n t  w o r k ) .  Hence,  2 -h y d r o x y - ,  and 
4—h y d ro x y —p t e r i d i n e  a r e  t h e  o n ly  h y d r o x y p t e r i d i n e s  l i k e l y  to  
g i v e  r e s p e c t i v e l y  a 3 , 4 - d i h y d r o - ,  and 1 , 2 - d i h y d r o - s t r u c t u r e  
on r e d u c t i o n .  I t  h a s  a l s o  b een  i n d i c a t e d  t h a t  t h e  o n ly  
examples  of  t h e  e l i m i n a t i o n  of  a  h y d ro x y  g ro u p  from  t h e  
p y r a  i n e  r i n g  d u r i n g  r e d u c t i o n  a r e  l o s s e s  o f  a 7 - h y d r o x y -  
g ro u p  from 6 , 7 - d i h y d r o x y p t e r i d i n e s  when sodium amalgam i s  
u s e d .  I n  such  c a s e s ,  7 , 8 - d i h y d r o - 6 - h y d r o x y p t e r i d i n e s  were 
o b t a i n e d  ( s e e  p .  1 4 ) .  No e l i m i n a t i o n  of a  h y d ro x y -  
g ro u p  from t h e  p y r i m i d i n e  r i n g  h a s  been  r e c o r d e d ,  and no 
1 , 2 , 3 , 4 - t e t r a h y d r o p t e r i d i n e s  have  e v e r  been  o b t a i n e d  by 
r e d u c t i o n .
most l i k e l y  t o  be o b t a i n e d  by r e d u c t i o n  of  s im p le  h y d ro x y ­
p t  e r i  d i n e s  .
A ,0 ,D ,k ,P ,G-  and H a r e  t h e r e f o r e  t h e  s t r u c t u r e s
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d ,  Method A v a i l a b l e  f o r  S y n th e s e s  o f  H ydrogena ted  
H y d r o x y p t e r i d i n e s »
B e fo re  t h e  p r e s e n t  work o n ly  7 , 8 - d i h y d r o -  and
5 . 6 . 7 . 8 -  t e t r a h y d r o - p t e r i d i n e s  have been  made by s y n t h e s i s .
The s y n t h e t i c  r o u t e  f rom c h l o r o n i t r o p y r i m i d i n e s  t o
7 . 8 -  d i h y d r o p t e r i d i n e s  h a s  been  w e l l  d e v e lo p e d  by Boon,
Ramage and t h e i r  c o l l a b o r a t o r s  and by P o lo n o v s k i  and 
c o l l a b o r a t o r s  ( s e e  p . 6  ) .  U n f o r t u n a t e l y ,  t h i s  method i s
s u i t a b l e  o n ly  f o r  p r e p a r i n g  t h o s e  7 , 8 - d i h y d r o p t e r i d i n e s  
which  have  an a l k y l - ,  o r  h y d ro x y - g r o u p  i n  t h e  6 - p o s i t i o n .
I n  t h e  p r e s e n t  work, t h e  s y n t h e s e s  o f  7 , 8 - d i h y d r o p t e r i d i n e s  
h a v in g  no s u b s t i t u e n t  i n  t h e  6 - p o s i t i o n  was d e s i r e d ,  and 
f o r  t h i s  p u r p o s e  c o n s i d e r a b l e  m o d i f i c a t i o n  o f  t h e  above 
method was n e c e s s a r y .  The o t h e r  s y n t h e t i c  method f o r
7 . 8 -  d i h y d r o p t e r i d i n e s  c o n s i s t s  o f  a  c o n d e n s a t i o n  o f  
4 - a l k y l a m i n o -5 - a jn in o p y r im id i n e s  ( 2 d - I )  w i t h  b e n z o in  
( F o r r e s t ,  H u l l ,  Rodda and Todd, 1951; F i d l e r  and Wood, 
1 9 5 7 ) .  But a l l  h y d r o p t e r i d i n e s  ( 2 d - I l )  which  were 
p r e p a r e d  by t h i s  method had  a l k y l  ( o r  a r y l )  g roups  i n  6 - ,  
7 - ,  and 8 - p o s i t i o n s .
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( 2 d - I I )( 2 d - I )
H,;  ; Rr  = a l k y l  ( o r  a r y l )  g ro u p
The e s s e n t i a l  p r o c e s s  o f  t h i s  method c o n s i s t s  o f  an 
o r i e n t a t i o n  of  t h e  in co m in g  d o u b le  1011!  t o  t h e  5 , 6 -  
p o s i t i o n  by an a l k y l  g ro u p  a t t a c h e d  t o  t h e  4-amino g roup  
o f  t h e  p y r i m i d i n e  ( 2 d - I )  r i n g .  T h e r e f o r e ,  no m o d i f i c a t i o n  
o f  t h i s  method t o  p r e p a r e  u n s u b s t i t u t e d  d i h y d r o p t e r i d i n e s  
i s  p o s s i b l e .
5 , 6 , 7 , 8 - T e t r a h y d r o p t e r i d i n e s  have been  prex^ared by 
two ways.  The f i r s t  method i s  a r e d u c t i o n  of  7 , 8 -  
d i h y d r o p t e r i d i n e s  ( s e e  p . l l )  and t h e  second  one i s  an 
unambiguous s y n t h e s i s  ( s e e  , l l ) .  These  a r e  g e n e r a l
methods and a r e  a p p l i c a b l e  f o r  t h e  p r e s e n t  p u rp o se  a f t e r  
some m o d i f i c a t i o n .
No g e n e r a l  method h a s  been  d e v e lo p e d  f o r  t h e  
s y n t h e s e s  o f  1 , 2 - ,  3 , 4 - ,  5 , 6 - ,  and 5 , 8 - d i h y d r o p t e r i d i n e s .  
However, f o r  t h e  p r e s e n t  work, some s y n t h e s e s  of t h e s e  r i n g  
sy s tem s  were d e s i r e d ,  and new m ethods had  t o  be t h o u g h t  o u t .
40
A method for the preparation of 7-amino-5,6- 
dihydro-1,3-dimethy1-2,4-dioxopteridine (2d-V) "by 
cyanomethylation of the corresponding 4,5-diaminopyrimidine 
(2d-IV) (Blicke and Godt, 1954), is an isolated instance 
of a method which is not general.
0 0 tr 0li i j iH„N CH, CNCH0NH CH, H /  \  OH,2 ^ R/ 3 y  xv/  3 ,_y  Yf 3
_  >  >
H A » / " 0 H2N'A \ NX  H2N ^ Y . rX \ N/
CH
1 !CH^ 0H3
(2d-III) (2d-IV) (2d-V)V)
41
SECTION 3
RESULTS AND DISCUSSIONS
a. Reduction
In the rjresent study of reduction of hydroxy- 
pteridines, there are four variables:
(i) the positions of the hydroxy groups attached to the 
pteridine ring, (ii) the presence of groups other than 
hydroxy, (iii) the ionic species of the pteridine, and (iv) 
the reducing agent.
In practice it was found that the position of the 
hydroxy group was the chief controlling influence on the 
position of the entering hydrogen atoms, 
i ) Position of the hydroxy group.
2-Hydroxypteridine was reduced in alkaline solution 
with j)Otassium borohydride to a small amount of a tetrahydro- 
2-hydroxypteridine and a fairly good yield of a dihydro-2- 
hydroxypteridine. Hydrogenation in alkaline solution over 
Adams' platinum oxide, palladium on carbon, or Raney-nickel 
catalyst, gave the same tv/o products as above. On the other 
hand, hydrogenation over Adams' catalyst in neutral solution 
led to the absorption of four moles of hydrogen, indicating 
that a complete hydrogenation (or hydrogenolysis) of the 
pteridine ring had occurred.
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Sodium dithionite reduced 2-hydroxypteridine to the 
same x,y-dihydro-2-hydroxypteridine and a highly insoluble 
product, presumably a polymerized compound. Sodium amalgam 
reduced 2-hydroxypteridine to an unstable compound which 
rapidly changed to a resin in air.
The tetrahydro-2-hydroxypteridine was shown to be 
5,6,7,8-tetrahydro-2-hydroxypteridine by comparison of its 
ultraviolet absorption and Rf values with an authentic sample 
prepared by synthesis (see p. 71)
The reduction product 
of 2-hydroxypteridine
5,6,7,8-tetrahydro-2- 
hydroxypteridine 
obtained by synthesis
Rf. NI-IaC1 0.74 23/3 G 0.74 2B/3G
Bu/.Ac 0.22 2/3 GB 0.22 2/3 GB
UV-absorptior 
A.max (mp.)
.
pH 7 230, 305 232, 306
1.0 327 327
Although the structure of the x,y-dihydro-2-hydroxy- 
pteridine is still not beyond doubt, it seems likely from the 
following evidence to be 3,4-dihydro-2-hydroxypteridine.
x,y-Dihydro-2-hydroxypteridine is not identical with 
7 ,8-dihydro-2-hydroxypteridine which was obtained by 
synthesis (see p. 70). Also, it is spectroscopically and 
chromatographically different from synthetic M5,6-dihydro-2-
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hydroxypteridine", (although an analytically pure sample of 
this substance was not obtained) (see 3b and 3d). The 
remaining probable structures for this compound are 3,4- 
dihydro-2-hydroxypteridine (3a-I) and 5,8-dihydro-2- 
hydroxypteridine (3a-II).
Dihydro-2-hydroxypteridines
x,y-dihydro- 7,8-dihydro- " 5,6-dihydro-"
Rf.(NH.C1) 0.69 2B/3V 0.61 2/3B 0.76 2B/3SB
(Bu/Ac) 0.50 2B/3V 0.32 2/3Y
pKa basic 0 3.50 + 0.02 0.4
acidic 13
UV-spectra
(\max mp) *
0 248, 317 223, 298 296 (pH 7)
+ 254, 337 229, 312 282 (pH 0)
- 281, 343 224, 308 (pH 12) 298 (pH 12)
H H HyVK. H AM. .
(3a-I) (3a-Il)
Attempts to synthesize (3a-l) were unsuccessful 
(see p. 75), and no synthetic route to (3a-Il) could be
* o: neutral molecule + : cation, : anion.
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f o u n d .
I n f r a r e d  s p e c t r a ,  and t r a c e r  methods c o u ld  n o t  he 
u s e d  f o r  r e a s o n s  d e s c r i b e d  e a r l i e r  ( s e e  2b ) .  N u c le a r  
m a g n e t i c  r e s o n a n c e  s p e c t r a  were lo o k ed  f o r  (by k i n d n e s s  o f  
Mr. N. Hayakawa),  b u t  t h e  i n s o l u b i l i t y  o f  t h e  s u b s t a n c e  
p r e v e n t e d  s t r o n g  enough s i g n a l s  b e in g  o b t a i n e d .
The f i r s t  e v id e n c e  i n  f a v o u r  of  th e  3 , 4 - d i h y d r o -  
s t r u c t u r e  was o b t a i n e d ,  however ,  from s t u d y i n g  t h e  r e d u c t i o n  
o f  t h e  x , y - d i h y d r o - 2 - h y d r o x y p t e r i d i n e  and 2 - h y d r o x y p t e r i d i n e .
x , y - D i h y d r o - 2 - h y d r o x y p t e r i d i n e  c o u ld  n o t  be f u r t h e r  r e d u c e d  
i n  a l k a l i n e  s o l u t i o n ;  b u t  i n  n e u t r a l  s o l u t i o n  i t  a b so rb e d  
hydrogen  ( e v e n t u a l l y  t h r e e  m o le s )  o v e r  Adams' c a t a l y s t ,  y e t  
no 5 , 6 , 7 , 8 - t e t r a h y d r o - 2 - h y d r o x y p t e r i d i n e  was d e t e c t e d  d u r in g  
any s t a g e  o f  t h e  h y d r o g e n a t i o n .  T h is  s u g g e s t s  t h a t  t h e  
3 , 4 -  i s  more l i k e l y  t h a n  t h e  5 , 8 -  o r i e n t a t i o n  f o r  t h e  
o r i g i n a l  h y d r o g e n a t i o n .
The second  p i e c e  o f  e v id e n c e  was o b t a i n e d  from t h e  
r e d u c t i o n  of  2 - h y d r o x y p t e r i d i n e . I t  h a s  been  e s t a b l i s h e d  
(Brown and Mason, 1956)  t h a t  2 - h y d r o x y p t e r i d i n e  e x i s t s  a s  
an  anhydrous  a n io n  ( 3 a - I I l ) ,  b u t  i n  n e u t r a l  s o l u t i o n  i t  
fo rm s  a more s t a b l e  h y d r a t e d  n e u t r a l  m o le c u l e .  These a u t h o r s  
a s s i g n e d  t h e  s t r u c t u r e  ( 3 a - IV )  t o  t h i s  h y d r a t e d  m o le c u le  f rom 
c o m p ar iso n  o f  i t s  u l t r a v i o l e t  sp e c t ru m  w i t h  t h a t  o f  i t s  1-  
m e t h y l - ,  and 3 - n i e t h y l - d e r i v a t i v e s .
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(3a-III)
It would be reasonable to obtain 3,4-dihydro-2-hydroxy- 
pteridine fro (3a-III), but not from (3a-IV). It will 
be recalled that the x fy-dihydro-2-hydroxypteridi le was 
the main product of the reduction of 2-hydroxypteridine 
anion (3a-I 'l) in al caline solution with potassium 
borohy rile or hy.r emanation over palladium but no such 
dihydro structure was obtained from hydrogenation of 
(3a-IV) in neutral■solution.
A few 5,8-dihydropteridines are known, the best 
established being 8-ethyl-2-ethylamino-5,8-dihydro—7- 
hydroxypteridine-6-carboxylic acid (3a-V) (Pfleiderer and 
Taylor, If60; see also Forrest, Baalen, Viscontini and
, 0). ci (3 er—V ) strong bat ho chromic
shift (54 mp) compared to its decarboxylation product, which 
is apparently a 5,6-dihydropteridine (3a-VI). Thus the 5,8-
e, s diminished conjugation, is
believed (ifleiderer and Taylor) only to be stabilized by 
special groups e.g. the hydrogen bond ring of (3a-V)#
01
1
T-T R
0 N N
H
0
I I
(3a-V) ( 3 a - V I )
x , y - D i h y d r o - 2 - h y d r o x y p t e r i d i n e  n e u t r a l  m o le c u le  showed 
o n ly  a  s m a l l  h a th o c h ro m ic  s h i f t  (10 mji) when compared t o  
t h e  h y d r a t e d  2 - h y d r o x y p t e r i d i n e  n e u t r a l  m o le c u le  ( P i g .  1, 
p #l 8 6  ) .  A s i m i l a r  sm a l l  h a th o c h ro m ic  s h i f t  ( A l b e r t ,  f rown
h y d ro x y p t  r i d i n e  n e u t r a l  m o le c u le  and h y d r a t e d  n e u t r a l  
m o le c u le  o f  6 - h y d r o x y p t e r i d i n e  ( P i g .  2, p .1 8 6  ) .  T h is  
e v id e n c e  s t r o n g l y  s u p p o r t s  t h e  3 , 4 - d i h y d r o - s t r u c t u r e  
( 3 a - l )  f o r  x , y - d i h y d r o - 2 - h y d r o x y p t e r i d i n e  ( s e e  a l s o  p .  1 1 2 ; .
The f a c t  t h a t  p y r i m i d i n e s  a r e  more d i f f i c u l t  t o  
r e d u c e  t h a n  p y r a z i n e s  s u g g e s t e d  t h a t  p t e r i d i n e s  sh o u ld  he 
r e d u c e d  p r e f e r e n t i a l l y  i n  t h e  p y r a z i n e  r i n g  ( A l b e r t ,  1952; 
T a y l o r  and Sherman, 1 9 5 9 ) ,  and no exam ples  t o  t h e  c o n t r a r y  
had been  found  p r i o r  t o  t h e  p r e s e n t  work.  However i t  i s  
r e l e v a n t  t h a t  i n  t h e  q u i n a z o l i n e  s e r i e s  t h e  p y r i m i d i n e  
r i n g  can be e a s i l y  r e d u c e d .  Por example  q u i n a z o l i n e  was
nd Oheeseman, 1952)  a l s o  e x i s t s  between
the
r e d u c e d  e a s i l y  t o  3 , 4 - d i h y d r o q u i n a z o l i n e  by h y d r o g e n a t i o n  o v e r  
Dams’ c a t a l y s t  (Ivlarr and B o g e r t , 1 9 3 5 ) ,  and 4 -  
c h l o r o g u i n a z o l i n e  gave  t h e  same 3 , 4 - d i h y d r o  gain z o l i n e  by
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catalytic hydrogenation over palladium on CaC0-> (Slderfield, 
./illiamson, G-ensler and Kremer, 1947).
All the above considerations point to 3,4-dihydro-2- 
hydroxypteridine (3a-I) as the most likely structure for 
x,y-dihydro-2-hydroxypteridine.
4-Hydroxy-oteridine was reduced with potassium borohydride to 
give a tetrahydro-4-hydroxypteridine and a dihydro-4- 
hydroxypteridine (roughly in a 1:1 ratio). Sodium amalgam 
reduction gave a product unstable to aerial oxidation and 
a small amount of the same tetrahydro-4-hydroxypteridine. 
Catalytic hydrogenation over Raney-nickel in neutral 
conditions gave only this tetrahydro-4-hydroxypteridine. On 
the other hand, hydrogenation over palladium catalyst in 
O.lN-sodium hydroxide solution absorbed SOcfo of the calculated 
hydrogen for 4H, and gave the same tetrahydro-4-hydroxy- 
pteridine along with a product unstable to aerial oxidation.
The structure of the tetrahydro-4-hydroxypteridine 
was established as 5,6,7,8-tetrahydro-4-hydroxypteridine by 
unambiguous synthesis (see p. 84).
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T e t r a h y d r o - 4 - h y d r o x y -  
p t e r i d i n e  o b t a i n e d  by 
r e d u c t i o n
5 , 6 , 7 , 8 - T e t r a h y d r o - 4 -  
h y d r o x y p t e r i d i n e  
o b t a i n e d  by s y n t h e s i s
m .p . 230° (decom p.) 230-238°  (decom p.)
*>Ka
b a s i c 3 .8 6  + 0 .0 2 3 .8 7  + 0 .0 2
a c i d i c 10 ,13  ± 0 .0 3 1 0 .1 0  + 0 .0 3
U V - s p e c t r a A max. (mu) l o g  £ A max. (mp) lo g  £
0 289 4 .0 1 289 4 .0 0
+ 259 4 .0 6 259 4 .0 4
— 284 4 .1 1 284 4 .0 9
The s t r u c t u r e  o f  t h e  x , y - d i h y d r o - 4 - h y d r o x y p t e r i d i n e  i s  
s t i l l  u n c e r t a i n  b e c a u se  i t  c o u ld  n o t  be s y n t h e s i s e d  ( s e e ,  3 b ) .  
However, i t  was n o t  i d e n t i c a l  w i t h  5 , 6 - d i h y d r o - 4 - h y d r o x y -  
p t e r i d i n e  which  was p r e p a r e d  s y n t h e t i c a l l y  ( s e e ,  p . 8 4 ) ,  and t h e  
1 , 2 - d i h y d r o  s t r u c t u r e  was e x c lu d e d  b e c a u se  i t  was r e d u c e d  
f u r t h e r  t o  5, (5 ,7 ,8- t e t r a h y d r o - 4 - h y d r o x y p t e r i d i n e  b o th  by sodium 
b o r o h y d r i d e ,  and by h y d r o g e n a t i o n  o v e r  R a n e y - n i c k e l  c a t a l y s t .  
T hree  p o s s i b l e  s t r u c t u r e s ,  5 , 8 - d i h y d r o - ,  7 , 8 - d i h y d r o - ,  and th e  
t r a n s p r o t o n a t e d  3 , 7 - d i h y d r o - ,  s t r u c t u r e s  ( s e e  p .  36 (Gr) there fore  
r e m a in .  The MR method was a t t e m p t e d  on t h i s  compound, b u t  
u n f o r t u n a t e l y  no s p e c t r u m  was o b t a i n e d  b e c a u se  i t  was n o t  
s u f f i c i e n t l y  s o l u b l e .  The u l t r a v i o l e t  sp e c t ru m  d id  no t  g iv e  
c o n c l u s i v e  i n f o r m a t i o n  b u t  was q u i t e  u n l i k e  t h a t  of any o t h e r  
7 , 8 - d i h y d r o p t e r i d i n e  o f  which many a r e  known (T ab le  15, p . ! 2 0 ) # 
However, t h e  I R - s p e c t r a  o f  t h i s  compound h a s  a  s t r o n g  0 = 0  
s t r e t c h i n g  a b s o r p t i o n  a t  1675cm- ^ w hich  p r e c l u d e s  t h e  p o s s i b i l i t y
o f  a  3 , 7 - d i h y d r o - s t r u c t u r e  i n  t h e  s o l i d  s t a t e  ( F i g . 38 , p .2 0 6  ).
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6-Hydroxy pteridine was reduced with potassium 
borohydride, or with sodium dithionite to a dihydro 
compound. This was identical with the product obtained by 
the reduction of 6-hydroxypteridine with sodium amalgam 
(Albert, Brown and Cheeseman, 1952 ). Hydrogenation of 
6-hydroxypteridine in O.lN-sodium hydroxide over palladium 
catalyst gave the same dihydro-6-hydroxypteridine as above. 
The structure of this compound follows from its identity 
with the 7,8-dihydro-6-hydroxypteridine (3a-VII) 
unambiguously synthesized by Boon, Jones and Ramage (1951 ) 
(see p. 7 ).
jjmax.(mp) log£*7,8-Dihydro-6-hydroxypteridine 0.1N-HC1 293 4.02
O.lN-NaOH 307 4.05
Dihydro-6-hydroxypteridine 0.01N-HC1 292 3.97
0.1N-K0H 308 4.05
Boon, Jones and Ramage, 1951 .
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7 - H y d r o x y p t e r i d i n e  was r e d u c e d  w i t h  p o t a s s i u m  b o r o h y d r id e  
t o  a  d i h y d r o - 7 - h y d r o x y p t e r i d i n e . The same compound was
o b t a i n e d  by t h e  r e d u c t i o n  o f  7 - h y d r o x y p t e r i d i n e  w i t h  c o ld  
r jo ta s s iu m  amalgam.
On t h e  o t h e r  hand ,  c a t a l y t i c  h y d r o g e n a t i o n  o v e r  
p a l l a d i u m  c a t a l y s t  i n  O . l N - p o t a s s i u m  h y d ro x id e  s o l u t i o n  gave 
t h e  same r i n g - o p e n e d  p r o d u c t  a s  t h a t  o b t a i n e d  by t h e  
r e d u c t i o n  of  t h i s  p t e r i d i n e  w i t h  sodium d i t h i o n i t e  o r  by t h e  
h y d r o g e n a t i o n  o v e r  Adams’ c a t a l y s t  i n  O . lN -sod ium  h y d ro x id e  
s o l u t i o n  ( A l b e r t ,  Brown and Cheeseman, 1952 ) .  The 
s t r u c t u r e  4 -a m in o - 5 - c a r b o x y m e th y la m in o p y r im id in e  was 
a s s i g n e d  t o  t h i s  p r o d u c t  on i t s  a n a l y t i c a l  f i g u r e s  and t h e  
f o r m a t i o n  of  t h e  m e th y l  e s t e r  w i t h  m e t h a n o l i c  hydrogen  
c h l o r i d e  ( A l b e r t ,  Brown and Cheeseman, 1952 ) .
However, t h i s  e v id e n c e  d id  no t  c o m p l e t e ly  e x c lu d e  t h e  
p o s s i b i l i t y  of  t h e  r e d u c e d  r i n g  s t r u c t u r e  (3a-XIX) f o r  t h e  
r i n g  opened p r o d u c t .  The s p e c t r o s c o p i c  d a t a  o f  t h e  p r e s e n t  
work do however e x c lu d e  any p o s s i b i l i t y  o f  t h e  s t r u c t u r e  
(3a-XIX) ( s e e  and hence  t h e  s t r u c t u r e  o f  t h e  p r o d u c t
2H
( 3 a - V I I l ) (3a-XIX)
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is confirmed as 4-amino-5-carboxymethylaminopyrimidine 
(3a-VTII). Since the reversible conversion between 
x,y-dihydro-7-hydroxypteridine and 4-amino-5-carboxymethyl- 
aminopyrimidine (3a-VIII) by heating with alkali or with 
acid has been established (Albert, Brown and Cheeseman, 
1952), the structure of the x,y-dihydro-7-hydroxypteridine 
is confirmed as 5,6-dihydro-7-hydroxypteridine (3a-XX).
H
(3a-XX)
2,4-Dihydroxypteridine absorbed two moles of hydrogen over 
Adams' catalyst in acidic solution and gave a product very 
unstable to oxidation. The same product was also obtained 
by hydrogenation over palladium or Raney-nickel in acidic 
or in alkaline solution, and by reduction with sodium 
amalgam under nitrogen. The product gave one spot on 
paper chromatography (developed and dried in a nitrogen 
atmosphere) and was reoxidized to 2,4-dihydroxypteridine 
by absorbing one mole of oxygen in alkaline solution (see
*In the reoxidation mixture a small amount of 2,4,6-
trihydroxypteridine was detected by paper chromatography,
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F i g ,  3 ) .  Thus t h i s  compound i s  a t e t r a h y d r o - 2 , 4 -  
d i h y d r o x y p t e r i d i n e .
pH 13 .
pH 12.5
pH 6.0
0 50 100 150
time (min.)
Fig.3.
absorption of oxygen by tetrahydro-2,4-dihydroxypteridine
Because  o f  i t s  i n s t a b i l i t y ,  t h e  c o r r e c t  a n a l y s i s  of 
t h i s  compound was o b t a i n e d  o n ly  a f t e r  u s i n g  a l i t t l e  2 , 3 “ 
d im e r c a p t o p r o p a n o l  a s  an a n t i o x i d a n t  i n  t h e  w a t e r  u s e d  f o r  
i t s  p u r i f i c a t i o n .  A c e t i c  f o rm ic  a n h y d r id e  gave t h e  more 
s t a b l e  f o r m y l  t e t r a h y d r o  d e r i v a t i v e .  The o n ly  p o s s i b l e  
t e t r a h y d r o  s t r u c t u r e  f o r  t h i s  compound i s  5 , 6 , 7 , 8 - t e t r a h y d r o  
2 , 4 - d i h y d r o x y p t e r i d i n e , and i t s  u l t r a v i o l e t  s p e c t r a  and 
i o n i z a t i o n  c o n s t a n t  a l s o  s u p p o r t  t h i s  s t r u c t u r e .
UBRARr
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4 , 5 - D i a m i n o - 2 , 6 - T e t  r a l l y  d r o  - 2 , 4 -
d i h y d r o x y p y r i m i d i n e d i h y d r o x y p t e r i d i n e
pK ( a p p r o x i m a t e )
cl
4 . 5 5
U Y -s p e  c t  r a , c  a t i o n  A  m a x . 250 mp ( a t  pH2) 253 mp ( a t  pH3 )
B e c a u s e  b o t h  s u b s t a n c e s  a r e  q u i t e  u n s t a b l e  t o  o x i d a t i o n ,
i t  l o g  £  an d  pK v a l u e s  w e r e  n o t  o b t a i n e d ,  a
A l t h o u g h  a l l  o t h e r  known h y d r o x y p t e r i d i n e s  a r e  r e d u c e d  
s i m i l a r l y  b y  e i t h e r  p o t a s s i u m  b o r o h y d r i d e  o r  c a t a l y t i c  
h y d r o g e n a t i o n ,  2 , 4 - d i h y d r o x y p t e r i d i n e  w as  u n a f f e c t e d  by 
Xiotassium b o r o h y d r i d e  r e d u c t i o n .
S o d iu m  d i t l i i o n i t e  r e d u c e d  2 , 4 - d i h y d r o x y p t  e r i d i n e  t o  t h e  
same t e t r a h y d r o  compound  a s  w as  o b t a i n e d  b y  c a t a l y t i c  
h y d r o g e n a t i o n ,  b u t  a l s o  p r o d u c e d  a  s u l p h u r  c o n t a i n i n g  p r o d u c t .  
The  s t r u c t u r e  o f  t h e  l a t t e r  h a s  n o t  f i n a l l y  b e e n  e s t a b l i s h e d ,  
b u t  t h e  a n a l y t i c a l  f i g u r e s ,  OgH^N^NaOgS, su  ; g e s t  t h e  
f o l l o w i n g  p o s s i b l e  s t r u c t u r e s  ( o r  t h e i r  i s o m e r s ) .
. H O
OK
OH
( 3 a - X X I )
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The f o l l o w i n g  a n a lo g y  s u g g e s t s  t h a t  f o r m u la  (3a-XXI) i s  
c o r r e c t ,  i . e . t h a t  a  s u l p h o n i c  g ro u p  i s  i n t r o d u c e d  i n t o  t h e  
6 - p o s i t i o n  o f  a p t e r i d i n e  n u c l e u s .  2 - A m in o - 4 - h y d r o x y p te r id in e  
( V i s c o n t i n i  and Weilenman, 1959; B a a l e n  and F o r r e s t ,  1959) 
h a s  b e e n  r e d u c e d  t o  an  u n s t a b l e  t e t r a h y d r o  d e r i v a t i v e  which 
was e a s i l y  o x i d i z e d .  The r e o x i d a t i o n  o f  t h e  t e t r a h y d r o - 2 -  
a m i n o - 4 - h y d r o x y p t e r i d i n e  i n  t h e  p r e s e n c e  of  such  a n io n s  a s ,
OH , SO^H , o r  ON , o r  i n  ammonia l e a d s  t o  an i n t r o d u c t i o n  of  
v a r i o u s  g ro u p s  i n t o  t h e  6 - p o s i t i o n  of  t h e  r i n g  (B a a len  and 
F o r r e s t ,  1959; V i s c o n t i n i  and Weilenman, 1959; F o r r e s t ,
B a a l e n ,  V i s c o n t i n i  and P i r a u x ,  I 9 6 0 ) .
(3a-XXV) (3a-XXVl)
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Thus they obtained 2-amino-4,6-dihydroxypteridine 
(xanthopterin) (3a-XXVT, R = OH), 2,6-diamino-4-hydroxy- 
pteridine (3a-XXVI, R = NH^) and the well known 2-amino-4- 
hyi ..roxypteridine-6-carboxylic acid (3a-XXVT, R = CO^H). The 
same sort of reaction can be expected with the sulphite ion, 
and they also isolated what they believed to be (3a-XXVI,
R = SO.H). But they seem to be mistaken as to the level of 
oxidation because their analytical figures suggest the 
tetrahydro-analogue (3a-XXV .HgO, R = SO^H).
2-Amino~4-h.vdrox.yi3t eri dine-6-carboxami de 
Forrest, IBaalen, Viscontini and Tiraux.
HeIv. Ohirn. Acta, I960, 43, 1005.
OH
N J.
/ V NH,
A, C7H6H402 B , ayIi10iT4°2
Found: 40.02 H, 4.69 N, 40.22
Calc. for °7H6N4°2 : G > 40.8 H, 2.9 N, 40.8
Calc. for C7IT oN4°2: °- 40.0 H, 4.8 N, 40.0
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2-Amino -  4 -hydroxy  yxt e r i  d i n e -  6 - s u l p h o n i  c a c i d
' OH
H03S
H
H
H
N
on
Found :
C a lc ,  f o r  0gH5N504S.H20 : 
C a lc ,  f o r  C6HgN50 4S.H20 :
y v 5
H
D . C6H9N5°4S 
27 .15  H, 4 .5 4  N, 25 .8
2 7 .6  H, 2 .7  N, 26 .8
27 .05  H, 4 . 0  N, 25 .5
NIL
1 1 .4
12.3
11.65
R e g a rd in g  t h e  mechanism of  t h e  r e d u c t i o n ,  t h e  same 
a u t h o r s  s u g g e s t  t h a t  a d d i t i o n  o f  t h e  a n io n  o c c u r s  t h r o u g h  
a 5 , 8 - d i h y d r o - i n t e r m e d i a t e  (3a-XXIV), "but t h e y  o f f e r  no 
e v id e n c e  f o r  t h i s  h y p o t h e s i s .  I t  seems more l i k e l y  t h a t  
such  an a d d i t i o n  would t a k e  p l a c e  t h r o u g h  a 7 , 8 - d i h y d r o  
s t r u c t u r e ,  "because t h e  C ,N -doub le  "bond i s  more e a s i l y  
p o l a r i z e d  t h a n  i s  t h e  C ,0 - d o u b le  bond, and would l e a d  an 
a t t a c k  o f  t h e  a n io n  t o  t h e  p o s i t i v e  c a rb o n  atom. Such 
a d d i t i o n s  o f  a n io n s  t o  c a rb o n  atoms of  h e t e r o c y c l i c  compounds 
a r e  w e l l  known. F o r  exam ple ,  CN~, SO-HI , Oil o r  H^Hg 
g ro u p s  e a s i l y  a t t a c k  t h e  4 - p o s i t i o n  ox q u i n a z o l i n e _ ( ja -X X V II ) 
w i t h  t h e  f o r m a t i o n  of  a d d i t i o n  compounds (3a-X XVIIl )
(R = CN, SC^H, OH, o r  N ^ )  ( . H ig a s h i n o ,  I 9 6 0 ) .
( 3a-ZXVII)
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2 . 6- P i h y d r o x y p t e r i d i n e  and 4 , 6- P i h y d r o p t e r i d i n e  were b o th  
r e d u c e d  w i t h  p o t a s s i u m  b o r o h y d r i d e  t o  a  r e s p e c t i v e  2-  and 
4- h y d r o x y - 7 , 8- d i h y d r o - 6- h y d r o x y p t e r i d i n e s . These
s t r u c t u r e s  were c o n f i rm e d  by com par ing  w i t h  t h e  
c o r r e s p o n d i n g  a u t h e n t i c  sam p les  u n a m b ig u o u s ly  s y n t h e s i z e d  
by t h e  method of  Boon and Ramage ( s e e  p .  8 ; 94 ) .
P i h y d r o - 2 , 6- d i h y d r o x y -  
p t e r i d i n e  o b t a i n e d  by 
r e d u c t i o n
7 , 8- D i h y d r o - 2 , 6-  
d i h y d r o p t e r i d i n e  
o b t a i n e d  by s y n t h e s i s
R f .  (fJH.Ol) 0 .5 2  2B/3V 0 .5 2  2E / 3V
( B u / A c ) 0 .0 8  2B/3X 0 .0 8  2B/3X
pK ( b a s i c )0/ 2 . 80  + 0 .0 2 2 .82  + 0 .0 2
( a c i d i c ) 10 .23  ± 0 .0 2 10 .26  + 0 .03
U V - s p e c t r a \ m a x .  (mp) l o g  £ \ m a x . ( m u )  l o g  £
0 237, 265* 3 .9 5 ,  3 .4 6 237, 265* 3 .9 5 ,  3 .46
+ 257, 317 3 . 9 4 ,  3 .85 257, 318 3 .9 4 ,  3 .85
- 279 4 .0 1 279 4 .0 1
IR s p e c t r a see  P i g . 40,  p .2 0 7 see  P i g . 3 9 , p .2 0 7
*
S h o u ld e r
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D i h y d r o - 4 , o - d i h y c r o x y -  
p t e r i d i n e  o b t a i n e d  by 
r e d u c t i o n
7 , 8 - D i h y d r o - 4 , 6 -  
d i h y d r o x y p t e r i d i n e  
o b t a i n e d  by s y n t h e s i s
Rf(H H .Cl) 0 .4 7  2 /3 3 0 .4 7  2/3B
(B u/A c) 0 .1 5  2X/3B 0 .1 5  2X/3B
pK ( b a s i c )
£L
9 .0 7  + 0 .0 2 9 .0 7  + 0 .0 5
U V - s p e c t r a A,max.(mp.) l o g  £ A max. (mp) lo g  £
0 275, 313 3 . 8 9 ,  3 .6 9 274, 318 3 . 9 0 ,  3 .69
- 275 3 .8 0 273 3 .83
I R - s p e c t r a P i g .  42, p . 208 F i g . 41, p . 208
C a t a l y t i c  h y d r o g e n a t i o n  o v e r  p a l l a d i u m  c a t a l y s t  i n  0 .1N -  
p o t a s s i u m  h y d r o x id e  s o l u t i o n  gave t h e  same r e s u l t s  a s  
a b o v e .  A l th o u g h  p o t a s s i u m  amalgam r e d u c t i o n  of  4 , 6 -  
d i h y d r o x y p t e r i d i n e  gave  7 , 8 - d i h y d r o - 4 , 6 - d i h y d r o x y p t e r i d i n e ,
2 , 6 - d i h y d r o x y p t e r i d i n e  was n o t  r e d u c e d  s u c c e s s f u l y  w i th  
p o t a s s i u m  amalgam and 7 , 8 - d i h y d r o - 2 , 6 - d i h y d r o x y p t e r i d i n e  
c o u ld  n o t  be d e t e c t e d  i n  t h e  r e a c t i o n  m ix tu re*  T h i s  i s  
due t o  t h e  i n s t a b i l i t y  of  t h e  p r o d u c t  u n d e r  these  c o n d i t i o n s .  
7 , 8 - D i h y d r o - 2 , 6 - d i h y d r o x y p t e r i d i n e  a l s o  decomposed w i t h  
p o t a s s i u m  amalgam t r e a t m e n t  and t h e  p r o d u c t  c o u ld  no t  
be d e t e c t e d  by p a p e r  c h ro m a to g r a p h y .
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2,7-Dihydroxypteridine and 4,7-dihydroxypteridine were 
reduced with potassium horohydride, or with potassium 
amalgam, to the corresponding dihydro-compounds. Catalytic 
hydrogenation over palladium catalyst in 0.lN-potassium 
hydroxide solution gave the same results.
The structure of the dihydro-4,7-dihydroxypteridine 
was shown to he 5,6-dihydro-4,7-dihydroxypteridine hy 
synthesis (see p.95 ). 5,6-Dihydro-2,7-dihydroxypteridine
was not obtained hy synthesis because of technical 
difficulties (see p.94 ), and two possible structures, 5,6- 
dihydro- and 3,4-dihydro-2,7-dihydroxypteridine, remain for 
this compound.
Dihydro-4,7-dihydroxy­
pteridine obtained by 
reduction
5,6-Dihydro-4,$- 
dihydroxypteridine 
obtained by synthesis
Kf. (NH.C1) 0.54 2D/3V* 0.54 2D/3V*
( B u / A c ) 0.08 2D/3V 0.08 2D/3V
pKa (acidic 8.45 + 0.02 8.48 + 0.05
UV-spectra ^max.(mii) log £ Xmax.(mii) log £
0 276, 328 3.78, 3.70 276, 328 3.78, 3.71
IR-spectra See Dig.44, p.209 See Fig.43, p.209
Violet fluorescence appeared after exposure to 245 m\i lamp.
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Sodium dithionite reduction of 2,7-dihydroxypteridine 
gave a sulphur containing product, C^H^N^NaO^S, whose 
structure was not investigated further. 2,7-Dihydroxypteridine 
also gave an addition compound, C^H^N^Na2 0 ,-S.H2 0 , with sodium 
hydrogen sulphit e.
$, 7-fihydroxypteridine was not reduced with potassium 
horohydride, sodium dithionite, or by hydrogenation over 
platinum or palladium catalyst. The reduction of this 
pteridine with sodium amalgam leads to elimination of the 
7-hydroxy-group, giving 7,8-dihydro-6-hydroxypteridine 
(Alb e rt, brown and Ghees email, 1952).
2.4« 6-Trihydroxypteridine was reduced with potassium 
horohydride to a dihydro-compound. The only possible 
dihydro-2,4,6-trihydroxypteridine is known to be 7,8-dihydro- 
2,4,6-trihydroxypteridine. Catalytic hydrogenation of 2,4,6- 
trihydroxypteridine over palladium on carbon gave the same 
dihydro-compound. 7,8-Dihydro-2,4,6-trihydroxypteridine has
been synthesized before (Boon and Leigh, 1952).
2.4.7- Trihydroxypteridine was not affected by reducing 
agents such as potassium horohydride, potassium amalgam, or 
by hydrogenation over palladium catalyst in 0.1IT -potassium 
hydroxide solution.
2.6.7- Trihydroxypteridine was not affected by potassium 
horohydride or by hydrogenation over palladium catalyst.
This compound behaved unusually towards potassium amalgam
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reduction, and 7,8-dihydro-2,6-dihydroxypteridine was not 
detected in the reduction mixture, presumably because
7 .8- dihydro-2,6-dihydroxypteridine is unstable to potassium 
amalgam (for the same reason as in the case of 2,6- 
dihydroxypteridine, see above).
4, 6,7-Trih.ydroxypteridine was not affected by 
potassium borohydride or by hydrogenation over palladium 
catalyst. However, this compound has been reduced by 
sodium amalgam with elimination of the 7-hydroxy-group, giving
7.8- dihydro-4,6-dihydroxypteridine (Albert and Brown, 1953).
2,4.6,7-Tetrahydroxypteridine was not affected by 
potassium borohydride or by hydrogenation over palladium 
catalyst. This compound has been reduced by sodium amalgam 
with elimination of the 7-hydroxy group to 7,8-dihydro- 
2,4,6-trihydroxypteridine (Albert, Lister and Pedersen,
1956).
ii) The presence of groups other than hydroxy group.
Some hydroxypteridines having other substituents were 
also reduced in order to examine briefly the effect of such 
substituents on the reduction.
2-Amino-4.6-dih.ydroxypteridine (xanthopterin) was 
reduced to the known 2-amino-7,8-dihydro-4,6-dihydroxy­
pteridine with potassium borohydride or sodium amalgam. This 
indicates a parallel between the effects of a 2-hydroxy- and 
a 2-amino-group on the course of reduction. This is of
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interest in connection with naturally-oocurri 1 pteridines, 
almost all of which have an amino-group in the 2-position.
2-Hydr o xg-6-methy 1 pteridine (like 2-hy droxypteridine) 
was reduced with potassium borohydride to two compounds, one 
was an x,y-dihydro-2-hydroxy-6-methylpteridine and had 
quite similar properties (ultraviolet spectra and pKa) to 
3,4-dihydro-2-hydroxypteridine. This suggests the 3,4- 
dihydro-structure for this compound. [The other product also 
had quite simil r Rf values and fluorescence to 5,6,7,8— 
t etrahydro-2-hydroxypt eridine j. The methyl group in the 
6-position has therefore no appreciable effect on the 
.‘eduction. This information is relevant to the folic acid 
series which always has a substituted methyl group in the 
6-position.
3,4-Dihydro-2-hydroxy- 
pteridine
3,4-Dihydro-2-hydroxy- 
6-methylpteridine
Rf.(NH.Cl) 0.60 2B/3V 0.58 2B/3V
(fu/ Ac) 0.50 2B/3V 0.50 2B/3V
pKa (basic) 0 0.20 + 0.06
(acidic) 12.5 13.05 + 0.02
UV-spectra Xmax.(mp) log 8 A max. (rap) log £
0 248, 3X7 3.96, 3.88 248, 321 3.83, 3.92
— 281, 343 3.94, 3.82 282, 350 4.01, 3.84
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iii) Ionic species.
A clear case of ionic species affecting reduction is 
that of the hydrogenation of 2-hydroxypteridine (see p.44 ).
This effect arises from the fact that the neutral molecule 
(unlike the anion) is hydrated across the 3,4-double bond 
(Brown and Mason, 1956), and is therefore already a 
dihydropt eridine.
iv) Reducing agent.
Close similarity was shown by the two reducing 
agents, potassium borohydride and hydrogenation over 
palladium catalyst in alkaline solution. There was 
however one exception. 2,4-Dihydroxypteridine, was 
successfully reduced over palladium catalyst but was not 
affected by potassium borohydride.
Palladium on carbon catalyst was more powerful than 
Adams' platinum oxide catalyst in alkaline solution, and 
this is seen in the rate of reduction by these two 
catalysts (see Table 4).
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Table 4.
Reduction period of hydroxypteridines in O.lN-potassium
hydroxide solution.
Catalyst
Pteridines 10>-palladium on carbon Adams' platinum oxide
a)2-Hydroxy- 20 min.
4-Hydroxy- 30 min.
6-Hydroxy- 20 min.
7-Hydroxy- ^ 40 min.
2,4-Dihydroxy- 40 min.
2,6-Dihydroxy- 10 min. 7 hr .**
2,7-Dihydroxy- 70 min. 40 hr.
4,6-Dihydroxy- 70 min.
4,7-Dihydroxy- q^ 17 hr .
2,4,6-Trihydroxy- 10 min.
a) mono-hydroxypteridine (1 in mole) in 1.5 eq. 0.1N-KCH
b) di-hydroxypteridine (l m mole) in 2 x 1.5 eq.
o) tri-hydroxypteridine (l m mole) in 3 x 1.5 eq.
were reduced over 50 mg. 10c/-palladium on carbon catalyst.
5 mg. Adams1 catalyst.4
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Sodium amalgam r e d u c e d  a l l  6 - h y d r o x y p t e r i d i n e s  t o  t h e  
c o r r e s p o n d i n g  7 , 8 - d i h y d r o - 6 - h y d r o x y p t e r i d i n e s , even  when i t  
r e q u i r e d  t h e  e l i m i n a t i o n  of  a  7 - h y d r o x y - g r o u p  a s  i n  t h e  c a s e  
o f  6 , 7 - d i h y d r o x y p t e r i d i n e s .  Two a p p a r e n t  e x c e p t i o n s  were 
n o t e d  ( t h e  r e d u c t i o n s  of  2 , 6 - d i h y d r o x y -  and 2 , 6 , 7 - t r i h y d r o x y -  
p t e r i d i n e s )  due t o  t h e  i n s t a b i l i t y  o f  th e  p r o d u c t  t o  t h i s  
r e a g e n t .
Sodium d i t h i o n i t e  x^oduced a s u l p h u r  c o n t a i n i n g  
p r o d u c t  ( s e e  e . g .  2 , 4 - d i h y d r o x y p t e r i d i n e , p . 5 3  ) i n  t h e
r e d u c t i o n  of  s e v e r a l  x ^ o ly h y d r o x y p t e r i d i n e s . 
v )  P o s i t i o n s  and numbers o f  h ydroxy  g r o u p s .
A s y s t e m a t i c  c o r r e l a t i o n  be tw een  t h e  f a c i l i t y  of 
h y d r o g e n a t i o n  and t h e  number and p o s i t i o n s  of  h ydroxy  g ro u p s  
can  be seen  i n  T ab le  4, p .  64. I t  can be s a i d  g e n e r a l l y  
t h a t  6 - h y d r o x y p t e r i d i n e s  a r e  more e a s i l y  r e d u c e d  t h a n  t h e  
7 - i s o m e r s ,  and 2 - h y d r o x y p t e r i d i n e s  a r e  more e a s i l y  re d u c e d  
t h a n  t h e  4 - i s o m e r s .  The r e s u l t s  which  v/ere o b t a i n e d  by 
r e d u c t i o n  of  h y d r o x y p t e r i d i n e s  a r e  summarized in  T ab le  5, 
p .  66.
Talile  5.
R e d u c t io n  p r o d u c t s  o f  h y d r o x y p t e r i d i n e s  by v a r i o u s  r e d u c i n g  a g e n t s .
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H y d r o g e n a t io n  ove r
r o t a s s i u m
b o r o h y d r i d e
P o ta s s iu m
amalgam
Sodium
d i t h i o n i t e Pd/C . P t  (Adams' )
Raney-
n i c k e l
2-Hydroxypt  e r i d i n e 3 , 4-DH-2 
5 , 6 ,7 ,8 - T H - 2
UI 3 , 4-DH-2 
UI
3 , 4-DH-2 
5 , 6 ,7 ,8 - T H - 2
3 , 4-DH-2 
5 , 6 ,7 ,8 -T H -2
3 , 4-DH-2 
5 , 6 ,7 ,8 -T H -2
4 - H y d r o x y p t e r i d i n e x ,y-DH-4 
5 , 6 ,7 ,8 -T H -4
UI
5 , 6 ,7 ,8 - T H - 4
UI
5 , 6 , 7 , 8 - T H - 4
5 ,6 ,7 ,8 -T K -4
6 - H y d r o x y p t e r i d i n e 7 ,8-DH-6 7 »8-DH-6 (1 ) 7 ,8-DH-6 7,8-DH-6
7-H ydroxyp t  e r i d i n e 5 , 6-DH-7 5 , 6-DH-7 RO (1 ) RO
2 , 4 - D i h y d r o x y p t e r i d i n e No 5 , 6 , 7 , 8-TH-4 5 , 6 , 7 , 8 - T H - 4s
5 , 6 , 7 ,8-TH-4 5 , 6 ,7 ,8 - T H - 4
2 , 6 -D ih y d ro x y p t  e r i d i n e 7 , 8 - D H - 2 , 6 D 7 , 8-DH-2,6
2 , 7 -D ih y d ro x y p t  e r i d i n e x ,y -D H -2 ,7 x ,y -D H -2 ,7 s x , y-DH-2 ,7
4 , 6 - D i h y d r o x y p t e r i d i n e 7 , 8-DH-4,6 7 , 8-DH-4,6  (2 ) 5 , 8 -D E -4 ,6
4 , 7 -D ih y d ro x y p t  e r i d i n e 5 , 6-DH-4,7 5 ,6 -D H -4 ,7 5 ,6 -D H -4 ,7
6 , 7 - D ih y d ro x y p t  e r i d i n e No 7 , 8 -D E -6 (1 ) No No No
2 , 4 , 6 - T r i h y d r o x y p t  e r i d i n e 7 , 8 - D H - 2 , 4 , 6 7 , 8 -D H -2 ,4 , 6 7 , 8 - D H - 2 , 4 , 6
2 , 4 , 7 - T r i h y d r o x y p t e r i d i n e No No No No
2 , 6 , 7 - f r i h y d r o x y p t e r i d i n e No D No
4 , 6 , 7 - T r i h y d r o x y p t  e r i d i n e No 7 ,8 - D H - 4 , 6 (2 ) No
2 , 4 , 6 , 7 - T r i h y d r o x y p t e r i d i n e No 7 , 8 - D H - 2 , 4 , 6—(3)
(1 )  A l b e r t ,  Brown and Oheeseman, 1952 l e y  t o  Symbols
(2 )  A l b e r t  and Brown , 1953 x ,y-DH-4  = x , y - D i h y d r o - 4 - h y d r o x y p t e r i d i n e
(3 )  A l b e r t ,  l i s t e r  and P e d e r s e n ,  1956 5 ,6 , 7 , 8 - T H - 2  = 5 , 6 , 7 , 8 - T e t r a h y d r o - 2 - h y d r o x y p t e r i d i n e
UI U n i d e n t i f i e d  u n s t a b l e  p r o d u c t
D D eco m p o s i t io n  
No No r e d u c t i o n  
RO Ring opened p r o d u c t
S u lp h u r  c o n t a i n i n g  p r o d u c t .
67
b .  S y n t h e s e s .
S y n t h e s e s  D i r e c t e d  Towards H y d ro g en a ted  2-IIydroxypt  e r i d i n e s .
7 , S - ) i h y d r o - 2 - h y d r Q x y p t e r i d i n e  (and i t s  6 - m e t h y l - d e r i v a t i v e ) . 
The s y n t h e s e s  of  7 , 8 - d i h y d r o p t e r i d i n e s  have  been  w e l l  developed ,  
and 7 , . : - d i h y d r o - 2 - h y d r o x y - 4 , 6 - d i m e t h y l p t e r i d i n e  h a s  been  
p r e p a r e d  ( L i s t e r  and Ramage, 1953) ( s e e  p . 1 0 ) .  I n  t h e  
p r e s e n t  work ,  7 , 8 - d i h y d r o - 2 - h y d r o x y - 6 - m e t h y l p t e r i d i n e  was 
s y n t h e s i z e d  by a  s i m i l a r  m ethod ,  i n  o r d e r  t o  compare t h e  
r e d u c t i o n  b e h a v i o u r  of  2 - h y d r o x y p t e r i d i n e  and i t s  6 -m e th y l  
d e r i v a t i v e .  2~:T y d ro x y -6 -m e th y lp te r i d i n e  was p r e p a r e d  from 
t h e  7 , 3 - d i h y d r o - d e r i v a t i v e  by o x i d a t i o n  w i t h  p o t a s s i u m  
p e rm a n g a n a te ,  and r e d u c e d  w i t h  p o t a s s i u m  b o r o h y d r i d e  ( s e e  
p . 6 2 ) .  The 6 - m e t h y l - i s o m e r s ,  2 - h y d r o x y - 6 - m e t h y l p t e r i d i n e ,
7 , ' - d i h y d r o - 2 - h y d r o x y - 6 - m e t h y l p t e r i d i n e  and x , y - d i h y d r o - 2 -  
h y d r o x y - 6 - m e t h y l p t e r i d i n e , had q u i t e  s i m i l a r  p r o p e r t i e s ,  
pka  v a l u e s ,  u l t r a v i o l e t  s j ^ e c t r a  and Rf .  v a l u e s  t o  th e  
c o r r e s p o n d i n g  2 - h y d r o x y p t e r i d i n e s  ( s e e  T a b le  6, p .  104 and 
T a b le  15, p .  1 2 0 ) .  A l th o u g h  no 7 , 8 - d i h y d r o p t e r i d i n e s  
u n s u b s t i t u t e d  i n  t h e  6 - p o s i t i o n  have  been  p r e p a r e d ,  i t  was 
hop>ed t h a t  7 , 8 - d i h y d r o x y - 2 - h y d r o x y p t e r i d i n e  c o u ld  be 
s y n t h e s i z e d  by u s i n g  amino a c e t a l  i n  p l a c e  o f  amino a c e t o n e  
i n  t h e  L is t e r - R a m a g e  s y n t h e s i s  ( s e e  p .  6, 1 0 ) .  A l th o u g h  some 
d i f f i c u l t i e s  were e n c o u n t e r e d  ( e . g .  t h e  t e n d e n c y  o f  
a m i n o a c e t a ld e h y d e s  t o  d i m e r i z e  t o  p y r a z i n e s ) ,  t h i s  new 
s y n t h e t i c  method was s u c c e s s f u l .
.  i l
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°*VX»
üj 10 k / 1>HGH0N H ^ \ tt^ x C1 
EtO *
(3D-II)
OH
V
OHC-GH
Condensation of 2,4-dichloro-5-nitropyrimidine (3b-I) with 
amino acetal has been attempted "before (Boon and Jones, 1950), 
but no product was isolated. In the present work, all 
attempts to isolate (3b-II) from its mixture with the 2,4- 
disubstituted analogues were unsuccessful. Accordingly, 
the crude condensation product was hydrolyzed directly with
( 313-1)
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sodium h y d r o x id e  t o  g i v e  4 - ß - d i e t h o x y e t h y l a m i n o - 2 - h y d r o x y -  
5 - n i t r o p y r i m i d i n e  ( 3 b - I I I ) .  At t h i s  s t a g e  t h e  d i s u b s t i t u t e d  
d e r i v a t i v e , 2 , 4 - b i s - ß - d i e t h o x y e t h y l a m i n o - 5 - n i t r o p y r i m i d i n e , 
was e a s i l y  removed b e c a u se  of  i t s  i n s o l u b i l i t y  i n  N-sodium 
h y d r o x i d e  s o l u t i o n .  H y d r o g e n a t io n  o f  ( 3 b - I I l )  gave t h e  
5-amino d e r i v a t i v e  (3b~IV ) .  A t tem p ted  b r i e f  h y d r o l y s i s  of  
t h e  a c e t a l  g roup  of  (3 b - IV )  w i t h  0 . I N - h y d r o c h l o r i c  a c i d  gave 
a p r o d u c t  showing t h r e e  s p o t s  on p a p e r  ch ro m a to g ra p h y .
V a r io u s  c o n d i t i o n s  of  pH and r e a c t i o n  t im e  were examined 
t o  s e p a r a t e  t h r e e  p r o d u c t s .  The f i r s t  s u b s t a n c e  c o r r e s p o n d e d  
t o  ( 3 b - V I I ) , and t h e  second  s u b s t a n c e  was l a t e r  c o n f i rm ed  
a s  7 , 8 - d i h y d r o - 2 - h y d r o x y p t e r i d i n e  (3 b -V I)  by t h e  s y n t h e s i s  
d e s c r i b e d  below, bu t  an a n a l y t i c a l l y  p u re  sample  co u ld  n o t  
be i s o l a t e d  from t h i s  r e a c t i o n .  The t h i r d  s u b s t a n c e  was 
t h e  a c i d  d e c o m p o s i t i o n  p r o d u c t  o f  7 , 8 - d i h y d r o - 2 - h y d r o x y -  
p t e r i d i n e .
( 3 b - V I l )
A s u c c e s s f u l  r o u t e  was found  i n  which  ( 3 b - I I l )  was
h y d r o l y s e d  by a c i d  b e f o r e  t h e  h y d ro g e n s / t io n .  Thus,  2- 
h y d r o x y - 4 - f o r m y l m e t h y l a m i n o - 5 - n i t r o p y r i m i d i n e  ( 3b-V) was 
o b t a i n e d  from ( 3 b - I I l )  by r e f l u x i n g  w i t h  N - h y d r o c h l o r i c  a c i d .
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The aldehyde was quite unstable in alkali, and it was
found necessary to stop the neutralization of the above
reaction mixture at pH 4; neutralization even to pH 7
caused partial decomposition of the product. The aldehyde
(3b-V) was successfully hydrogenated over Raney-nickel in
methanol (but not in ethanol) to give 7,8-dihydro-2-
hydroxypteridine (3b-VI). This 7,8-dihydro-2-hydroxy-
a
pteridine (see xD* 43) had high basic pKa (see Table 9, p.107) 
compared to 2-hydroxypteridine.
5« 6«7«8-Tetrahydro-2-hydroxypteridine. One 
attempt to synthesize 5,6,7,8-tetrahydro-2-hydroxypteridine 
through 8-benzyl-5,6,7,8-tetrahydro-2-hydroxypteridine has 
been reported, but it was unsuccessful because of difficulty 
in the debenzylation (Brook and Kamage, 1955) (see, p. 12).
On the other hand it has been known that 7,8-dihydro- 
pteridines can be hydrogenated to 5,6,7,8-tetrahydro- 
pteridines (Lister and Hamage, 1953). (This method is a little 
ambiguous because of the possible hydrogen migration by the 
metal catalyst). 5,8,7,8-Tetrahydro-2-hydroxypteridine was 
synthesized from the above 7,8-dihydro-2-hydroxypteridine by 
hydrogenation over Adams' catalyst in neutral aqueous solution 
(hydrogenation in water gave better results than in acidic 
conditions). The structure was confirmed as 5,6,7,8- 
tetrahydro-2-hydroxypteridine by comparison of its pKa values, 
and ultraviolet spectra with those of 4,5-diamino-2-
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hydroxypyrimidine (see Talle 8 , p. 10$,and Tablel3, £118 ).
The structure of the minor product obtained by 
reduction of 2-hydroxypteridine with potassium borohydride, 
and by hydrogenation over palladium, Raney-nickel, or Adams’ 
catalyst in alkaline solution, was shown to be 5,6,7,8- 
tetrahydro-2-hydroxypteridine by comparison of its ultra­
violet spectra and Rf values with the above (see pa42).
5.6-lih.ydro-2-hydrox.ypteridine. No attempts to prepare 5,6- 
dihydropteridines had previously been made. The two 
following routes are possibilities for the preparation 
of 5,6-dihydropteridines (3b-X):
a) by cyclization of 4,5-diaminopyrimidines substituted on 
the 4-amino group (e.g. 3b-VIII)
b) by cyclization of 4,5-diaminopyrimidines substituted on 
the 5-amino group (e.g. 3b-IX)
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(3 b - IX )
(Where R^, and Y = OH o r  H;
X = h a lo g e n ;
Z = -CHO, -COOH o r  any g r o u p s  which  can he 
changed t o  t h e s e  g r o u p s )
Method ( a )  c o u ld  n o t  he u s e d  f o r  t h e  s y n t h e s i s  of' 5 , 6-  
d i h y d r o - 2 - h y d r o x y p t e r i d i n e  b e c a u se  o f  d i f f i c u l t i e s  i n  t h e  
p r e p a r a t i o n  o f  i n t e r m e d i a t e s  o f  t h e  ty p e  ( 3 h - V I I l ) .  The 
o n l y  d i f f i c u l t y  i n  method (h )  i s  t h e  p r e p a r a t i o n  of 5-  
a l k y l a m i n o p y r i m i d i n e s .  D i r e c t  a l k y l a t i o n  l e a d s  t o  
q u a t e r n i z a t i o n .  However, two m ethods f o r  i n d i r e c t  
a l k y l a t i o n s  a r e  p o s s i b l e .  One i s  r e d u c t i o n  o f  5 -  
f o r m y la m in o p y r im id in e s  w i t h  l i t h i u m  a lum in ium  h y d r i d e  
( B a k e r ,  Schaub and J o s e p h ,  1 9 5 4 ) ,  and t h e  o t h e r  i s
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reductive alkylation (or reduction of the Schiffs hase) 
of 5-aminopyrimidines. It is known that 5-amino- 
pyrirai dines condense with benzaldehyde to give Schiff* s 
bases (Traube and Nithak, 1906; Shirakawa, 1953), but 
with aliphatic aldehydes only resinous products are 
produced (Shirakawa, 1953). The sole example of 
reductive alkylation of aminopyrimidine is the conversion 
of 5-amino-4-methylpyrimidine (3b-XI) to 5-*ethylaniino-4- 
methylpyrimidine (3b-XIl) using a palladium catalyst and 
an excess of acetaldehyde (Overberger, Kogon and Einstman, 
1954).
(3b-XI)
0H-.CH0 J,----->H^/Pd
(3b-XII)
In the present work the following route was used to prepare 
5,6-dihydro-2-hydroxypteridine (3b-XVI)
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EtO
HJtTX EtO
EtO
\ EtOCHOHO/
H2N OH (glyoxal monoacetal) 
(31-XIII)
CHOH=N
HgN- "N-
(3b-XIV)
OH
EtO
EtO
)c h c h 2n h
Hp/Hi
h2n
(3b-XV)
OH
4.5- *Biamino-2-hydroxypteridine (3b-XIII) was condensed v/ith 
glyoxal monodiethyl acetal (this was prepared from acrolein, 
Witzemann, Evans, Hass and Schroeder, 1943 b,a,c; Fischer 
and Baer, 1935), and although no product could be isolated 
paper chromatograms showed that the reaction had taken place. 
The reaction mixture was then hydrogenated over Raney-nickel 
catalyst, and 4-amino-5-ß-diethoxyethylamino-2-hydroxy- 
pyrimidine (3b-XV) was isolated. The structure of (3b-XV) 
was confirmed by its non-identity with 5-amino-4-ß- 
diethoxyethylamino-2-hydroxypyrimidine (3b-IV), prepared
by an unambiguous synthesis (see, p.58 ). The pyrimidine 
gave a yellow amorphous product on treatment with 
N-hydrochloric acid. This substance is believed to be
5.6- dihydro-2-hydroxypteridine because pure 5,6-dihydro- 
4-hydroxypteridine was made from 4,5-diamino-6-hydroxy-
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pteridine in the same way (see below). Although a good 
analysis could not be obtained for this compound because 
of partial decomposition during purification, paper 
chromatography indicated its essential homogeneity and 
that it was not x,y-dihydro-2-hydroxypteridine.
3 t -hi • no-l-h;;:-. vox, teridine. No att. mpt i to preps 
3,4-dihydropteridines h .ve been previously made. However, 
an example of t synthesis of a fused 3,4-dihydropyrimidine 
ring is seen in the preparation of 3,4-dihydroquinazoline 
(3b-XVIII)from the oyaminobenzylamine derivative (3b-XVTI) 
Gabriel and Jansen, 1890),
1
(3b-XVII)
H H
n r j  Oil -
(3b- Till)
The following routes were considered for the synthesis of 
3,4-dihydro-2-hyc.roxypteridine (3b-XXI):
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(3b-XIX) (3 Id-XX)
1 ClC02Et,
I UreaZ\,
I or NH2C02Et
H H
2-Amino-3~foraiylpyrazine oxime (3b-XIX) was synthesized hy 
a known method (Albert, Brown and Wood, 1956), Reduction 
of the oxime (31-XIX) to 2-amino-3“aminomethylpyrazine 
(3"b-XX) under several sets of conditions was examined 
(hydrogenation over Adams’, palladium, or Raney-nickel 
catalysts, and reduction with lithium aluminium hydride, 
sodium amalgam (under neutral conditions) and sodium 
hydrosulphite). The catalytic hydrogenation of the 
corresponding nitrile was also unsuccessful.
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T h e  m o s t  p r o m i s i n g  r e s u l t  w a s  t h e  h y d r o g e n a t i o n  o v e r  A d a m s '  
c a t a l y s t  w h e r e  t h e  o x im e  a b s o r b e d  2 . 5  m o l e s  o f  h y d r o g e n  
( t h e o r e t i c a l  a m o u n t  i s  2 m o l e s )  a n d  g a v e  a  g r e e n  o i l .  
C h r o m a t o g r a p h y  s h o w e d  t h a t  t h e  p r o d u c t  h a d  o n e  m a i n  s p o t ,  
b u t  n o  s o l i d  m a t e r i a l  c o u l d  b e  i s o l a t e d  f r o m  t h e  r e a c t i o n  
m i x t u r e ,  a n d  t r e a t m e n t  o f  t h e  c r u d e  p r o d u c t  w i t h  u r e a ,  c y a n i c  
a c i d ,  e t h y l  c h l o r o f o r m a t e , o r  w i t h  u r e t h a n e  g a v e  a  c o m p l e x  
m i x t u r e  i n  w h i c h  n o  p r o d u c t  i d e n t i c a l  w i t h  t h e  x , y - d i h y d r o -  
2 - h y d r o x y p t e r i d i n e  c o u l d  b e  s e e n  w h e n  c o m p a r e d  o n  a  p a p e r  
c h r o m a t  o g r a m .
A n o t h e r  s y n t h e t i c  r o u t e  t h r o u g h  2 - a m i n o - 3 - c a r b o x y -  
p y r a z i n e  ( 3 b - X X I I ) w a s  e x a m i n e d :
COOH
L i A l H
( 3 b - X X I I ) ( 3 b - X X I I I )
V
CONH
( 3 b - X X I V )
I H B r ,
I u r e a ,
I o r  KCNO
\ ! /
(3b-xxy)
*  L I B R A R Y  %.)
( 3h-XXII) was prepared from 2,4-dihydroxypteridine (Weijlard,
Pi dil Jric son, 1945), but direct i eduction of the
acid (3b-XXXl) with aluminium amalgam, failed. /ever,
.•';h„ 1 enter (3b“X.fEIl) was easily reduced with lithium 
luminium hydride to 2-amino-3-hydroxymethylpyrazine 
(3b-'vvIV). However, the attempted replacement of the hydroxy 
;roup with bromine by heating with hydro bromic acid led only to 
decomposition. Other attempts to utilize this intermediate 
(3b-X IV), such as fusion with urea, or reaction with cyanic 
acid, gave no better results (such reactions had been successfully 
carried out in the _ inazoline field, Söderbaum and Widman,
1889; Gabriel and Stelzner, 1896).
Another approach to 3,4-dihydro-2-hydroxypteridine was 
planned, starting fro., the bed pyri ddine,
(3b-XXVI) ---> (3b-CXI). In hydrochloric acid 4,5-diamino-
2-hywrowypyrimidine (3b-XJCVI) absorbed one mole of hydrogen 
over palladium catalyst. The product, however, did not 
correspond to C^HgN.O.HCl, 4,5-diamino-dihydro-2- • 
hydroxypteridi'ne ( 3b-XX7II), but analysed as C AllpO,
These figures show that one amino group of (3b-XXVII) was 
replaced by a hydroxyl group and the compound could therefore 
not be used as an intermediate for dihydro-2-hydroxypteridine
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OH H2N^ \ n. / X°H
2H
( 3H -X X V I) ( 3 H - X X V I I )
OHO
GHO
H H
( 3 b - X X I )
S y n t h e s e s  D i r e c t e d  T o w a r d s  H y d r o g e n a t e d  4 - H y d r o x y p t e r i d i n e s  
3 , 6 , 7 « 8 - T e t r a h y d r o - 4 - h y d r o x y p t e r i d i n e . An u n a m b i g u o u s  r o u t e  
t o  5 , 6 , 7 , 8 - t e t r a h y d r o p t e r i d i n e s  h a s  b e e n  d e s c r i b e d  b y  B r o o k  
a n d  R am ag e  ( 1 9 5 5 ,  1 9 5 7 )  ( s e e  p .  1 1 ) .  I n  u s i n g  t h i s  m e t h o d  
i t  i s  e s s e n t i a l  t o  p r o t e c t  a l l  g r o u p s  ( s u c h  a s  NH« o r  OH) 
w h i c h  h a v e  h y d r o g e n  a t o m s  t a u t o m e r i z a b l e  w i t h  t h e  r i n g  
n i t r o g e n  a t o m s .  T h i s  p r o t e c t i o n ,  w h i c h  c o u l d  b e  a f f o r d e d  
b y  O - a l k y l a t i o n  ( -O M e)  o r  N - b e n z y l a t i o n  ( -N H C H ^ P h ) ,  i s  
r e q u i r e d  t o  j o r e v e n t  a l t e r n a t i v e  r i n g  c l o s u r e  t o  p y r i m i d i n o -  
i m i d a z o l e s  (R a m a g e  a n d  T r a p p e ,  1 9 5 2 ;  B r o o k  a n d  R a m a g e ,  1 9 5 5 ,  
1 9 5 7 ) .
f a i l u r e  t o  a f f o r d  s u c h  p r o t e c t i o n  t o  g r o u p s  o t h e r  
t h a n  t h o s e  f o r m i n g  t h e  p y r a z i n e  r i n g  h a s ,  i n  p r a c t i c e ,  l i m i t e d
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t h e  number of  known 5 , 6 , 7 , 8 - t e t r a h y d r o p t e r i d i n e s  t o  t h o s e  
h a v i n g  a h y d r o g e n - ,  m e t h y l - ,  o r  c h l o r o - g r o u p  i n  t h e  2 -  or  
t h e  4 - p o s i t i o n .  The s o l i t a r y  e x c e p t i o n  i s  5 , 6 , 7 , 8 — 
t  e t r a h y d r o - 2 - h y d r o x y - 4-m e th y 1 - 8 - b  e n z y I p t e r i d i n e  ( lb-XXVI) 
which  was p r e p a r e d  by h y d r o l y s i s  o f  t h e  c o r r e s p o n d i n g  2 -  
c h l o r o  d e r i v a t i v e  ( s e e  p .  1 2 ) .
I n  t h e  p r e s e n t  work, t h i s  method was a t t e m p t e d  f o r  t h e  
4- h y d r o x y - i s o m e r  b u t  found  u n s u c c e s s f u l ,  a l t h o u g h ,  a s  w i l l  
be shown l a t e r ,  t h e  d e s i r e d  s u b s t a n c e  was e v e n t u a l l y  
o b t a i n e d  by m o d i f i c a t i o n  of  t h e  r o u t e ;
01 Cl
2 2
( 3b-XXVIII) ( 3b-XXIX)
Cl
( 3b-2XII) (3h-XXXII)
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4,6-I)ichloro-5-nitropyrimidine (3b-XXVTII) was condensed with 
ß-benzylaminoethanol in chloroform to give (3b-XXIX) hut 
the product could not he isolated. The product was 
hydrogenated over Raney-nickel and 5-amino-4-(benzyl-ß- 
hydroxyethylamino)-6-chloropyrimidine hydrochloride (3b-XXX) 
was isolated. (This hydrochloride, was
isomerized when hoiled in ethanol to an unidentified compound, 
^13^16^2^4^ * which did not cyclize on treatment with 
phosphorus trichloride). The 5-aminopyrimidine hydrochloride 
(3b-XXX) was cyclised directly with phosphorus trichloride to 
8-benzyl-4-chloro-5,6,7,8-tetrahydropteridine (3b-XXXI) the 
structure of which was confirmed hy reduction with sodium in 
liquid ammonia to the known 5,6,7,8-tetrahydropteridine 
(3b-XXXIl). However, the 4-chloro group could not he replaced 
with a hydroxyl group hy such treatment as refluxing for three 
hours with (a) pH 5 buffer, (h) glacial acetic acid plus sodium 
acetate, (c) 6N-hydrochloric acid, (d) 12N-hydrochloric acid, 
(e) N-sodium hydroxide, or (f) methanolic sodium methoxide. 
Heating in trietliylene glycol at 120° with sodium hydroxide 
decomposed the material.
Because of the difficulty of replacement of the 
4-chloro group in the above tetrahydropteridine, it seems 
reasonable to introduce other types of group into the 4- 
position. It is well known, that the benzyloxy group can be 
reduced to a hydroxy group by catalytic hydrogenolysisjusing 
palladium on carbon. The following route was therefore
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attempted.
Gl
gh9ch9ohHF  ^ ^
N0HoEh ------2-----^
(1)
(3b-:aTin)
(2) '
PCI
Attempts to isolate the product from each of the steps 
(l and 2) were unsuccessful, hut (3b-XXXIIl) was finally 
isolated as the hydrochloride in low yield. Treatment of 
(3h~XXKIII) with phosphorus trichloride gave the pyrimidine 
(3h-XXXIV) instead of the desired tetrahydropteridine, and 
the method was therefore abandoned.
However, the facile hydrolysis of the 4-benzyloxy 
grour) suggested a new synthetic route in which ethyl replaced 
benzyl.
« 'J -v83
n i 
^  - L
°2N N
N
(3b-3CC/III)
OSt
TT T'T
/---- >
00HoCHoN  ^ 2
N
OSt
OgN
Cl N
(3b-XX)CV)
1:C1
^  H
H
IHgPh !H0Ph2
OSt
OgN
HOCHgCHgN
OK
JHpPh
( 311-aXXVI ) 
OH
T O T
IT'
(3TD-XXXYII) (3b-XXXVIII)
•N
II
(3b-xxnx)
4-Chloro-6-ethoxy-5-nitropyrimidine (3b-XXXV) (Boon and Jones, 
1931) was condensed with ß-henzylaminoetlip.no 1 and the 
condensation product (3b-XXXVI) was hydrogenated over Raney- 
nickel. The aminopyrimidine (3b-XRXVTI) could not he 
isolated, hut was treated with phosphorus trichloride at room 
temperature to cyclise it. Not only cyclisation hut also 
simultaneously slow hydrolysis of the 4-ethoxy group occurred. 
Paper chromatography showed that the hydrolysis was complete 
after two days at room temperature, and from the reaction 
mixture 8-henzyl-p ,6,7,8-tetrallydro-4-hydroxypteridine 
(3b-ZXXVTIl) was isolated. Debenzylation of (3h-TCGCVTII) was
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accomplished with sodium in liquid ammonia, and 5,6,7,8- 
tetrahydro-4-hydroxypteridine (3b-XXXIX) was obtained. By 
comparison of their pICa values, ultraviolet and infrared 
spectra, the 5,6,7,8-tetrahydro-4-hydroxypteridine was 
shown to he identical with the product obtained by reduction 
of 4-hydroxypteridine (see p .48 ).
5,6-Dihydro-4-hydroxypteridine (3b-XLII) was 
synthesized by essentially the same method as was used in 
the preparation of the 2-hydroxy-isomer (see p .74 ).
(3b-XLIl)
4,5-Biamino-6-hydroxypyrimidine (3b-XL), hydrogenated over 
Raney-nickel in ethanol containing glyoxal monoacetal, 
gave 4-amino-5-ß-diethoxyethylamino-6-hydroxypyrimidine 
(3b-XLI). This pyrimidine, when boiled with N-hydrochloric 
acid for one minute, gave 5,6-dihydro-4-hydroxypteridine
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( 3 b - X L I I ) .  The compound was n o t  i d e n t i c a l  w i t h  t h e  x , y -  
d i h y d r o - 4 - h y d r o x y p t e r i d i n e , formed by r e d u c t i o n ,  which must  
t h e r e f o r e  be an i s o m e r .
x , y - D i h y d r o - 4 - h y d r o x y -  
p t e r i d i n e  o b t a i n e d  by 
r e d u c t i o n
5 , 6 -D ih y d r o - 4 - h y d r o x y -  
p t e r i d i n e  o b t a i n e d  by 
s y n t h e s i s
c o l o u r y e l lo w c o l o u r l e s s
rn.p. 263-265 (decom p.) 230 (decom p.)
pKa b a s i c 0 .3 2  + 0 .0 5 2 .9 4  + 0 .0 4
a c i d i c 12 .13  ± 0 .0 3 10 .24  + 0 . 1
7 . 8-h ih .ydro-4-h .ydrox .yp te r i d i n e  (and 7 , 8 - d i h y d r o - 4 -  
h y d r o x y - 6 - m e t h y l p t e r i d i n e ) .  A method s i m i l a r  t o  t h e  one 
u s e d  f o r  t h e  s y n t h e s i s  o f  7 , 8 - d i h y d r o - 2 - h y d r o x y p t e r i d i n e  
( 3 b - V I ) ( s e e  p #68 ) was a t t e m p t e d  f o r  t h e  p r e p a r a t i o n  of
7 . 8 -  d ih y d r o - 4 -h y d r o x y i j t  e r i  d in e  , b u t  i t  f a i l e d  t o  y i e l d  a
7 . 8 -  d ih y d ro  compound.
3 , 7-Dih .ydro-4-hydrox .yp t  e r i  d in e  . ITo s u i t a b l e  method 
c o u ld  be found  t o  p r e p a r e  3 , 7 - d i h y d r o - 4 - h y d r o x y p t e r i d i n e . 
However, 3 , 7 - d i h y d r o - 4 - h y d r o x y p t e r i d i n e  and i t s  7 , 8 -  
d i h y d r o - i s o m e r  have  a  common c a t i o n .  I f  t h e  3 , 7 - i s o m e r  
i s  more s t a b l e  t h a n  t h e  7 , 8 - d i h y d r o - i s o m e r ,  t h i s  compound 
would be o b t a i n e d  by any s y n t h e s e s  s u i t a b l e  f o r  t h e  7 , 8 -  
d i h y d r o - i s o m e r .  U n f o r t u n a t e l y ,  t h e  s y n t h e s i s  o f  7 , 8 -  
d i h y d r o - 4 - h y d r o x y p t e r i d i n e  was a l s o  u n s u c c e s s f u l .
86
o2n
Cl
Cl
i
Cl
02n
HN'
>
(3b-xxmi)
M  .
^)Et CHoaH/0S't
* NjE-fc / d N)Et
(3'b-XLIIl) /  1 
/  1
(3b-XLIV)
OH £
/  or Zn-AcOH lH+
I
OH
OgN
HN
c h2cho
(3b-XLV) (3b-XLVI)
4,6-Dichloro-5-nitropyrimidine (3b-XXVIII) was condensed with 
aminoacetal and although the intermediate (3b-XLIIl) could 
not he isolated,the condensed product was hydrolysed by 
heating with N-sodium hydroxide to give 4-ß-diethoxyethylamino- 
6-hydroxy-5-nitropyrimidine (3b-XLIV). This absorbed five
moles of hydrogen (cf. three moles for a nitro group) over 
Raney-nickel and none of the desired aminopyrimidine (3b-XLV) 
could be isolated. Reduction of (3b-XLIV) with zinc dust in 
acetic acid also gave a mixture from which (3b-XLV) could not
87
Tje isolated. Hydrolysis of (3b-XLIV) with N-hydrochloric 
acid gave a product analysing for G-^ ;HgNgO - . ,  and this 
compound absorbed ten moles of hydrogen over Raney-nickel 
(calculated on the above formula) and gave a dark resinous 
product. No 7,8-dihydro-4-hydroxypteridine was obtained by 
this method.
Because of the difficulty of synthesizing the 6- 
unsubstituted derivative, the synthesis of 7,8-dihydro-4- 
hydroxy-6-methylpteridine was attempted because it should 
have similar pKa values and spectra. The following route 
was used:
01 01 OH
NHoCHoG0GH
(3b-XXVIII) (3b-XLVII) (3b-XLVIII)
4,6-Dichloro-5-nitropyrimidine was condensed with aminoacetone 
by Boon’s method (Boon and Jones, 1951), and the xoroduct 
(presumably 3b-XLVII) was hydrolyzed with aqueous ethanol to 
4-acetonylamino-6-hydroxy-5-nitropyrimidine (3b-XLVTII). 
However, in the hydrogenation of the pyrimidine (3’b-XLVIII) 
over Raney-nickel, a side-reaction took place similar to that
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3h happened  i n  t h e  r e d u c t i o n  o f  t h e  4 - ß - d i e th o x y e th y la m in o -  
iso m e r  ( 3 t - v j J 7 )  ( s e e  p .  8 6 ) .  ITo 7 ,3 —d ih y d r o - 4 —hyd ro x y —6-
l e t h y l p t e r i d i n e  was o b t a i n e d .
1 , 2 -N ihydro -4 -h y d ro x y p t  e r i  d i n e . The 1 , 2 - d ih y d r o -  
s t r u c t u r e  i s  im p ro b ab le  f o r  t h e  r e d u c t i o n  p ro d u c t  o f  4-h y d ro x y -  
p t e r i d i n e , b e ca u se  i t  was found  p o s s i b l e  t o  r e d u c e  t h e  x , y -  
u ih y d r o - 4 -h y d r o x y p te r i d i n e  f u r t h e r  w i th  p o ta s s iu m  b o ro h y d r id e  o r  
•N" h y d r o g e n a t io n  o v e r  H a n e y - n ic k e l  c a t a l y s t  t o  g iv e  5 , 6 , 7 , 8 -  
~ e t r a h y d r o - 4 - h y d r o x y p t e r i d i n e .
No a t t e m p t s  have been  p r e v i o u s l y  made to  p r e p a r e  1 , 2 -
y d ro p t  'i i s .  An sxampl o f  y n t h e s i s  o f  a fu s e d
I ,2 - d i h y d r o p y r i m id i n e  r i n g  in  s e e n  i n  t h e  p r e p a r a t i o n  of
3 - p h e n y l - l , 2 - d i h y d r o - 4 - q u i n a z o l i n e  ( 3 b - l )  from
o- mi i l i  (3b CLIX) and fo rm a ld eh y d e  (F e ld  - and
T'a g n e r ,  19 4 2 ) .
0
t -> b-XLIX) (3b -L )
3ecause  t h i s  r e a c t i o n  see  1 t o  o f f  r  in e a sy  o p p o r t u n i t y  to  
'■ i n  a  1 , 2 - d i h y d r o p t e r i d i n e , 2 -am i no -  3 -  c arbamoy lp y  r a z  i  ne 
3 b -L l)  was warmed w i th  fo rm a ld eh y d e  b u t  no r e a c t i o n  o c c u r r e d
under t h e  d e s c r ib e d  c o n d i t i o n s .
89 0
/ V “ 2
\ | / ^ OTI2 
(3’o-LI)
Synthesis Directed Towards Hydrogenated 7-Hydroxypteridine
5.5- Dihydro-7-hydroxypteridine . As it seemed likely that 
the reduction product of 7-hydroxypteridine had this 
constitution, its synthesis was attempted "by the following 
three routes:
a) The reduction of a Schiff’s "base (3h-LXVl) of ethyl 
glyoxylate hemiacetal and 4,5-diamino-6-hydroxypyrimidine gave 
the corresponding 5-alkylaminopyrimidine (3b“LXVII) which 
cyclized to 5,6-dihydro-4,7-dihydroxypteridine (see, p.95). 
Unfortunately this promising method was not successful with
4.5- diaminopyrimidine (3h-LIII). Thus 4,5-diaminopyrimidine 
(3h-LIIl) showed no tendency to condense with ethyl glyoxylate 
hemiacetal (3U-LIV) in ethanol, and although it did so in 
aqueous ethanol, there followed srjontaneous cyclization to 
7-hydroxypteridine (3U-LVI) and no Schiffs "base (ßb-LV) 
could "be isolated.
(3h-LIl)
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( 3b-LV I)
b) By a n a lo g y  w i t h  a d e r i v a t i v e  of  5 , 6 - d i h y d r o - 7 - a m i n o -  
p t e r i d i n e  ( 2d-V) which h a s  'been p r e p a r e d  t h r o u g h  t h e  5-  
c y a n o m e th y la m in o p y r im id in e  ( 2 d - I V ) ( B l i c k e  and G-odt, 1954) 
( s e e  p . 4 0  ) f 4 , 5 - d i a m in o p y r im id in e  ( 3 b - L I I I )  was condensed  
w i t h  fo rm a ld e h y d e  and hydrogen  c y a n id e  t o  4 -a m in o -5 -  
c y a n o m e th y la m in o p y r im id in e  ( 3 b - L V I l ) ,  However, t h i s  compound 
( 3 b - L V I l )  was q u i t e  u n s t a b l e  t o  a c i d  and a l k a l i  ( h y d r o l y s i s )  
and i t  decomposed t o  4 , 5 - d i a m in o p y r i m id i n e  ( 3b-LV I) and 
hydrogen  c y a n id e  on a t t e m p t e d  c y c l i z a t i o n *
HJN
i : 2 h  ^
( yo-Lvi)
.
H2N
c) An a t te m p te d  p r e p a r a t i o n  o f 5 r 6 -d ih y d ro -7 * -h y d ro x y p te r id in e  
th ro u g h  a 4 - s u b s t i t u t e d  am in o p y rim id in e  ( s e e  p .7 2 )  i s  shown 
below , b u t i t  was u n s u c c e s s f u l :
P h th a lo y lg ly c y l
c h lo r id e
(3 b -L V III )
--------------4
(3 b -iX )
( 3b-LIX )
C o n d e n sa tio n  o f  4-am ino*-5-brom o p y r im id in e  ( 3 b -L V III)  w i th  
p h th a lo y lg ly c y l  c h lo r id e  gave 5 -b ro m o -4 -p h th a lo y lg ly c y la m in o -  
p y r im id in e  (3 b -L IX ). However, th e  am ide l in k a g e  betv /een
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the phthaloylglycyl group and the 4-aminopyrimidine was so 
labile that 2-amino-5-bromopyrimidine (3b-LVIII) was formed 
by hydrolysis of (3b-LIX) with hydrazine hydrate or with acid, 
and none of the desired (3b-LX) was obtained. These three 
routes are therefore abandoned.
As synthetic methods v/ere unsuccessful, conversion of 
the ring opened product obtained by reduction of 7-hydroxy- 
pteridine (believed to be* 4-amino-5-carboxymethylamino- 
pyrimidine; 3b-LXI) to 4-amino-5-cyanomethylaminopyrimidine 
(3b-LVIl) was attended. The methyl ester (3b-LXII) gave 
x,y-dihydro-7-hydroxypteridine on treatment with aqueous or 
methanolic ammonia. Heating the ammonium salt of the acid 
(3b-LXl) gave the same x,y-dihydro-7-hydroxypteridine, but 
ammonolysis of this (3b-LXIIl) was unsuccessful.
*This constitution was later established, see p.lll .
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HOgCCHgNH
^2^ ^ N J
(3b-LXI)
Vh2n.gogh2nh
^2^ \i^
(3b-LXIV)
gh3o2g-ch2nh
>
/ H2N ^
/
/
(3"b-LXII)
K
V
HO
N
>IK
(3b-LXIIl)
(3H-LVII)
Later, confirmation of the constitution of (3b-LXI) established 
that of x,y-dihydro-7-hydroxypteridine as 5,6-dihydro-7- 
hydroxypteridine. Hence other attempts to synthesize 
(3b-LXIIl) were dropped.
Syntheses Directed Towards Hydrogenated 2.4-Bihydroxypteridine.
Because of the instability of tetrahydro-2,4-dihydroxy- 
pteridine to oxidation (see p,51 ), a route through 7,8- 
dihydro-2,4-dihydroxypteridine was sought. This involved 
condensation of 2,4,6-trichloro-5-nitropyrimidine with
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a m i n o a c e t a l .  A complex m ix t u r e  o f  p r o d u c t s  r e s u l t e d ,  b u t  
none o f  t h e  d e s i r e d  s u b s t a n c e  was i s o l a t e d .  I b i s  s y n t h e s i s  
was n o t  f u r t h e r  p u r s u 3d s t h e  c o n s t i t u t i o n  o f  t h e  t e t r a h y d r o -  
compound i s  n o t  i n  d o u b t ,
^ n t h e s e g  1 t r e a t e d  Howards Hydro genated 1 , 6-Ailc/dnon./,  i ' - r x d i n e  .
7 18-'  ) i h y d r o - 2 . 6- d ih y d ro x y -  t e r i d i n e  w a s sy n t  he s i  z e d 
a c c o r d i n g  t o  t h e  method of  Boon, J o n e s  md Ramage (1951)  ( s e e  
p .  8 ) .  The 7 , 8 - d i h y d r o - 2 , 6 - d i h y d r o x y p t e r i d i n e  was i d e n t i c a l  
/ i t h  t h e  s o l e  p r o d u c t  o b t a i n e d  by r e d u c t i o n  o f  2 , 6 - d ih y d r o x y -  
p t e r i d i n e  ( s e e  p .  5 7 ) .
dy-nth j ;;e: d i r e c t e d  . a r d  If  f r y  mi- t e d  4 , 6 -  i y  Iroxy t e r i d i n e  .
7 . 0 - h i  y -m..A l i n e  was s y n th e  sd
a c c o r d i n g  t o  t h e  method of  Boon, J o n e s  and Ramage (1951)  ( s e e  
p . 8 ) .  The 7 , 8 - 4 t i h y d r o - 4 , 6 - d i h y d r o x y p t e r i d i n e  was i d e n t i c a l  w i th  
t h e  s o l e  p r o d u c t  o b t a i n e d  by r e d u c t i o n  o f  4 , 6-dihydroxyjrfc e r i d i n e  
( s e ^  p .  5 8 ) .
S y n t h e s e s  d i r e c t e d  To a r d s  H y d ro g en a ted  2 , 7 - B i h y d r o x y p t e r i d l n e .
5 , 6 - D i h y d r o - 2 , 7~diI iydrony t  e r i d i n e  . The s y n t h e s i s  o f  
t h i s  compound by t h e  ame 'method u s e d  f o r  th e  p r e p a r a t i o n  of  
5 , 6 - d i h y d r o - 4 , 7 - d i h y d r o x y p t e r i d i n e  ( see  p . 9 5 ) ,  p roved
f u l .  Because  c o n d e n s a t i o n  of  4 , 5 - d i a m in o - 2 - h y d r o x y -  
p y r i m i d i n e  an stl  y l  g l y o x y l a t e  h e m i a c e t a l  gave 2 , 7 - d i h y d r o x y -  
p t e r i d i n e  i n  p l a c e  o f  t h e  d e s i r e d  S c h i f f * s  b a s e .  P r o c e e d i n g  
by a n o t h e r  r o u t e  4 , 5 - d i a m i n o - 2 - h y d r o x y p t e r i d i n e  d id  n o t  g iv e  
a  c y a n o m e t h y 1 - d e r i v a t i v e  a s  d id  4 , 5 - d i a m i n o p y r i m i d i n e .
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S y n t h e s i s  D i r e c t e d  Towards H y d ro g e n a ted  4 «7 - O i h y d r o x y p t e r i d i n e » 
5, b - D i h y a r o - 4 , 7 - d i h y d r o x y p t e r i d i n e  (3b -L X V II l )  was s y n t h e s i z e d  
by t h e  f o l l o w i n g  r o u t e  ( s e e  a l s o  p .7 1  ) ,  which  i s  an e n t i r e l y  
new m e th o d :
OH OH
The r e d u c t i o n  o f  a S c h i f f s  b a s e  i s  a  w e l l  known 
method of  p r e p a r i n g  a s e c o n d a r y  amine (Emerson, 1 948) .  
4 - A m i n o - 5 - e th o x y c a r b o n y lm e th y le n a m in o - 6 - h y d r o x y p y r im id in e  
( 3b-LXVT) ( P f l e i d e r e r ,  1959) a b s o r b e d  one mole of hydrogen  
o v e r  R a n e y - n i c k e l  and gave 4 - a m in o - 5 - e t h o x y c a r b o n y l a m in o - 6 -  
h y d r o x y p y r im id in e  ( 3b-LXVTI) .  On t r e a t m e n t  w i t h  h y d r o c h l o r i c  
a c i d ,  t h i s  p y r i m i d i n e  gave 5 , 6 - d i h y d r o - 4 , 7 - d i h y d r o x y p t e r i d i n e  
(3 b - L X Y I I l ) .  T h is  s u b s t a n c e  was shown t o  be i d e n t i c a l  w i th  
t h e  d i h y d r o - 4 , 7 - d i h y d r o x y p t e r i d i n e  o b t a i n e d  a s  s o l e  p r o d u c t  
by r e d u c t i o n  o f  4 , 7 - d i h y d r o  x y p t e r i d i n e  ( s e e  p #59 ) *
' T  I I R I M D V
V
L I 3 K A R V
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Synthesis of 7,8-I>ihydro-4,6-dimethylpt eridine. The synthesis 
of unsubstituted 7,8-dihydropteridine was desired in order to 
lay a foundation for correlating the basic pK values of 7,8- 
dihydropteridines and of the corresponding pteridines. However 
no suitable method was found to prepare 7 ,8-dihydropteridine. 
Fortunately, however, it was found possible to prepare a simple 
methyl derivative, 7 ,8-dihydro-4,6-dimethylpteridine, by the 
following route:
(3b-LXXII)
2-0hloro-7,8-dihydro-4,6-dimethylpteridine (3b-LXXI) has been 
prepared by Lister and Ramage (1953) from 2,4-dichloro-6- 
methyl-5-nitropyrimidine (3b-LXIX) via 4-acetonylamino-2-chloro
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6-methyl-5-nitropyrimidine (ßb-LXX). Replacement of a 
2-chloro-group "by hydrogen had not been attempted before. 
Reduction with hydriodic acid was unsuccessful in this case, 
as the dihydropteridine was unstable to such conditions. 
However, 7,8-dihydro-4,6-dimethylpteridine was obtained by 
catalytic hydrogenation of 2-chloro-7,8-dihydro-4,6- 
dimethylpteridine over palladium on carbon catalyst.
S8
o . I o n i z a t i o n  C o n s t a n t s  .
I o n i z a t i o n  c o n s t a n t s  a r e  v e ry  u s e f u l  t o  h e l p  i n  
i d e n t i f i c a t i o n  o f  s u b s t a n c e s  which  have  no m e l t i n g  p o i n t s  
and have  been  u s e d  s e v e r a l  t i m e s  f o r  t h i s  p u rp o se  i n  t h e  
p r e c e d i n g  j^ages ( r e s u l t s  summarized i n  T ab le  7 ) .  But 
a p a r t  f rom  t h i s ,  i o n i z a t i o n  c o n s t a n t s  y i e l d  two f u r t h e r  
t y p e s  o f  i n f o r m a t i o n ,  b o t h  o f  them i m p o r t a n t .
F i r s t ,  an i o n i z a t i o n  c o n s t a n t  can i n d i c a t e  which  of 
t h e  i o n i c  s p e c i e s  o f  t h e  m o le c u le  i s  p r e s e n t  i n  t h e  s o l u t i o n  
a t  a  p a r t i c u l a r  pH. T h i s  i n f o r m a t i o n  i s  e s s e n t i a l  when 
c o r r e l a t i o n  of  u l t r a v i o l e t  s p e c t r a  and s t r u c t u r e  i s  a t t e m p t e d .
Second,  i n f o r m a t i o n  can be o b t a i n e d  from 
i o n i z a t i o n  c o n s t a n t s  which  c o n c e r n s  d i r e c t l y  t h e  m o l e c u l a r  
s t r u c t u r e .  A l th o u g h  i t  i s  d i f f i c u l t  t o  d i s c u s s  t h e  m o l e c u l a r  
s t r u c t u r e  o f  an i s o l a t e d  compound w i th  o n ly  t h e  i n f o r m a t i o n  
s u p p l i e d  by i t s  i o n i z a t i o n  c o n s t a n t s ,  one can do so when 
such  i n f o r m a t i o n  i s  a v a i l a b l e  a b o u t  a s e r i e s  o f  r e l a t e d  
compounds. I n  such  a  c a s e ,  a good d e a l  of  im p o r t a n t  
i n f o r m a t i o n  on t h e  s t r u c t u r e  of  a  new compound i n  a s e r i e s  
can  be o b t a i n e d  f rom a  s t u d y  of  t h e  i o n i z a t i o n  c o n s t a n t s  of
The i o n i z a t i o n  c o n s t a n t s  o f  s e v e r a l  h y d r o g e n a t e d  h y d ro x y -  
p t e r i d i n e s ,  o b t a i n e d  by s y n t h e s i s  and by r e d u c t i o n ,  a r e  
shown i n  T a b le  3 ( p .1 0 4  ) and 7 . They a r e  e x p r e s s e d
a s  pKa v a l u e s ;  which  a r e  n e g a t i v e  l o g a r i t h m s  of  t h e  
c o n s t a n t s .  The h i g h e r  t h e  pKa v a l u e  t h e  s t r o n g e r  t h e  b a s e ,  
and t h e  w eak e r  t h e  a c i d .
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the series.
In the present wo ionization constants of a 
iber of (mainly hydrogenated) pteridines were determined 
for the above reasons, and the values are summarized in 
fable 6, p. 104.
The following paragraphs exemplify how knowledge of 
ionization constants was used in the present work to throw 
light on structures.
(a) 7/hen one looks at the structure of 5,6,7,8-tetrahydro- 
pteridine (3c-II), it is evident that this substance may 
be thought of as 4,5-diaminopyriniidine (3c-l), in which 
the two primary amino groups are alkylated by ethylene. 
Fence the two substances should have similar ionization 
constants. This turns out to be the case, for 4,5- 
diaminopyrimidine has pKa 6.03 and 5,6,7,8-tetrahydro- 
pteridine has pKa 6.63 (see Table 8).
H
N
5 1
H
(3c-I) (3c-II)
The charge of the cation is It is known that acylation of
shared between N p  N/^) ^(8) s"kr Singly reduces the
and the 4-amino group. The basic strength of this
5-amino group has almost no molecule.
basic properties.
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In the present work, it was seen that 5,6,7,8- 
tetrahydro-4-hydroxypteridine (pK , 3.86, 10,13) is related 
in this way to 4,5-diamino-6-hydroxypyrimidine (pKa 3.57,
9.86). Hence the pKa of the tetrahydro-2-hydroxypteridine 
(obtained by reducing 7,8-dihydro-2-hydroxypteridine, and 
susioected to he the 5,6,7,8-tetrahydro derivative) was 
examined to see if it had a pKa similar to that of 4,5- 
diamino-2-hydroxypteridine. The tetrahydro-2-hydroxypteridine 
had pKa values (4.35 and 12.5) similar to those of 4,5— 
diamino-2-hydroxypyrimidine (4.37 and 11.45) and the 
structure was suggested to he 5,6,7,8-tetrahydro-2- 
hyd ro xypteridine.
(h) Usually, 7,8-dihydropteridine have much higher pKa 
values (both acidic and basic) than have the corresponding 
pteridines (Table 9, p. 107). This difference does not exist 
if hydrated forms of the non-hydrogenated pteridines are 
used for comparison (only 2-, and 6-, hydroxypteridines have 
stable hydrated forms). The hydrated form of 6-hydroxy- 
pteridine, which is actually 7,8-dihydro-6,7-dihydroxypteridine 
(3c-IV) (Brown and Mason, 1956) has a molecular structure 
similar to 7,8-dihydro-6-hydroxypteridine, and shows the same 
base-strengthening and acid-weakening effect (Table 9, p. 107), 
when compared with the anhydrous form of 6-hydroxypteridine. 
This base strengthening affect is considered to be due to 
resonance stabilization of the cations of the 7,8-dihydro 
structure, (3c-V) «---* (3c-VI), (R = H, or OH).
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H
(3c-V)
H
This kind of base strengthening effect has been shown 
(Albert, Goldacre and Phillips, 1948) to be general in those 
nitrogen heterocyclic compounds having a jo-amino structure 
which permits a resonance stabilization of the cation as 
above (Table 10, p.108). The base strengthening effect due 
to the £-amino structure is much less marked than that due to 
the jj-amino structure (Table 10, p.108), and m-amino groups 
show only the expected small inductive effect.
The constitution of x,y-dihydro-2-hydroxypteridine is 
also illuminated by comparison with the hydrated form of 2- 
hydroxypteridine, neither of which has any basic pICa value 
higher than 2, and both of which have very high acidic pK’s 
(12.6 and 11.1 respectively). It has been known that 2- 
hydroxypteridine is hydrated at the 3,4-position (Brown and
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Mason, 1956; see p. 44). Again, x,y-dihydro-2-hydroxy-6- 
methylpteridine has pICa values (both basic and acidic) 
somewhat similar to those of the hydrated 2-hydroxy-6-methyl- 
pteridine (Table 9, p. 107). ?or this reason, and because the 
ultraviolet spectra of the neutral molecules of hydrated 2- 
hydroxypteridines and their x,y-dihydro compounds are similar 
(see p.113), it is suggested that x,y-dihydro-2-hydroxy- 
pteridine has the 3,4-dihydro structure. (The close similarity 
of 2-hydroxypteridine and its 6-methyl derivative suggest that 
these two compounds are hydrated at the same positions). It is 
unfortunate that it proved impossible to synthesize 3,4- 
dihydro-2-hydroxypteridine (see p. 75, for attempts), 
c) x,y-Dihydro-4-hydroxypteridine is not an appreciably 
stronger base than 4-hydroxypteridine (see Table 9, p.107).
This may seem to support the 3,7-dihydro-structure (3c-V) 
for this compound, because it was found that 7,8-dihydro- 
pteridines are much stronger bases than the corresponding 
pteridines.
However, the other two possible dihydro-4-hydroxypteridines 
would exist mainly in the lactam forms (3c-VI) and (3c-VH), 
and such structures can not take part in the above base 
strengthening resonance.
(3c-V)
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0
H
(3C-YI) (3C-VII)
The acidic pKa of x,y-dihydro-4-hydroxypteridine is much 
higher than that of 4-hydroxypteridine. ' • ’
v/ealiening effect might he expected from the above three 
formulae but it does not help in the choice of any one of 
these structures.
In conclusion, no effective information on the 
structure of x,y-dihydro-4-hydroxypteridine can he obtained 
from ionization constants at the present stage.
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Table 6
Ionization constants of ptoridines and hydrogenated pteridines 
(obtained in the present work except where indicated) (20°)
Pteridines basic acidic
2-Hydroxy-6-uiethylgteridine
0.2
g q *(anhydrous) 
I1.0 *(hydrated)
l)i hydro pteridines
7, l-Dihydro-4
7.8- Dihydro-2 
3,4-Dihydro-2
7.8- Dihydro-2 
pteridine
3, f-Dihydro-2- 
pteridine
7.8- Dihydro-2- 
pteridine
5.6- Dihydro-4 
x ,y-Dihydro-4 
7,3-!Dihyc'ro-6
5.6- Pihydro-7 
7 ,r -Dihyc.ro-2 
x,y-Dihydro-2
7.8- Dihydro-4
5.6- Dihydro-4
7.8- Pihydro-2
,6-dimet hylpte ridine 
-hydroxypte ridine 
-hydroxypt ridine 
-hydroxy-6-methyl-
•hydroxe--6-methyl-
•hydroxy-4,6-dimethyl-
-hydroxypteridine 
-hy d r o xy pt e ri di n e 
-hydroxypt eridine 
-hydroxypteridine 
,d-dikyn roxypteridine 
,7-dihydroxypteridine 
, 6- dih; - ro Xj -pt eridine 
,7-dihydroxypteridine 
,4,6—0 ' ridine
6.00 ± o o
3.50 + 0.02 ***
0 12.6
3.42 + 0.06 11.85 + 0.02
0.20 + 0.06 13.05 + 0.02
3.99 + 0.02 12,50 + 0.04
2.94 + 0.04 10.24 + 0.1
0.32 + 0.05 12.13 ± 0.03
4.53 + 0.03 10.54 ± 0.02'**3.36 ± 0.01 9.94 ± 0.05
2.80 ± 0.02 10.22 + 0.01
5.84 + 0.02
9.14 + 0.02
8.55 + 0.02
7.07 + 0.03
* *
* *
T et rahydropt eridines
5.5.7.8- Tetrahydro-2-hydroxypteridine
5.6.7.8- Tetrahydro-4-hydroxypteridine
4.35 ± 0.05 12.5
3.86 + 0.02 10.13 + 0.03
* * *
Determined by Dr. D.D. Perrin using rapid titration method.
rAlbert, krown and Chee seman, 1952.
'ecause of its instability in strong alkali, no exact pK_ value
.
was obtained.
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Table 7
Use of Ionization constants to establish identity.
pK values of hydrogenated pteridines prepared by synthesis and a
by reduction.
______Pfa
(basic)
7.8- Dihydro-2,6-dihydroxypteridine
(authentic)
Dihydro-2,6-dihydroxypteridine
(by reduction)
7 .8- Dihydro-4,6-dihydroxypteridine
(authentic)
Dihydro-4,6-dihydroxypteridine
(by reduction)
5,6-Dihydro-4,7-dihydroxypteridine
(authentic)
Dihydro-4,7-dihydroxypteridine
(by reduction)
5.6.7.8- Tetrahydro-4-hydroxypteridine
(authentic)
Tetrahydro-4-hydroxypteridine
(by reduction)
2.82 + 0.02
2.80 + 0.02
3.87 + 0.02 
3.86 ± 0.02
(20°)
(acidic)
10.26 + 0.03 
10.23 + 0.02
9.07 + 0.05
9.07 ± 0.02 
8.45 ± 0.02 
8.48 + 0.05
10.10 + 0.03 
10.13 ± 0.03
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Talle 8.
pK values of tetrahydropteridines and the corresponding a
4,5-diaminopyrimidines.
(20°)
hasic acidic
5,6,7,8-Tetrahydropt eridine 6.63*
4,5-Biaminopyrimidine 6.03**
5,6,7,8-fet rally dro-4-hydroxypteri dine 3.86 10.13
4,5-Hiamino-6-hydroxypyrimidine **3.57 9.86
5,6,7,8-fetrahydro-2-hydroxypteridine 4.35 12.5
4,5-Hiamino-2-hydroxypyrimidine **4.37 **11.45
Brook and Ramage, 1957.
aX”#‘Mason , 1954.
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Table 9
pK values of hydroxypteridines and their dihydro derivatives.cA
Pteridines
7 ,8-Dihydropteridines 
(basic) (acidic)
x,y-Dihydropt eri dines 
(basic) (acidic)
Anhydrous Hydrated
(basic) (acidic) (basic) (acidic)
4.6- Dimethylpteridine 
2-Hydroxypteridine 
2-Hydroxy-6-me thylpt eridine 
2-Hydroxy-4,6-dimethylpteridine 
4-Hydroxypteridine 
6-Hydroxypteridine
2.6- Dihydroxypt eridine
4.6- Dihydroxypteridine
_ 1)
7.72) 24  ^ 11.052^
8.03  ^ -0.4 11.0
Substance unknown
-0.17 7.89°^ Does not hydrate
6.452  ^ 3.674  ^ 9.902^
5.99,9.662) 8.84,10.292^
6.05,9.512' 8.3 4,10.082^
6.00
3.50 125^
3.42 11.85
3.99 12.50
4.78 10.54
2.80 10.22
9.14
2 12.6
0.2 13.05
0.32 12.13
1) This compound is not known, but the pK values of similar methyl derivatives (respectively 2.94 and 2.93cl
for 4-methyl- and 6,7-dimethyl-pteridines) suggest that the pK value of this compound is about 3.8 l2) Perrin and Inoue, I960.
3) Kindly measured by Dr. D.D. Perrin by a special rapid technique.
4) Albert, Brown and Gheeseman, 1951.
5) This compound has an acidic pK near 12, but because of its instability in strong alkali a good value was not
obtained.
6) Brown and Mason, 1956.
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d . Spectra
i) Ultraviolet Absorption Spectra
Ultraviolet spectra are important in molecular 
structure determination, not only in identification of 
specimens prepared by different routes, but also for the 
fundamental information that they can contribute (see p. 31).
In the present work, ultraviolet spectra of 
hydrogenated pteridines were used for both reasons. The 
spectra were determined on each ionic species of the 
substances, carefully isolated from other species by using 
buffers whose pH values were indicated by knowledge of the 
appropriate pKa values. These spectra are summarized in 
Table 11, p. 116.
The following cases exemplify the use of ultraviolet 
spectra in determining the structure of hydrogenated pteridines. 
a) It has been reported that 5,5,7,3-tetrahydropteridines 
h ve ultraviolet absorptions similar to those of the 
corresponding 4,5-diaminopyrimidines, and that a 15-13 mji 
bathochromic shift is observed in the spectra of tetrahydro-
pteridinos when compared to the corresponding 4,5-diamino- 
pyrimiuines (Lister and Homage, 1953; Taylor and .Sherman,
1959) (Table 12, p. 117).
In the present v/ork the synthesis of 5,6,7,8- 
t’etrahydro—2-hydroxy;, teridine involved the catalytic 
hydrogenation of 7 ,8-dihydro-2-hydroxypteridine (see p. 70). 
result of this reaction is rather ambiguous due to the
* UBRMY r-
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possibility of migration of hydrogen atoms in the presence 
of a metal catalyst. Evidence for the 5,6,7,8-tetrahydro 
structure, however, was obtained by comparing the ultra­
violet spectra of the substance (neutral molecule, cation 
aid anion) with those of 4,5-diamino-2-hydroxypyrimidine 
(Table 13, p. 118, and Pig. 4,5 and 6). It will be 
noticed that each ionic species of tetrahydro-2-hydroxy- 
pteridine has an absorption curve closely similar to that 
of the corresponding species of 4,5“diamino-2-hydroxyr- 
pyrimidine, but shifted to longer wavelengths by 
approximately 12-22 mp. These facts are in accord with 
the results obtained by Lister and Ramage (1253), and by 
Taylor and Sherman (1959), and it may therefore be 
reasonably concluded that the hydrogen atoms in tetrahydro- 
2-hydroxypteridine occupy the 5-, 6-, 7-, and 8-, positions. 
Further, 5,6,7,8-tetrahydro-4-hydroxypteridine, prepared 
unambiguously, also has ultraviolet spectra (of neutral 
molecule, cation and anion) closely similar to those of the 
corresponding ionic species of 4,5-diamino-6-hydroxypyrimidihe 
(Table 13, end Fi^  . 7,8 and 9).
b) As already state" (p.ly) the product obtained by alkaline 
hydrolysis of dihydro-7-hydroxypteridine seemed to be 4- 
amino-5-carboxymethylaminopyrimidine (3d-I) on reasonable 
chemical evidence (Albert, 'Brown and Cheeseman, 1952 ). 
However, the possibility of its being 4-amino-5-
Ill
ecarboxymethylenaminodihydropyrimidine (3d-Il) was not 
completely excluded. The structure (3d-l) has a 
conjugated system similar to 4,5-diaminopyrimidine (3d-III), 
and therefore the ultraviolet spectra of (3d~l) should he 
similar to those of 4,5-diaminopyrimidine (3d-III). On 
the other hand, the conjugated system of the dihydro- 
pyrimidine (3d-Il) is dissimilar to that of (3d-III). It 
would he possible to distinguish these two structures,
3d—I and 3d-II, hy comparing their ultraviolet spectra 
with those of 4,5-diaminopyrimidine (3d-III).
H
2H
(3d-I) (3d-Il)
(3d-III) (3d-IV)
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However, 4-amino-5-oarboxymethylaminopyrimidine exists 
mainly as a zwitterion (3d-IV), as described before (p.32 ),
and therefore care was taken to compare the ultraviolet 
spectrum of the acid’s neutral molecule with the spectrum 
of the 4,5-diaminopyrimidine cation, and similarly the 
spectrum of the acid's anion with that of the neutral 
molecule of 4,5-diaminopyrimidine . The ultraviolet si>ectra 
of these two pairs have indeed a close similarity (Table 14, 
and Fig, 10, ll), and this eliminates the possibility of the 
dihydropyrimidine structure (3d-II), thus the product 
obtained by alkaline hydrolysis of dihydro-7-hydroxypteridine 
is 4-amino-5-carboxymethylaminopyrimidine (3d-l), Accordingly, 
the parent x,y-dihydro-7-hydroxypteridine is 5,6-dihydro-7- 
hydroxypteridine.
c) The structure of x,y-dihydro-2-hydroxypteridine could 
not be confirmed by synthesis, but it had pKa values 
somewhat similar to those of hydrated 2-hydroxypteridine 
(3d-V) (see p. 101). This hydrated 2-hydroxypteridine 
(3d-V) has the same conjugated system as had 3,4-dihydro- 
2-hydroxypteridine (3a-Vl), thus the pair of the
compounds would be expected to have similar ultraviolet
■&spectra . Marked similarity of ultraviolet
*As a basis for this expectation, correlations between the 
spectra of hydrated pteridines and hydrogenated pteridines 
which have the same conjugated systems have been observed in 
some 7,8-hydrated 6-hydroxypteridines (3d-VII) and the 
corresponding 7,8-dihydro derivatives (3H-VIII) (Fig,2,12,13).
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spectra is seen between the x,y-dihydro-2-hydroxypteridine 
and hydrated 2-hydroxypteridine (Pig. 1). Since the 
structure of hydrated 2-hydroxypteridine has been 
established as 3,4-dihydro-2,4-dihydroxypteridine (3d-V) 
(frown and Mason, 1956), the above spectroscopic evidence 
supports the 3,4-dihydro structure for x,y-dihydro-2- 
hydroxypteridine.
H OH
,.N
H H/
N N
(3d-Yl)
OH
d) As described before (p. 48, 85 and 102) the x,y-dihydro- 
4-hydroxypteridine obtained by reduction of 4-hydroxypteridine 
with potassium borohydride could reasonably be 5,8-, 3,7- or 
7,> <-, dihydro-4-hydroxypteridine. The x ,y-dihydro-4- 
hydroxypteridine shows a strong bathochromic shift (57 mp) in
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its ultraviolet ab section when compared with 4-hydroxy- 
pteridine (see Table 15, p. 120). Such a strong 
bathochromic shift has never been observed between 
pteridines and their 7,8-dihydro derivatives (Table 15, 
p. 120). However, an unusually strong bathochromic shift 
(54 mp) was recently found between a pteridine and its 5,8- 
dihydro derivative (Pfleiderer and Taylor, 1980, see p. 45) 
who explained this shift by the stabilization, by the 
external ring formation, of a 5,8-dihydro structure. In 
the present case, two possible structures, 5,8-dihydro-, and 
3,7-dihydro-, 4-hydroxypteridine remain. But no decision can 
be reached on the constitution of this minor product of 
the reduction of 4-hydroxypteridine. 
ii) Infrared Absorption Spectra.
Because of the insolubility of hydrogenated 
pteridines in organic solvents, all infrared absorption spectra 
were determined in the solid state (potassium bromide disk 
method). This prevented an intensive discussion about the 
structure of the compounds as revealed by the infrared sx^ectra, 
because solid state measurements present a bewildering variety 
of peaks arising from interactions between the molecules. For
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this reason infrared spectra were used in the present work,
mainly for testing identity.
iii) Nuclear Magnetic Resonance Spectra.
The nuclear magnetic resonance spectra of solids can 
only he determined in solution. For this reason, in 
spite of its great value in the determination of the position 
of hydrogen atoms in a molecule, this method could not he 
used in the present work. Several attempts to use the 
method are described (see p, 33), hut in no case could a 
sufficiently concentrated solution he obtained to give clear 
signals.
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T a l l e  11.
U l t r a v i o l e t  s p e c t r a  o f  h y d ro g e n a te d  p t e r i d i n e s  ( o b ta in e d  i n  t h e  p r e s e n t  w o rk ) .  
V a lu es  u n d e r l i n e d  r e f e r  t o  s h o u ld e r s  o r  i n f l e x i o n s .
1 hydro p t e r i d i n e s ___________________
, 8 - D ih y d r o - 4 , 6 - d i m e t h y l p t e r i d i n e
,4 - D ih y d r o x y - 2 - h y d r o x y p te r id in e
, 8 - D i h y d r o - 2 - h y d r o x y p te r id in e
, 4 i  hy d r  o -  2 -  hy d r  o xy -  6 -m e t  hy lp  t  e i id  in  e
, 8 -D i hy d r  o -  2 -hy  cl r  o xy -  6-me t  hy lp t  e r  id  ine
, 8 - D ih y d r o - 2 - h y d r o x y - 4 , 6 - d im e th y l -  
p t e r i d i n e
_______ (m easu red )  s p e c i e s  A max. ______________i°U  £
8 . 2 0 2 1 8 ; 293 4 . 2 7 ; 3 . 7 3
5 . 0 0 + 0 . 0 4 3 . 0 + 2 1 8 ; 293 4 . 1 3 ; 3 . 9 1
7 . 0 0 2 4 8 ; 317 3 . 7 2 ; 3 . 8 9
0 - 2 + 2 5 4 ; 337 3 . 7 8 ; 3 . 8 5
1 2 ..6 1 4 . 1 6 - 2 8 1 ; 343 3 . 9 8 ; 3 . 8 4
7 . 0 0 2 2 3 ; 290 4 . 3 5 ; 3 . 8 8
3 . 5 0 + 0 . 0 2 1 . 0 + 2 2 5 ; 2 8 2 ; 2 9 0 ; 310 3 . 8 5 ; 3 . 7 5 ;
a) 1 4 . 1 6 - 308 3 . 9 5
7 . 0 0 2 4 8 ; 321 3 . 8 3 ; 3 . 9 2
0 . 2 0 + 0 . 0 6 - 2 . 0 3 + 2 5 7 ; 347 3 . 8 6 ; 3 . 8 8
1 3 .0 5 + 0 . 0 4 1 4 . 1 6 - 2 8 1 ; 352 4 . 0 1 ; 3 . 8 4
7 . 0 0 2 2 0 ; 287 4 . 4 6 ; 3 . 9 9
3 . 4 2 + 0 . 0 6 2 . 0 + 279  + 2 8 7 ; 310 4 . 0 6 + 4 . 0 4 .
H C
O
\j
i + 0 . 0 4 1 4 . 1 6 - 3 0 8 . 5 4 . 0 8
7 . 0 0 2 2 2 ; 289 4 . 3 9 ; 4 . 0 4
3 . 9 9 ± 0 . 0 2 2 . 0 + 283  + 2 8 8 ; 312 4 . 0 7  ■+ 4 . 0 7 ;
1 2 .50 + 0 . 0 4 1 4 . 0 - 2 2 3 ; 304 4 . 3 7 ; 4 . 1 0
7 . 0 0 2 5 7 . 5 3 . 7 4
2 . 9 4 + 0 . 0 4 0 . 0 + 2 8 6 3 . 7 8
1 0 .2 4 + 0 . 1 1 2 . 3 — 2 7 8 . 5 3 . 8 2
3 .7 9 ;
. '  2
3.-9
3 ! ' ■•  I .
, o -U ih y d ro -4 -h y d ro x ^  p t e r i d i n e
Talile 11 (continued)
x-,y-I)ihydro-4-hydroxypt eridine
7.8- Dihydro-6-hydroxypteridine ^ ^ 
5,6-Dihydro-7-hydroxypt eridine ~ ^
7.8- Dihyüro-2,6-dihydroxypteridine
7.8- Dihyclro-4,6-dihy roxypt eridine 
x ,y-Dihydro-2,7-dihydroxypt eridine 
5, S-Dilaydro-4,7-dihydroxypt eridine
7.8- Dihydro-2,4,6-trihydroxy- 
pteridine
7.0 0
0.32 + 0.05 - 2 -0 h) +
12.13 + 0.03 14.15 —
7.0 0
4.53 + 0.03 2.0 +
10.54 + 0.02 13.0 -
6.0 0
3.36 + 0.01 1.02 +
9.94 + 0.05
6.0 0
2.80 + 0.02 0 +
10.22 + 0.01 12.3 -
6.5 0
9.07 + 0.05 12.0 -
3.52 0
5.84 + 0.02 7.98 -
5.0 0
8.45 + 0.02 10.90 -
4.78 0
7.07 + 0.03 9.14 -
248; 367 3.86; 3.68
257; 374 3.87; 3.80
253; 364 3.97; 3.70
295 3.93
292 4.02
227; 308 4.09; 4.05
271; 319 3.58; 3.70
223; 284; 352 4.47; 3.74; 3.71
237; 265; 290 4.11; 3.90; 3.46
257; 317 4.01; 3.86
279; 315 4.01; 3.70
274; 318 3.90; 3.69
273; iOO 3.83; 3.67
252; 324 3.50; 3.97
258; 340 3.49; 4.01
217; 275; 328 4.23; 3.78; 3.71
254; 310 3.72; 3.59
267; 306 3.90; 4.09
222,:5; 272; 306 4.34; 4.05; 3.89
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Talle 12
Ultraviolet spectra of 5,6,7,8-tetrahydropteridines and the
corresponding 4,5-diaminopyrimidines (from literature), 
("neutral molecule" for those done in alcohol, and "cation" for 
those done in acid .)
(N.Ü, The and 6-positions in pyrimidine are equivalent).
i
5,6,7,8-Tetrahydropteridine 4,5-Diaminopyrimidine
A max.(mp) A max.(mp)
Unsubstituted 208; 304D Unsubstituted 284
2,4-Dichloro- 318 3) 2,6-Dichloro- 303
4,6-Dimethyl- 213; 3064) 6-Methyl- 288 4 5
2-Chloro-4,6-dimethyl- 221; 3104' 2-Ohioro-6-methyl- 214; 2924^
2-Hydroxy-4,6-dimethyl- 230; 3254^ 2-IIydroxy-6-methyl- 214; 2934
1) cation ; Brook and Ramage, 1957.
2) cation ; Mason , 1954.
3) neutral molecule (in ethanol); Taylor and Sherman, 1959.
tion ; Lister and Ramage, 1953.
*  — —  ■
Many of the above measurements were not made on isolated ionic 
species of the substance . However, the spectra which were 
determined in O.lN-hydrochloric acid are considered to be largely 
those of cations and those determined in ethanol are considered to 
be largely those of neutral molecules.
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Talle 13.
Comparison of ultraviolet spectra of isolated species of 
tetrahydropteridines and the corresponding 4,5-diaminopyrimidines. 
(N.B. The 4- and 6-positions are equivalent in pyrimidine).
ionic
±L±L-\L
species Xmax. (mil) log £
_ * 5,6,7,o-Tetrahydro-2-hydroxypteridine 0 306 3.70
+ 327 3.69
- 315 3.79
4,5-Pianino-2-hydroxypyrimidine 0 292 3.58
+ 305 3.70
- 303 3.67
*5,6,7,o-Tetrahydro-4-hydroxypteridine 0 289 4.10
+ 259 4.06
- 284 4.11
* *4,5-Biamino-6-hydroxypyrimidine 0 278 3.95
+ 258 3.74
— 272 3.87
Present work.
Mason , 1954.
0 : neutral molecule, + : cation, : anion.
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T ab le  14
U l t r a v i o l e t  s p e c t r a  o f  4 , 5 - d i a m in o p y r i m id i n e  and o f  t h e  
p r o d u c t  o b t a i n e d  by a l k a l i n e  h y d r o l y s i s  o f  d i h y d r o - 7 -  
h y d ro x y p te  r i d i n e .
i o n i c  s p e c i e s pH Xmax(mp) l o g  t
4 , 5 - B ia m in o p y r im id in e n e u t r a l  m o le c u le 8 .0 5 289 3 . 8 6 ^
c a t i o n 3 .25 284 3 . 9 4 1 '
A l k a l i n e  h y d r o l y s i s  p r o d u c t c a t i o n 3 . 0 288 3 . 9 4 2)
o f  d i h y d r o - 7 - h y d r o x y p t e r i d i n e z w i t t e r i o n 6 .67 282 3 . 9 3 2 '
1) Mason , 1954
2) A l b e r t , Brown and Cheeseman, 1952
r* L I B R A R Y  P J
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Table 15
Ultraviolet spectra of pteridines and their 7,8-dihydro-derivatives. 
(Values underlined refer to shoulders or inflexions).
1 }Aminopt eridine J' 1 
(both in 0.1N-HC1)
Pteridine 
A max. (mji)
7,8-Dihydro- 
Amax.(mp)
2-Amino- 6-met hy lpt eri dine 
2-Amino-6,7-diphenylpt eridine 
2-Diethylamino-6,7-diphenylpteridine 
4-Amino-6,7-diphenylpteridine 
4-Dimethylamino-o,7-diphenylpteridine
235; 305 
275; 335 
230; 273; 335 
278; 375 
395
290
232; 335 
232; 280; 337 
257; 370
230; 265; 310; 385
ionic
Hydroxypteridine species
2-IIydroxypt eridine 0
+
2-Hydroxy-o-methylpteridine 0
+
2-Kydroxy-4,6-dimethylpteridine 0
+
230; 307 
233; 308 
260; 375
235; 315 
240; 310; 331 
261; 377
223; 290
290; 310 *_ *308
220; 287
279; 310_ _ *308.5
222; 289 
283+288; 312 
222; 304
4-Hydroxypteridine 0
+
x,y-Dihydro-
230; 310 2'
257; 303 2'
242; 333 ^
248; 367 
257; 374 *
l) Boon and Jones ,1951.
2) Brown and Mason ,1956. 
* ---- it work
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SECTION 4.
EXPERIMENTAL
M i c r o a n a ly s e s  were k i n d l y  c a r r i e d  out  by Dr.  J . E .
P i l d e s  and h e r  s t a f f  i n  t h e  D epar tm en t  o f  M e d ic a l  C h e m is t ry  
i n  t h i s  u n i v e r s i t y .  Samples s u b m i t t e d  f o r  a n a l y s e s  were 
d r i e d  a t  1 0 S ° / 0 . 1  mm., u n l e s s  o t h e r w i s e  i n d i c a t e d .  I n  t h e  
e x p e r i m e n t a l  p a r t ,  t h e  a n a l y t i c a l  v a l u e s  be tw een  0 .0 7  and 
0.13/0 a r e  r e c o r d e d  a s  0 . 1 $  and t h o s e  be tw een  0 .1 4  and 0 .1 6 $  
a s  0.15/0.
A l l  m e l t i n g  p o i n t s  r e c o r d e d  below were t a k e n  i n  soda  
g l a s s  c a p i l l a r i e s  and a r e  u n c o r r e c t e d .
A l l  p a p e r  c h r o m a to g r a p h ic  r u n s  m en t io n ed  i n  t h i s  
t h e s i s  were c a r r i e d  out  by t h e  " a s c e n d i n g  f r o n t "  method 
u s i n g  Y/hatman No 1 o r  No 4 p a p e r .  Both  ( a )  3f° aqueous 
ammonium c h l o r i d e  (NH^Cl) and (b )  n - b u t a n o l  (7 vo lumes)  +
5 IT -ace t ic  a c i d  (3 vo lum es)  (Bu/ A c ) were u s e d  a s  s o l v e n t s .
The p a p e r  chromatograms were examined u n d e r  u l t r a v i o l e t  
l i g h t  a t  two w a v e l e n g th s ,  ( a )  p r i n c i p a l l y  365 mji, w i t h  a 
m erc u ry  v a p e r  lamp and a  Wood’ s g l a s s  f i l t e r ,  and (b )  
p r i n c i p a l l y  254 mp, w i t h  a m e rc u ry  r e s o n a n c e  lamp and a 
Chance B r o t h e r ’ s 0X7/19Ö74 f i l t e r .  The c o l o u r s  of 
o b s e rv e d  f l u o r e s c e n c e s  a r e  r e c o r d e d  i n  t h e  e x p e r i m e n t a l  p a r t  
o f  t h i s  t h e s i s  a s  f o l l o w s :  Y = y e l l o w ,  G- = g r e e n ,  W = w h i t e ,
SB = sky b l u e ,  B = b l u e ,  V = v i o l e t .  Two f u r t h e r  symbols 
mean: D = d a rk  ( i . e .  a b s o r p t i o n  o c c u r s ) ,  X = n e i t h e r  a b s o r p t i o n
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nor fluorescence occurs. Thus 0.75 2D/3B indicated a dark 
spot visible in the light of the 254 mp lamp, and blue 
fluorescence in the light of the 365 mp lamp, and 0.75 is 
the Rf value. Similarly 2/3B indicates a blue fluorescence 
under both the 254 mp and the 265 mp lamps.
•./hen two substances had to be compared for identity, 
they were always run simultaneously.
All new compounds can be distinguished from previously 
reported compounds by the convention of The Chemical Society, 
namely that the ideal analytical figures for a new compound
are cited as "......requires...... ", and for a previously
known compound as M......calc, for...... " . The names of
new compounds are underlined at their first mention in the 
experimental part. (As in the Journal of the Chemical Society, 
names which are paragraph headings are also underlined but this 
does not indicate that the compound is new), 
a. Reduction.
Reduction of 2-hydroxy uteridine.
i) with potassium borohydride. Potassium 
borohydride (330 mg.) was added to a solution of 2-hydroxy- 
pteridine monohydrate (1.0 g.) in O.lN-sodium hydroxide 
(100 ml.), and the mixture was kept under nitrogen overnight 
at room temperature. Neutralization with phosphoric acid 
gave a precipitate which on recrystallization from water 
gave 3,4-dihydro-2-hydro xy-pt eridine (610 mg., 55/0, it
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darkens at 250° (Pound: G, 48.1; II, 4.1; N, 36.9. 
CgHgN^O requires 0, 48.0; H, 4.0; N, 37.0C/'). Prom the 
filtrate of the reaction mixture, 5,6,7, -tetrahydro-2- 
hydroxypteridine was detected hy paper chromatography.
NH4C1 Bu/Ac.
3,4-dihydro-2-hydroxypteridine o. 69 2B/3V 0. 37
the filtrate 0.74 23L/3G 0.22 2/3G-
_ -x-5,6,7,8-tetrahydro-2-hydroxypteridine 0.74 2SB/3G 0.22 2/30
ii) with sodium dithionite. Sodium dithionite (4.8 g.) 
was added to a boiling solution of 2-hydroxypteridine 
monohydrate (l.O g.) in N-sodium carbonate (30 ml.). After 
chilling overnight under carbon dioxide, the precipitate 
was extracted with hot water (20 + 20 ml.), the second 
extract was concentrated to 5 ml. and added to the first. 
Chilling gave 3,4-dihydro-2-hydroxypteridine (230 mg., 25/«), 
decomposing at 250cC without melting (Pound for material 
dried at 20°: C, 47.9; H, 4.05; N, 37.1. Calc. for CgHgN.O: 
C, 48.0; H, 4.0; N, 37.3',.'). A product (65 mg.) insoluble 
in boiling water, remained on recrystallization.
Greneral procedure for catalytic hydrogenation.
The hydrogenation of hydroxypteridines was carried 
out using a semimicro hydrogenation apparatus at room 
temperature (20-22°0) and atmospheric pressure (about 710- 
720 mm.). After absorption of hydrogen by the catalyst had
* Obtained by synthesis, see p. 152.
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ceased, the sample was introduced and further absorption 
of hydrogen was recorded. The following is a typical 
example of the hydrogenation over palladium on carbon 
catalyst, and the results of all such hydrogenations are 
summarized in Table 11. Only exceptional cases are detailed 
in the experimental part.
Hydrogenation of 2-hydroxypt eridine.
i) over palladium catalyst in 0. HT-sodium hydroxide 
solution. 2-Hydroxypteridine monohydrate (l.O g., 0.6 m mole)
in O.lN-sodium hydroxide (100 ml.) was hydrogenated over 
palladium on carbon (10$ Pd; 500 mg.), and 120 ml. of 
hydrogen (80$ of theoretical for 2H) was absorbed in 20 min., 
when the rate of absorption fell sharply. After filtering off 
the catalyst, the filtrate was adjusted to pH 6, giving 3,4- 
dihydro-2-hydroxypteridine (600 mg., 67$), which was 
crystallized from water and identified by paper chromatography. 
Rf. 0.69 213/3V (NKfll), 0.50 2B/3V (Bu/Ac).
ii) over Raney-nickel. (a) 2-Iiydroxypt eri dine (1.0 g. ,
6 m mole) in methanol (500 ml.) was hydrogenated over Raney- 
nickel, and the absorption of hydrogen stopped after 20 ml. 
was absorbed (13$ of theoretical for 2H).
(b) 2-Hydroxypteridine (1.0 g., 6 m  mole) in methanol 
(500 ml.) containing N-sodium hydroxide (6 ml.) was 
hydrogenated over Raney-nickel, and 170 ml. of hydrogen 
(120$ of theoretical for 21“) was absorbed in 4 hr. After 
removal of the catalyst, the filtrate was evaporated to
d r y n e s s  ( i n  v a c u o ), and r e c r y s t a l l i z a t i o n  ox t h e  r e s i d u e
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f rom w a t e r  gave 3 , 4 - d i h y d r o - 2 - h y d r o x y p t e r i d i n e  (311 mg. 42/-),
i t  d a rk e n s  a t  250° (Found: C, 4 7 .9 ;  H, 4 . 1 ;  N, 3 7 .2 .
C a lc ,  f o r  CgH6N40 : 0 ,  4 8 . 0 ;  H, 4 . 0 ;  N, 3 7 . 3 # ) .
The f i l t r a t e  f rom t h e  r e c r y s t a l l i z a t i o n  was t a k e n  t o
d r y n e s s  and e x t r a c t e d  w i t h  w a t e r  ( 1 . 5  m l . ) .  The e x t r a c t
a
was e v a p o r a t e d  t o  d r y n e s s  i n  d e s i c c a t o r , and r e e x t r a c t e d  
w i t h  m e th a n o l .  The m e th a n o l  s o l u t i o n  was examined hy 
p a p e r  c h ro m s to g ra p h y  and hy u l t r a v i o l e t  s p e c t r a .  I t  gave 
R f .  v a l u e s  0 .7 4  2SB/38 ( N H ^ l ) ,  0 .2 2  2 /3 0 .  ( A u t h e n t i c  
5 , 6 , 7 , 8 - t e t r a h y d r o - 2 - h y d r o x y p t e r i d i  ie gave  0 .7 4  2SB/30 
(ITH.Cl), 0 .2 2  2 / 3 0 ) ,  and A .max. 325 mp a t  pH 1 , and 304 mp 
a t  pH 7 ( a u t h e n t i c  sample  g i v e s  \  ~ >7 t  pH i . O ,
306 mp a t  pH 7 . 1 6 ) .
i i i ) o v e r  Adams* p l a t i n u m  o x id e  c a t a l y s t , ( a )  2-
r o x y p t e r i d i n e  i n  f o r m ic  a c i d  o r  i n  d i m e t h y l f o  ide  
l i d  n o t  a b s o r b  h y d ro g en  o v e r  Adams’ c a t a l y s t .
(b )  2 - H y d r o x y p t e r i d i n e  (166 m g. ,  1 m mole)  i n  w a t e r  
(300 m l . )  o v e r  Adams’ c a t a l y s t  a b s o r b e d  100 ml,  o f  h y drogen  
( t h i s  c o r r e s p o n d e d  t o  8H). The s o l u t i o n  was c o n c e n t r a t e d ,  
b u t  n e i t h e r  a b s o r p t i o n  n o r  f l u o r e s c e n c e  was d e t e c t e d  on 
p a p e r  c h ro m a to g r a p h y . The p r o d u c t  i s  v e r y  s o l u b l e  i n  w a t e r  
and f u r t h e r  i n v e s t i g a t i o n  was abandoned  b e c a u se  i t  was e i t h e r  
a  f u l l y  h y d r o g e n a t e d  p r o d u c t  o r  i t s  d e c o m p o s i t i o n  f r a g m e n t s .
y 1
As t h e r e  was no t  enough m a t e r i a l  t o  p u r i f y ,  t h e  c o r r e c t  
e x t i n c t i o n  c o u ld  no t  be d e t e r m i n e d .  __ _
L I B R A R Y  + . )
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""eduction of 3, 4-dihydro-2-hydroxy uteri dine over
1 cat ~_fc. Ti by. 3,4-dihydro-2-hydroxypteridine (150 mg.,
.3 m mole) was hydrogenated in water (150 ml.), it absorbed 
> ml. of hydrogen (6 h) in 40 hr. As in the above case, 
neither absorption nor fluorescence was detected in the 
reduction mixture and no further investigation of the 
product was undertaken.
!e duct ion of 4-hydroxy ,ot eri dine .
i) with ,jQtasciu.il borohydride. Potassium borohydride 
(500 mg., 8 L) was ..deed to a solution of 4-hydroxypt eri dine 
(740 mg. 5 m mole) in N-potassium carbonate (10 ml.), and 
kept overnight at room temperature. The mixture was 
adjusted to pH 5 with hydrochloric acid to deconrpose the 
excess of borohydride, and then adjusted to pH 10 with 
potassium hy."roxide. The solution was evaporated to dryness 
in vacuo with "Hyflo-supercelM (2 g.) and extracted with 
ethyl acetate using a Soxhlet extractor (for 40 hr.).
The extract gave a mixture of di- and tetra- hydro-4- 
hydroxypteridine (224 mg.) whereas the unchanged 4- 
hydroxypteridine remained in the thimble. The mixture of 
hydro-derivatives was extracted with warm ethanol (20 ml.), 
and the residue, crystallised from water (2.5 ml.), gave 
x ,y-dihydro-4-hydroxypteridine as yellow needles (56 mg.,
7.5/0, m.p. 263-265° (decomp.) (Found: G, 48.2; K, 4.05;
N, 36.95. C5H6N40 requires C, 48.0; H, 4.0; N, 37.3>0.
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The ethanol extract, on concentration and recrystallisation 
from ethanol (2 ml.), gave 5, 6.7.8-tetrahydro-4-hydroxy- 
gteridine as huff prisms (66 mg., 8.8$«), m.p. 230° (decomp.) 
Found: 0, 47.35; , 5.5. CgHgN^O requires 0, 47.35;
j 5.3/). (See p. 48 for establishment of its identity 
with synthetic material; see below for material obtained 
by hydrogenation).
ii) with sodium amalgam. Sodium amalgam (4$«, 4 g. ) 
was added with stirring to a suspension of 4-hydroxy- 
pteridine (148 mg., 1 m mole). The mixture changed first 
to yellow, then brown and finally it became colourless.
After removal of the mercury, the solution (on adjustment to 
pH 7) gave a white precipitate, which in air changed to a 
brown substance, Rf. 0.41 2/3W (NH4Cl)l 0.05 2V//3Y. Paper 
chromatography of the filtrate detected 5,6,7,8-tetrahydro- 
4-hydroxypteridine, Rf. 0.68 2B/3V (NH^Cl), 0.26 213/3V 
( Bn/Ac ).
Hydrogenation of 4-H.ydroxypteridine.
i) over Raney-nickel. 4-Hydroxypteridine (2.25 g.,
15 m mole) in ethanol (300 ml.) was hydrogenated over Raney- 
nickel (20 g.) and 470 ml. of hydrogen was absorbed in 40 
min. The filtrate from the catalyst was concentrated to 
dryness and the residue crystallized from ethanol, giving 
5,6,7,8-tetrahydro-4-hydroxypteridine as pale buff prisms
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(1.38 g., 6050, m.p. 228-230° (Pound C, 47.5; H, 5.45;
N, 36.95. Calc, for CgHgN^O: 0, 47.35; H, 5.3; N, 36.8?»).
ii) over palladium on carbon. 4-Hydroxypteridine 
(148 mg*, 1 m mole) in 0.lN-potassium hydroxide (10 ml*) 
was hydrogenated over palladium on carbon. Absorption of 
hydrogen ceased after 40 min. and 32.2 ml. (60c/o for 4H) 
of hydrogen was absorbed. No crystallizable substance was 
isolated from the reaction mixture but an unstable product 
(20 mg.) was obtained, which oxidized to a brown substance 
in air. In the filtrate 5,6,7,8-tet'rahydro-4-hydroxy- 
pteridine was detected by paper chromatography, Rf. 0*68 
2B/3V (NH^Cl), 0.26 2B/3V (Bu/Ac ), (5,6,7,8-tetrahydro- 
4-hydroxypteridine gave Rf. 0.68 2B/3V (NH^Ol), 0.26 2B/3V 
(Bu/Ac)).
Reduction of 6-hydroxypteridine.
i) with potassium borohydride. Reduction of 6-hydroxy- 
pteridine is one of the most typical examples of the 
reduction of hydroxypteridines with potassium borohydride. 
The results of all such reactions are summarized in Table 
17, p.140 , and only exceptional cases are detailed in the 
experimental part.
Potassium borohydride (55 mg.) was added to 6-hydroxy- 
pteridine monohydrate (156 mg., 1 m mole) in 0.lN-potassium
129
hydroxide (10 ml.), and kept overnight at room temperature. 
The mixture was adjusted to pH 6 with phosphoric acid.
The precipitate of 7,8-dihydro-6-hydroxypteridine (143 mg.,
36$), crystallized from water, decomposed at 310° 
without melting (Found: 0, 47.6; H, 4.0; N, 36.59. Calc, 
for C6H6N40: 0, 48.0; H, 4.0; N, 37.37$).
ii) with sodium dithionite. Sodium dithionite 
(300 mg.) was added to a hot solution of 6-hydroxypteridine 
monohydrate (200 mg., 1.2 m mole) in N-sodium carbonate 
(6 ml.), boiled for one min., and cooled to room temperature. 
Neutralization of the mixture with phosphoric acid gave a 
crude product, which was boiled with IT-hydrochloric acid 
and then adjusted to pH 7 with sodium hydroxide. 
.Recrystallization of the precipitate from water gave 7, - 
dihydro-6-hydroxypteridine as colourless micro needles 
(132 mg., 65.77$), decomposing at 310° without melting 
(Found: G, 48.25; H, 4.2; N, 36.6. Gale, for CgHgN^O 
G, 48.0; H, 4.0; N, 37.3/0 .
Hydrogenation of 6-hydroxypteridine over palladium 
on carbon. This gave 7,8-dihydro-6-hydroxypteridine in 
637$ yield (see Table 16, p.139 ).
Reduction of 7-hydroxypteridine.
i) v/ith potassium borohydride. This gave 5,6-
dihydro-7-hydroxypteridine in 807$ yield (see Table 17).
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ii) with potassium amalgam. 4$-Potassium amalgam 
(5 g. , a 150$ excess for 2 H) was added with stirring to 
an ice cooled suspension of 7-hydroxypteridine (148 mg.,
1 m mole) in water (10 ml.). After 10 min. the supernatant 
solution was adjusted to pH 7 with hydrochloric acid, 
recrystallization of the precipitate gave 5,b-dihydro-7- 
hydroxypteridine as colourless needles (63 mg., 43$), 
decomposing at 235° without melting (Pound: G, 48.25;
H, 3.9; N, 36.86. Calc, for CgHgN^O: C, 48.00; H, 4.0;
N, 37.3$).
Hydrogenation of 7-hydroxypteridine over palladium 
catalyst. This gave 4-amino-5-carboxymethylaminopyrimidine 
in 63$ yield (see Table 16).
Hydrogenation of 2,4-dihydroxypteridine.
i) over Adams* catalyst. When 2,4-dihydroxypteridine 
(164 mg., 1 m mole) in formic acid (12 ml.) was hydrogenated 
over Adams’ catalyst, it absorbed 48 ml. (4 H) of hydrogen 
and gave the same sxoot on paper chromatography as that 
obtained by the reduction of 2,4-dihydroxypteridine with 
sodium amalgam.
ii) over palladium on carbon. When 2,4-dihydroxy­
pt eridine (164 mg. 0.1 mole) in O.lN-sodium hydroxide was 
hydrogenated over palladium on carbon, it absorbed 50 ml. 
of hydrogen (4 H). Paper chromatography indicated that the
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product is the same 5,6,7,8-tetrahydro-2,4-dihydroxy- 
pteridine obtained by reduction of the pteridine with 
sodium amalgam.
Reduction of 2t4-dihydroxypteridine.
i) with sodium amalgam. (a) 2,4-Dihydroxypteridine
(300 mg., 3 m mole) was reduced with 4$-sodium amalgam (9 g.) 
under a nitrogen atmosphere. 2,3-himercaptopropanol 
(l x 10 J M solution, 3 ml.) was added to the mixture as an 
antioxidant and then the mercury was separated by decantation. 
The solution was quickly adjusted to pH 5 with acetic acid 
and the precipitate centrifuged, washed with 1 x 10  ^M 
dimercaptopropanol solution (3 x 50 ml.), and dried at room 
temperature under nitrogen at 10  ^mm. This gave 
5.6.7.8-tetrahydro-2.4-dihydroxypteridine as a pale buff 
powder (317 mg., 63/0. This sample quickly changed to a 
brown substance in air and no accurate decomposition point 
was determined. (Pound for substance dried at 20°,
10 1 mm»: G, 42.2; H, 4.1; N, 32.2, adjusted for presence of
5 sodium acetate* to G, 42.95; H, 4.2; N, 33.3 .
■&As the substance precipitated as a slime, and had to be 
centrifuged, some sodium acetate remained injspite of 
repeated washing. This explains the trace of ash in the 
combusted sample. Further washing caused decomposition 
of the substance due to oxidation.
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C^HgO^N^ requires G, 42.85; H, 4.8; N, 33.3/0. It gave Rf.
•X’X"0.69 2D/3B (NH4C1) .
(b) 2,4-Dihydroxypteridine (500 mg.) was reduced with 
sodium amalgam as above, and the solution was added to 10$ 
acetic acid containing 1 x 10 J mole dimercaptopropanol
(20 ml.). The precipitate was centrifuged and dried under 
nitrogen at 10 x mm. over I-pO; . formic acid (50 ml. ) and 
acetic formic anhydride (5 ml.) were added to the product 
and kept at room temperature overnight. The small amount 
of precipitate was discarded and the filtrate was evaporated 
to dryness under reduced pressure. Crystallization of the 
residue from water gave N-formy1-5.6,7.8-tetrahydro-214- 
dihydroxyyteridine (140 mg., 28$), m.p. ca 300° (decomp.) 
(Pound: 0, 40.55; H, 4.1; N, 27.2. C?H g N ^ . - ^ O  requires 
0, 41.0; H, 4.4; N, 27.05$).
(c) reoxidation. 2,4-Bihydroxypteridine (164 mg.,
1 m mole) was reduced with sodium amalgam exactly as above, 
and the solution was reoxidized with air using a semimicro­
hydrogenation apparatus, and 20 ml. of oxygen was absorbed 
(80$ calc, for 0o).
ii) with sodium dithionlte. Sodium dithionite (4.8 g.) 
was added to a hot solution of 2,4-dihydroxypteridine (1.64 g., 
0.01 mole) in O.lN-sodium hydroxide (100 ml.) and boiled
All processes of paper chromatography for tetrahydro-2,4- 
dihydroxypteridine, i.e. spotting, development and drying, 
were undertaken under nitrogen.
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for two min. The mixture was refrigerated overnight under 
a nitrogen atmosphere and the white precipitate centrifuged. 
The precipitate wa ..ashed with 30p, 45f und 60y ethanol and 
wlen dried under nitrogen at 10 ^ mm, gave a pale huff 
powder (900 mg., 54/3). This product changed to brown in air 
as tetrahydro-2,4-dihydroxypteridine did, and gave the same 
Hf. 0.69 2D/3B (ITH^OI under nitrogen).
The supernatant solution from the centrifuge was 
concentrated to about 50 ml. under reduced pressure at room 
temperature and ethanol (30 ml.) was added. After removal of 
the precipitate, the filtrate was concentrated to 30 ml. and 
60 ml. ethanol was added, and the precipitate was 
recrystallized from 30/3 ethanol, giving sodium tetrahydro- 
2,4-dihydroxypteridine sulphonate as a white powder, slowly 
decomposing at 80° (found for substance dried at room 
temperature 10-1 mm. C, 24.75; H, 3.1; N, 19.15; S, 10.65. 
CgH'yKaO.S.H^O requires 0, 25.0; H, 3.15; K, 19.4; S, 11.1'/«). 
Reduction of 2.6-dihydroxypteridine.
i) with potassium borohydride. This gave 7,3-dihydro- 
2,6-dihydroxypt eri dine in 8 0/3 yield (see Table 17) (found: 
o, 43.3; H, 3.75; N, 33.7 Calc, for C g H g N ^  : C, 43.35;
N, 3.65; N, 33.7/3).
ii) with potassium amalgam. 2,6-Dihydroxypteridine
monohydrate (182 mg., 1 m mole) was reduced with 3/3- 
potassium amalgam (5 g. , 100?c excess for 2 II). This method
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gave no insoluble product and it was abandoned when it was 
found that potassium amalgam decomposed 7,8-dihydro-2,6- 
dihydropteridine to a similar compound.
Hydrogenation of 2,6-dihydroxypteridine.
i) over palladium on carbon. This gave 7,8-dihydro- 
2, 6-dihydroxypteridine in 73/ yield (see Table 16).
ii) over Adams1 catalyst. When 2,6-dihydroxypteridine 
monohydrate (91 mg., 0.5 m mole) in O.lH-potassium hydroxide 
(10 ml.) was hydrogenated over Adams' catalyst (10 mg.),
13 ml. of hydrogen (=2 H) was abosrbed in 7 hr. After removal 
of the catalyst the filtrate was dropped into boiling N-sodium 
acetate (50 ml.), giving 7,8-dihydro-2,6-dihydroxypteridine 
(71 mg., 85/).
Reduction of 4.6-dihydroxypteridine.
i) with potassium borohydride. This gave 7,8- 
dihydro-4,6-dihydroxypteridine in 96/ yield (see Table 17) 
(Round: G, 43.15; H, 3.6; N, 33.5. Gale, for OgHgN^g :
0, 43.4; H, 3.65; N, 33.7/0.
ii) with potassium amalgam. 4,6-Dihydroxypteridine 
(182 mg., 1 m mole) was reduced with 3/ potassium amalgam 
(5 g. 4 H), The solution, on adjustment to pH 6 with 
hydrochloric acid, gave 7,8-dihydro-4,6-dihydroxypteridine, 
which was recrystallized from water (120 mg., 72/). 
Hydrogenation of 4.6-dihydroxypteridine over palladium on
carbon. This gave 7,8-dihydro-4,6-dihydroxypteridine in
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79/ö yield (see Talle 16).
Reduotion of 217-diIiydroxyyt eridine .
i) with pot assium lorohydride. This gave x ty-dihydro- 
2,7-dihydroxypteridine in 84$ yield (see Talle 17) (Found:
C, 43.45; H, 3.75; N, 33.65. 0 ^ 1 1 ^  requires 0, 43.4;
H, 3.65; N, 33.7g).
ii) with potassium amalgam. 3'/"-Potassium amalgam 
(5g., 4 H) was added to a suspension of 4,7-dihydroxypteridine 
monohydrate (182 mg., 1 m mole) in water (5 ml.). After 
removal of the mercury the solution was adjusted to pH 6 with 
acetic acid. Recrystallization of the precipitate from water 
gave x,y-dihydro-2,7-dihydroxypteridine as colourless needles 
(96 mg., 64/5).
iii) with sodium dithionlte. Sodium dithionite (600 mg.) 
was added to a hot solution of 2,7-dihydroxypteridine 
monohydrate (1-2 mg., 1 m mole) in 0.5 N-potassium hydroxide 
(6 ml.) and loiled for 1 min. The mixture was cooled to 
room temperature, adjusted to pH 0 with hydrochloric acid, 
and refrigerated overnight. This gave sodium tetrahydro- 
217-dihydroxypteridine su1phonate as yellow needles (160 mg., 
6O/0 calc, for G-H^N^NaO^S), which was reprecipitated from 
cold water (2 ml.) with hydrochloric acid (pH 0) as yellow 
needles, decomposing at 245° without melting (Found for 
material dried at 65°/lO-1 mm.: 0, 27.05; H, 2.7; S, 11.10;
10>. ash. C.-H„NJTaO-S requires 0, 26.7; H, 2.6; S, II.855S).
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Sodium dihydro-2,7-dihydroxypteridine sulphonate .
Sodium met abi sulphite (600 mg, in 0.3 ml. water) was i to a 
solution of 2,7-dihydroxypteridine (323 mg.) in N-sodium 
hydroxide (1.5 ml.) and kept at room temperature for 5 hr., 
and refrigerated overnight. The product, recrystallised 
from water, gave sodium dihydro-2.7-dihydroxypteriuine 
sulphonate as colourless needles (147 mg.), m.p. 310v' (Found 
after drying at 60o/l0-1 mm.: 0, 23.3; H, 2.4; N, 18.3; S, 10.9. 
CgHJT^Na^O^S.II^O requires C, 23.4; H, 2.0; N, 18.1; S, 10.4/-).
Sodium dihydro-2-hydroxypteridine sulphonate. Sodium 
metahisulphite (500 mg.) was added to a solution of 2-hydroxy- 
pteriaine monohydrate (164 mg.) in N-sodium hydroxide ( 1 ml.). 
After refrigeration overnight the percipitate on 
crystallization fro wat r gave sodium dih;-; ..ro-2- 
hydroxypteridine sulphonate as colourless needles (90 mg.), 
m.p. 310° (deconp.) (Pound: 0, 27.85; N, 2.4; H, 21.45;
3, 12.25. C6H5N4HaC,S.iE£0 requires C, 27.6; H, 2.3; N, 21.45; 
S, 12.3/0.
deduction of 4 t7-dihydrox.ypteridine with potassium
bore1 • ~ ~ ; - e . This r 5, S^dih • ~'-4,7-. ~ ‘  * t^ . mi dine
in 85$» yield, m.p. 300° (decomp.) (Found: 0, 43.5;
H, 3.9; N, 33.4. CrH6H402 requires C, 43.4; H, 3.65;
IT, 33.7#) (see table 17).
Hyorogeny tion of 4«7-dihydroxypteridine over palladium 
on carbon. Thi gave 5,6-dihydro-4,7-dihydroxyp1reridine
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in 6?>3 yield (see Table 16).
Reduction of 2,4t6-trihydroxypteridine.
i) with potassium borohydride. This gave 7,8-dihydro- 
2,4,6-trihydroxypteridine in 77$ yield (see Table 17).
ii) with potassium amalgam. 2,4,6-Trihydroxypteridine 
(198 mg., 1 m mole) was reduced with 3$-potassium amalgam
(5 g., 4 K). The solution, on adjustment to pH 6 with 
hydrochloric acid, gave 7,8-dihydro-2,4,6-trihydroxypteridine, 
which was crystallized from water (11.) (120 mg., 65/0.
Hydrogenation of 2,4« 61 -trihydroxypteridine over 
alladium on carbon. This gave 7,8-dihydro-2,4,6- 
trihydroxypteridine in 75$ yield (see Table 16).
Reduction of 2-amino-4. 6-dl.hydroxypteridine (xanthopterin)
i) with potassium borohydride. This gave 2-amino-7,8~ 
dihydro-4,6-dihydroxypteridine in 90$ yield (see Table 17).
ii) with sodium amalgam. 2-Amino-4,6-dihydroxy- 
pteridine (l g.) was reduced with 4$— sodium amalgam (10 g. ,
3.4 H) to 2-amino-7,8-dihydro-4,6-dihydroxypteridine (752 mg., 
75$).
Reduction of 2-hydroxy-6-methyl ;teridine with potassium 
borohydride. 2-Hydroxy-6-methylpteridine (380 mg.)
(see p.148 ) was reduced by the method used for 2-hydroxy- 
pteridine and gave 3^ 4-dihydro-2■-hydr0xy-6-methy1pteridine 
(96 mg., 30$), darkening above 265° but unmelted even at 
300° (Found: 0, 51.3; H, 4.95; N, 34.0. C^Hgl^O requires
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0, 51.2; K, 4.9; IT, 34.1$). Chromatography indicated 
that this product was not identical with 7,8-dihydro-2- 
hydroxy-6-methylpteridine prepared unambiguously. In 
the reduction mixture a trace of a product, possibly 
5,6,7,8-tetrahydro-2-hydroxy-6-methylpteridine was 
detected by paper chromatography, Rf: 0.75 23B/3G (NE^Cl), 
0.23 2/3 GB (Bu/Ac).
Table 16
Hydrogenation of hydroxypteridines over 10;*-palladium on carbon
Reduction Absorption 
period of
|pteridine solvent (ml.) (min.) hydrogen Product Yield
2-Hydroxy- 0.1N-K0H 10 20 80$ for 4H 3,4-Dihydro- + 5,6,7,8-Tetrahydro- 67
4-Hydroxy- " t ! 30 60$ for 4H 5 ,6,7,8-Tetrahydro- + unstable
substance -
[ 6-Hydroxy- " t ! 20 2H 7,8-Dihydro- 63
■7-Hydroxy- " I t 40 2H 4-Amino-5-carboxymethylaminopyr imidi ne 64
12,4-Dihydroxy- " 20 40 4H 5,6,7,8-Tetrahydro- -
12 ,j 6-Dihydroxy- " f t 10 2H 7,8-Dihydro- 73
4,, 6-Dihydroxy- " f t 70 2H 7,8-Dihydro- 79
12,7-Dihydroxy- " ff 70 2H x,y-Dihydro- 92
4,7-Dihydroxy- " f t 17 hr. 2H 5,6-Dihydro- 67
16,7-Di hydroxy- " t f - 0 -
2,4,6-Trihydroxy- 0.2N-K0H 15 15 2H 7,8-Dihydro- 75
! 2,4,7-Trihydroxy- " f f - 0 -
2,6,7-Trihydroxy- " ft - 0 -
4,6,7-Trihydroxy- " I t - 0 -
;2,4,6,7-Tetrahydroxy- 0.5N-K0H 10 - 0 ■ -
w____
(3,4-dihydro-)
* * * *
Fin all experiments 1 m. mole of hydroxypteridines were reduced over 10^-palladium on carbon catalyst (50 rag.) 
|( Found: G, 48.4; H, 4.2; N, 37.0. Calc, for CgHgOI^ G, 48.0; H, 4.0; IT, 37.355).
[(Found: G, 42.7; H, 4.8; N, 33.3. Gale, for C g H g O ^  G, 42.85; H, 4.8; N, 33.3$).
This product was detected by paper chromatography.
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' Table 17
Reduction of hydroxypteridines with potassium borohydride
Starting
material
Pteri dines (m.Mole) Solution
2-Hydroxy- 6 0.1N-K0H
4-Hydroxy- 5 n -k 2c o 3
6-Hydroxy- 1 0.1N-K0H
p  Hydroxy- 1 0.5N-Kp00,
2,4-Di hydroxy- 1 0.1N-K0H
2,6-Dihydroxy- 1 0.2N-K0H
4,6-Dihydroxy- 2 0.1N-K0H
2,7-Di hydroxy- 1 0.1II-K0H
4,7-Dihydroxy- 1 H 20
6,7-Dihydroxy- ■ 1 0.1N-K0H
2,4,6-Trihydroxy- 0.75 0.3N-K0H
2,4,7-Tri hydroxy- 0.5 0.2N-K0H
2,6,7-Trihydroxy- 0.5 0.2N-K0H
4,6,7-Trihydroxy- 0.5 0.2N-K0H
2,4,6,7-T etrahydro xy- 0.5 0.2N-K0H
2-Amino-4,6-dihydroxy-- 1 H 20
ml.)
XBH4 
(ms.) Product
Yield
(r )
100 330 3,4-Dihydro- 
5,6,7,8-Tetrahydro-
55
10 500 x,y-Dihydro- 7.5
5,6,7,8-Tetrahydro- 8.8
10 55 7,8-Dihydro- 86
8 55 5,6-Dihydro- 80
20 100 No reduction -
10 54 7,8-Dihydro- 80
20 108 7,8-Dihydro- 96
10 54 x,y-Dihydro- 84
20 2x100 5,5-Dihydro- 85
20 100 No reduction
10 54 7,8-Dihydro- 77
10 54 No reduction
10 54 No reduction
10 50 No reduction
20 50 No reduction
5 80 7,8-Dihydro- 90
Pound:
C H N 0 H N
48.1 4.1 36.9 W 4 0 48.0 4.0 37.3
48.2 4.05 36.95 G6H6N4° 48.0 4.0 37.3
47.35 5.5 a6H8H4°2 47.35 5.5
47.6 4.0 36.55 °6H6N4° 48.0 4.0 37.3
47.5 4.1 cs W 48.0 4.0
43.2 3.75 33.6 °6H6IT4°2 43.4 3.65 33.7
43.15 3.6 33.5 a6H6K4°2 43.4 3.65 33.7
43.45 3.75 33.65 °6HSH4°2 43.4 3.65 33.7
43.5 3.9 33.4 °6H6H4°2 43.4 3.65 33.7
38.5 3.3 30.25 °6H6H4°2- 38.6 3.5 30.0
iH20
39.6 4.0 38.65 C6H7iI5°2 39.8 3.9 38.65
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b. Syntheses of Starting Materials 
1) Chloronitropyrimidines.
2,4-Bichloro-5-nitropyrimidine
2,4-Dihydroxy pyrimidine (uracil) was prepared (89)« 
yield) from 4-hydroxy-2-mercaptopyrimidine (thiouracil) 
according to Brown (1952). 2,4-Dihydroxy-5-nitropyrimidine
was prepared (85$ yield) from 2,4-dihydroxypyrimidine by 
nitration according to Brown (1952). 2,4-Dichloro-5-
nitropyrimidine was prepared (77$ yield) from 2,4- 
dihydroxy-5-nitropyrimidine according to Whittaker (1951). 
It distilled at 130°/l0 mm.(lit. 138-139°/l4 mm.).
4.6-"Dichloro-i5-nitro pyrimidine.
4,6-Dihydroxypyrimidine was prepared (61$ yield) 
from malondiamide and ethyl formate according to Hull 
(1951). The product was identified by paper chromatography 
with an authentic sample and it had . . > 300° (Hull gives 
56$ yield, m.p. >300°). 4,6-Dihydroxy-5-nitropyrimidine
was prepared (93$ yield) by nitration of 4,6-dihydroxy- 
pyrimidine according to Boon, Jones and Ramage (1951). The 
product was identified by paper chromatography with an 
authentic sample. 4,6-Dichloro-5-nitropyrimidine was
prepared (77$ yield) from 4,6-dihydroxy-5-nitropyrimidine 
by the action of phosphorus oxychloride and diethylaniline 
according to Boon, Jones and Ramage. It had m.p. 103° (no 
m.p. in lit. ).
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2.4- Dichloro-6-methyl-5-nilropyrimidine was prepared (69A 
yield) by chlorination of 2,4-dihydroxy-5-methyl-5-
nitropyrimidine according to Albert, Brown and Wood (1954). 
It had m.p. 53° (lit. 53-54°).
2.4.6- Trichloro-5-nitropyrimidine.
2,4.6-Trihydroxypyrimidine (barbituric acid) was 
prepared (665* yield) by condensation of urea and diethyl 
malonate according to Dickey and dray (1943). 5-Nitro-
2.4.6- trihydroxy pyrimidine was prepared (857* yield) by 
nitration of 2,4,6-trihydroxypyrimidine according to 
Hartman and Sheppard (1943). It had m.p. 187° (decomp.) 
(lit. 181-183° (decomp.)). 2,4,6-Trichloro-5- 
nitropyrimidine was prepared (23/« yield) by chlorination of
2.4.6- trihydroxy-5-nitropyrimidine according to Robins, 
Dille and Christensen (1954). It had m.p. 57° (lit. m.p. 
57-58°).
2) 4,5-Diaminop.yrimidines
4.5- Diaminopyrimidine
4-Amino-2-chloro-5-nitropyrimidine was prepared 
(79/« yield) from 2,4-dihydroxy-5-nitropyrimidine by the 
action of phosphorus oxychloride and then ammonia according 
to Brown (1952). The product after two recrystallization 
from ethanol had m.p. 216°. (lit. 215-217°). 4,5-Diamino- 
2-mere apt opyrimi dine was prepared (54/« yield, lit. 42 >'«)
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from 4-amino-2-chloro-5-nitropyrimidine by the action of 
sodium hydrogen sulphide according to brown (1952). The 
product gave the same Bf. values as the authentic sample.
4.5- Biaminopyrimidine was prepared (70/? yield) from 4,5- 
diamino-2-mercaptopyrimidine by the action of Raney-nickel 
according to brown (1952). The product had m.p. 203-204.5° 
(lit. 65/* yield and m.p. 201°).
4.5- Piamino-2~h.ydrox.yp.yrimidine.
2.4-Dimercaptooyrimidine was prepared (65£/* yield) from 
4-hydroxy-2-mercaptopyrimidine by the action of phosphorus 
pentasulpjhide according to Brown (1950). The product 
darkened at 240° and decomposed at 255°, and was used for 
the next reaction without further purification as it gave 
only one spot on paper chromatography (Rf: 0.50 2D/3Y 
(NH.CX), 0.74 2D/3Y (Bu/Ac) (lit. m.p. 265-270° (deoomp.)). 
4-Amino-2-mercaptopyrimidine (thiocytosine) was prepared 
(75/* yield) from 2,4-dimer capto pyrimidine by the action of 
ammonia, according to Brown (1950), it had m.p. 266°
(decomp.) (lit. 85/* yield, m.p. 265°for crude and 273° for 
pure material). The crude material was used for the next 
synthesis without further purification. 4-Amino-2-
hydroxypyrimidine (cytosine) was prepared (95y* yield) by 
hydrolysis of 4-amino-2-mercaptopyrimidine according to 
Brown (1950). It had m.p. 306° (decomp.) (lit. 75£/*
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yield and m.p. 305-308° (decomp.)). 4-Amino-2-hydroxy-
5-nitropyrimidine was prepared (89$ yield) by nitration 
of 4-amino-2-hydroxypyrimidine according to Johns (1911).
The product was identified by paper chromatography with an 
authentic sample. 4,5-Biamino-2-hydroxypyrimidine was 
prepared (76^ 0 yield) by reduction of 4-amino-2-hydroxy-5- 
nitropyrimidine according to Brown (1957), m.p. 270-275° 
(decomp.) (Found: 0, 38.3; H, 4.85; N, 44.35. Calc, for 
G6H6N40 : 0 , 38.1; H, 4.83; N, 44.4#).
4 1 5-Diamino-6-hydroxypyrimi dine
4-Amino-6-hydroxy-2-mercapto pyrimidine was prepared 
(79/* yield) from urea and ethyl cyanoacetate according to 
Traube (1904). 4,5-Biamino-6-hydroxy-2-mercaptopyrimidine
was prepared (897* yield) from 4-amino-6-hydroxy-2-mereapt0- 
pyrimidine by nitrosation and then reduction according to 
Albert, Brown and Cheeseman (1951). The product was 
identified with an authentic sample by paper chromatography.
4.5- Biamino-b-hydroxypyrimidine was prepared (46yo yield) from
4.5- diamino-6-hydroxy-2-mercaptopyrimidine by the action of 
Raney-nickel according to Albert, Brown and Cheeseman (1951). 
It had m.p. 238° (decomp.) (lit. 239°).
4. ^ -Diamino-2.6-dihydroxypyrirnidine .
4-Amino-2,6-dihydroxypyrimidine was prepared from urea 
and ethyl cyanoacetate according to Cain, Mallette and Taylor 
(1946). 4,5-Biamino-2,6-dihydroxypyrimidine was prepared
from 4-amino-2,6-dihydroxypyrimidine by nitrosation and
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su b s e q u e n t  r e d u c t i o n  w i t h  sodium d i t h i o n i t e  a c c o r d i n g  
t o  Gain e_b a l .  ( 1 9 4 6 ) .  The o v e r a l l  y i e l d  from e t h y l  
c y a n o a c e t a t e  was 27/*. The p r o d u c t  was i d e n t i f i e d  w i t h  an 
a u t h e n t i c  sample by p a p e r  c h ro m a to g ra p h y .
2 . 4 .  5~Tr i a m i n o - 6 - h y d r o x y p y r im id in e  b i s u l p h i t e . was 
p r e p a r e d  (70/* y i e l d )  f rom g u a n id in e  h y d r o c h l o r i d e  and e t h y l  
c y a n o a c e t a t e  a c c o r d i n g  t o  Gain ,  M a l l e t t e  and T a y l o r  (1 9 4 6 ) .  
The p r o d u c t  was i d e n t i f i e d  w i t h  an a u t h e n t i c  sample  by 
p a p e r  ch ro m a to g ra p h y .
3) P t e r i d i n e s .
A l l  p t e r i d i n e s  i n  Table .  18 were p r e p a r e d  i n  one s t e p  
by known methods from t h e  4 , 5 - d i a m in o p y r i m id i n e s  d e s c r i b e d  
ab o v e .  Most p t e r i d i n e s  have  no m e l t i n g  p o i n t s  and u s u a l l y  
have  no s h a r p  d e c o m p o s i t i o n  p o i n t s .  Hence a l l  such  
p t e r i d i n e s  d e s c r i b e d  i n  t h i s  e x p e r i m e n t a l  p a r t  were 
examined f o r  t h e i r  i d e n t i t y  and p u r i t y  by p a p e r  
ch ro m a to g ra p h y  . These  r e s u l t s  a r e  summarized i n  T a b le  18.
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T ab le  13
S y n th e s i s  o f  h y d r o x y p t e r i d in e s
P t e r i d i n e B e f .
Y ie ld
m .p.
_ B f . 
NH4C1 Bu/Ac
Unsub s t i t u t  e d 1 70 138-139 0 .7 8 2Ü./3T; 0 .7 1 2X/3B
2-H y d ro x y - 1 37 240(d)* ' 0 .7 4 27S/3X 0 .8 0 2YF/3B
4 -H ydroxy - 2 60 ^ 3 0 o ( a ) 0 .S8 23/3S 0 .2 6 2D/3X
6-H ydroxy- 3 85 240(d) 0 .6 6 2D/3X
7-H y d ro x y - 4 70 V 8 0 .6 4 2B/3V 0 .5 4 2X/3B
2 , 4 -D ih y d ro x y - 1 51 250(d) 0 .6 5 2D/3B 0 .2 3 2W/3B
2 , 6 -D ih y d ro x y - 4 61 " >  280 (d ) 0 .6 7 2/3B 0 .13 2/3B
2 ,7 -D ih y d ro x y - 4 35 >  320(d ) 0 .5 0 2DU/3V 0 .1 6 2D/3V
4 , 6 -D ih y d ro x y - 5 50 > 300(d ) 0 .6 3 2/3B 0 . 3 2 2 /3 3
4 ,7 -D ih y d ro x y - 6 20 ^  300(d) 0 .6 1 2BB/3BV 0 .1 4 2X/3B
6 ,7 -D ih y d ro x y - 7 88 ^  3 0 0 ( d ) 0 .6 0 2I/3VB 0 .2 5 2B/37
2 , 4 , 6 - T r ih y d r o x y - 4 50 ^  3 0 0 ( d ) 0 .5 0 2/3SB 0 .2 5 2/33B
2 , 4 , 7 - T r ih y d r o x y - 8 >  3 0 0 ( d ) 0 .4 3 2/3B 0.05 2B/3VB
2 , 6 , 7 - T r ih y d r o x y - 4 95 > 300(d) 0 .6 3
,  *•*
2/3B 0 .0 6 2V/B/3B
•0.55 2/3B
4 , 6 , 7 - T r ih y d r o x y - 5 90 > 300(d) 0 .3 7 2WB/3B 0 .0 4 2'7/3X
2 , 4 , 6 , 7 -T e t r a l iy d ro x y - 4 45 =► 3 0 0 ( a ) 0 .3 0 2 V S/3B 0 . 0 2 23/3X
2-A m ino -4 , 6 - d ih y d r o x y - 9 45 ^  3 0 0 ( a ) 0 .3 6 2/3Y 0 .1 5 2/3Y
l A l b e r t , Brown and Cheeseman, 1951
2 A l b e r t , Brown and Ho o d , 1956
3 A l b e r t , 1955
4 A l b e r t ,  L i s t e r  and P e d e rs e n , 1956
5 ' Alb e r t  and Brown, 1953
6 P f l e i d e r e r , 1959
7 A l b e r t ,  Brown and Oheeseman, 1952
8 P f l e i d e r e r , 1957
9 K ö r t e , 1954
*
**Decomposed w i th o u t m e l t i n g .
j.n aqueous s o l u t i o n ,  t h i s  compound p r e s e n t  a s  an eq u ilib r iu m  
m ix tu re  o f  two s p e c i e s ,  A l b e r t ,  L i s t e r  and P e d e rs e n  (1 9 5 4 ) .
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c . Syntheses of Hydrogenated Pteridines.
7 ,8-Dihydro-2-hydroxy-6-methylpt eridine .
Bhthalimi do acetone was prepared as follows according to 
hr, F. Reich (personal communication): Bromoacetone (60 g.
0.43 mole) was added to potassium phthalimide (92 g. 0.5 mole) 
in dimethylformamide at 60-70° and kept at this temperature 
for 1 hr. Water (450 ml.) was added to the reaction mixture 
and then extracted with chloroform (3 x 150 ml.). The 
chloroform layer was washed with 0.5 N - sodium hydroxide and 
with water. Removal of the chloroform gave a solid which 
melted at 122° (Ellinger and Goldberg, 1949 give m.p. 111-120°). 
Aminoacetone hydrochloride was prepared (74/^  yield) by 
hydrolysis of phthalimidoacetone according to Ellinger and 
Goldberg (1949)* It had m.p. 8l°. 4-Acetonylamino-2-chloro- 
5-nitropyrimidine v/as prepared (62fi yield) from 2,4-dichloro- 
5-nitropyrimidine (see p.141) and aminoacetone hydrochloride 
according to Boon and Jones (1951). It had m.p. 129-130°
(lit. 131°). The chloro-substituent was changed into a 
hydroxy group as follows: 2-chloro-4-acetonylamino-5” 
nitropyrimidine (6.9 g. 0.03 mole) and sodium acetate trihydrate 
(6 g., 0.054 mole) in glacial acetic acid (100 ml.) were 
refluxed for 80 min. Recrystallization of the product from 
water gave 4~acetonylamino-2-hydroxy-5-nitropyrimidine as 
colourless prisms (2.3 g., 36/0, m.p. 186° (decomp.) (Found:
0, 39.55; H, 3.9* C7H8N4°i re(luires c > 39.6 ; H, 3 . W .
This product v/as reduced and cyclized simultaneously as follows:
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4-acetonyl-2-hydroxy-5-nitropyrimidine (2.12 g., 10 m mole) 
in 90^ ethanol (500 ml.) was hydrogenated at 50°G over Raney- 
nickel (5 g*). When absorption of hydrogen ceased the mixture 
was refrigerated overnight, and the catalyst was filtered off. 
Extraction of the catalyst with "boiling water (250 ml.) gave a 
product, which was recrystallized from water. The 7,8-dihydro- 
2-hy droxy~6-methyl yb eridine , micro prisms (0.866 g. , 53(y), 
decomposed at 280° hut did not melt below 320° (found, after 
drying at 135°/lO-1 mm.: C, 50.95; H, 4.8; N, 34.0.
07HgN40 requires C, 51.2; H, 4.9; N, 34.ly»).
2-Hydroxy-6-methylpteridine. 0.1 M - Potassium
permanganate (20 ml.) was added dropwise with stirring to
7.8- dihydro-2-hydroxy-6~methylpteridine (520 mg.) in 0.1 N - 
potassium hydroxide at 0°. The manganese dioxide was filtered 
off and washed with hot water (10 ml.). The combined filtrate 
and washings were adjusted to pH 6 with acetic acid and 
refrigerated overnight. Crystallization of the product from 
water gave 2-hydrox.y-6-methylpteridine as colourless needles 
(380 mg., 67/i). It decomposed at 245° but did not melt below 
300° (Pound: 0, 46.95; H, 4.55; N, 31.3. C-Hgiqo.Hy requires 
C, 46.65; H, 4.5; N, 31.15-/0.
7.8- Dihvdro-2-hydroxypteridine
Aminoacetal was prepared by a modification of the method 
of Allen and Clark (1944). Promoacetal (110 g.) was heated in 
an autoclave with liquid ammonia (450 g.) at 110° for 4 hr.
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After removal of the ammonia, 6 IT - sodium hydroxide was 
added to the residue and the solution was continuously 
extracted with benzene. The extract, after drying over 
sodium sulphate, was fractionated, and the product distilled 
at 65°/17 mm (55.2 g., 75/0. (Allen et al. give 32-39/^ 
yield). Woodward and Doering (1945) record 72.5/* and 
b.p. 99“103<“/l00 mm., but such a high yield has not been 
obtained here by following their direction which evidently 
lack some essential detail.
4~ -Diet ho xy et hy lami no - 2-hydroxy- 5 -ni t ro pyrimidine . 
Aminoacetal (135 g., 0.1 mole) in water (100 ml.) was 
adjusted to pH 7.5 with acetic acid and sodium bicarbonate 
(12 g.) was added. The solution was added dropwise, with 
shaking, to 2,4-*dichloro-5-nitropyrimidine (20 g., 0.101 
mole) in chloroform (100 ml.). Shaking was continued for 
a further 3 hr. until evolution of carbon dioxide had 
ceased. The chloroform layer was distilled with N - sodium 
hydroxide (500 ml.) on a steam bath while bubbling nitrogen 
through the solution for about 20 min. (during this time the 
2-chloro-substituent was replaced by a. hydroxy group).
The mixture was extracted with benzene (3 x 30 ml.) and the 
aqueous solution, after adjustment to pH 6 , was refrigerated 
overnight. The product crystallized from ethanol giving 
4-, -diethoxyethy1amino-2-hydroxy-5-nitropyrimidine as 
colourless leaflets (14.4 g., 53/’), m.p. 157° (Hound:
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0, 44.15; ii, 5.9. g ioK16N405 reluires 0, 44.1; H, 5.9/»).
The benzene extract was evaporated to dryness, and the 
residue recrystallized from, aqueous ethanol giving 
214~bis-, -diethoxyetIi.ylamino-5-nitropyrimidine as colourless 
needles, m.p. 99-100° (Pound: 0, 49.8; H, 7.3.
C16H29N5°6 reluires c > 49.6; H, 7.55#).
5-Amino-4-j-diethoxyethy1amino-2-hydroxypy rimidine.
4-ß-Diethoxyethylamino-2-hydroxy-5-nitropyrimidine (2.53 g.) 
in ethanol (300 ml.) was hydrogenated over Raney-nickel.
After the absorption had ceased (640 ml. of hydrogen, 89# 
for 6 li) the catalyst was filtered off and the filtrate was 
evaporated to dryness at room temperature in a nitrogen 
atmosphere. The residue crystallized from ethanol-ethyl 
a,cetate (l:9) to give 5~amino-4-i'-diethoxyethylamino-2- 
hydroxypyrimidine as a pale green powder (1.2 g., 53/0, m.p. 
174-175° (Pound for substance dried at 20°/l0  ^mm. :
C, 47.0; H, 7.9; N, 22.1. C ^ H ^ N ^ O  V 3/4 H2° reluires 
0, 46.95; H, 7.7; IT, 21.95#).
Attempted cyclization of 5-amino-4-| -diethoxyethylamino- 
2-hydroxypyrimidine (a) The 5-aminopyrimidine (154 mg.) in 
0.1 IT - hydrochloric acid was refluxed under nitrogen for 
15 min., and adjusted to pH 6 with sodium hydroxide. The 
precipitate was filtered off and reprecipitated from 0.1 N - 
hydrochloric acid solution with N- sodium hydroxide giving a 
XJale buff powder (22 mg.) which decomposed at 220-230°
151
without melting (Found: G, 42,7; H, 4.65; N, 32.95.
Gale, for CgHgN^O.HgO : G, 42.85; H, 4.8; N, 33.3/0.
Bf. 0.61 2/3B (I'TH^Gl), 0.07 (Bu/Ac). (7,8-Dihydro-2- 
hydroxypteridine prepared by a different method (see, p.152) 
had Bf. 0.61 2/3 B (NI^Cl)).
The filtrate was evaporated to dryness under nitrogen 
and the residue was extracted with hot ethanol (6 ml.) and 
evaporated to dryness. The residue was crystallized from 
ethanol-ethyl acetate (1:1) giving a pale buff powder .(It 
behaved life (3b-VII) see p. 69)* m.p. 170-175° (decomp.) 
(Found: 0, 41.1; H, 5.65; N, 23.1. C g H - ^ O ,  .H20 requires 
G, 41.4; H, 6.9; N, 24.1/). Bf. 0.83 2/3 B (JJH^Cl), 0.35 
2/3 B (Bu/Ac), Although paper chromatography showed that 
it contained a small amount of the former compound (Bf.
0.61 2/3 B), further purification of this compound was 
abandoned because during the purification it changed to 
the former compound.
(b) The 5-amino-4-ß-diethoxyethylaminopyrimidine, when 
refluxed with IT-hydrochloric acid for 45 min. under nitrogen, 
gave a buff powder, Bf. 0.29 2B/3B (iTH^Cl), 0.08 2/3B 
(Bu/Ac). The same compound was also obtained from the above
two compounds by heating with N- hydrochloric acid.
4-F oriiiy In e t hy I ami no- 2 -hy d ro xy - 5 - n i t ro pyrimidine . 4-ß-
Biethoxyethylamino-2-hydroxy-5-nitropyrimidine (14 g. ) was 
refluxed with N- hydrochloric acid (100 ml.) for 20 min.
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Adjustment of the mixture to pH 4 with sodium bicarbonate 
pave 4~formylnethylanino-T-hydroxy^-nitrooyrimidine as 
colourless needles (6.4 g., 82cg) which were recrystallized 
from water. It darkened at 220-225° without melting 
(Hound: 0, 36.5; H, 3.15. OgHgN^O„ requires C, 36.4;
H, 3.05$).
7.8- Dihydro ~2-hydroxyrf eri dine. 4-Roriay line thy lamino- 
2-hydroxy-5-nitropyrimidine (1.98 g.) was hydrogenated 
over Raney-nickel. The catalyst was collected and 
extracted*with boiling water (SO ml.) giving 7.6-dihydro-2- 
hydroxypteridine (352 mg., 23/’) which recrystallized from 
water as micro-prisms, decomposing at 190° without melting 
(Hound, after drying at 135°/lO ^ mm.: G, 47.0; 1, 4.1;
IT, 36.6. 06H6N40.l/4 Hp0 requires 0, 46.6; H, 4.25; IT,
36.2$). Rf. 0.61 2/3 B (ITIT^ CI): in Bu/Ac it decomposed.
The methanolic filtrate on concentration, gave more of the 
crude dihydro-compound which had the same Rf. values as 
above, but this did not satisfactorily recrystallize from 
water, probably due to impurity.
5.6.7.8- T et rahydro-2-hydroxy ~pt eri dine.
7.8- Bihydro-2-hydroxypteridine in water (100 ml.) was 
hydrogenated over Adams’ catalyst. After removal of the 
catalyst the filtrate was evaporated to dryness. The 
residue, on crystallization from water (5 ml.), gave
5.6.7.8- tetrahydro-2-hydroxypteridine as pale buff needles,
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decomposing at 220° without melting (Found, after drying 
at 106°/l0_1 mm.: 0, 47.5; H, 5.9; N, 36.4. CgHgOI^ 
re quires 0, 47.35; H , 5.3; N , 36.8$). The anhydrous 
material was unusually hygroscoxoic and absorbed one mole 
of water from air in 20 min.
5.5- Dihydro~2-hydroxypteridine
, -Ohloroproptonaldehyde acetal was prepared (19$ 
yield) from acrolein by the action of ethanolic hydrogen 
chloride according to fitzemann, Evans, Hass and- Schroeder 
(1943). It had h.p. 65-70°/l5 iw. (lit. 53-S2°/8 mm.).
It was converted to acrolein acetal (in 78$ yield) by the 
action of potassiu i hydroxide (same reference). It boiled 
at 120-121°/720 mm. (lit. 122-126°). Olyceraldehyde acetal 
was pr<epared (50$ yield) from acrolein acetal by oxidation 
with potassium permanganate (same reference). It boiled 
at 79°/l mm. (lit. 120-l21°/8 mm.). Olyoxal monoacetal was 
prepared (46$ yield) from glyceraldehyde acetal according to 
Fischer and Laer (1935). It boiled at 50-60°/l3 mm. (lit. 
42-43°/l2-13 mm.).
4-Amino-5"5-diethoxyethylamino-2-hydroxypyrimidine.
4.5- Diamino-2-hydroxypyrimidine (630 mg., 5 mmole) and 
glyoxal monoacetal (850 mg., 5.2 m mole) in water (25 ml.) 
were heated for 10 min. on a steam bath. The mixture was 
evaporated to dryness under reduced pressure and the residue 
was triturated with acetone. The solid, in 97/- ethanol (50 ml.
was h y d ro g e n a te d  o v e r  R a n e y - n i c k e l . Removal o f  t h e  c a t a l y s t ,
and c o n c e n t r a t i o n  o f  t h e  f i l t r a t e  gave  4 - a m i n o - 5 - ß -  
d i e t h o x y e t h y l a m i n o - 2 - h y d r o x y p y r i m i d i n e  (117 m g. ,  1 0 / )  a s
C, 49 . 6 ; H, 7 . 5 ;  N, 2 3 . I p .
A t te : i , : t  t o  p r e p a r e  3 . 4 - d t h .y d r o - 2 - h . y d r o x y p t e r i d i n e .
2 -A m in o p y ra z in e -3- a l d e h y d e  oxime was p r e p a r e d  ( 3 4 /  
y i e l d )  from p t e r i d i n e  hy t h e  a c t i o n  o f  h y d ro x y lam in e  
h y d r o c h l o r i d e  i n  2N-sodiurn c a r b o n a t e  f o l l o w e d  by h e a t i n g  w i t h  
N - a c e t i c  a c i d  a c c o r d i n g  t o  A l b e r t ,  Brown and Wood ( 1 9 5 6 ) .  I t  
h d m .p .  200° ( l i t .  1 9 9 - 2 0 0 ° ) .
R e d u c t io n  of  2 -a ia inopyraz ine -3 - -a ldeh ,yde  ox im e . V a r io u s
c o n d i t i o n s  ( s e e  T ab le  19) were u s e d  f o r  t h e  r e d u c t i o n  o f  t h e  
oxime, and h y d r o g e n a t io n  o v e r  Adams' c a t a l y s t  i n  N - a c e t i c  
a c i d  gave t h e  b e s t  r e s u l t .  A l th o u g h  t h e  r e d u c t i o n  m ix t u r e  
e x h i b i t e d  one main s p o t  on p a p e r  ch ro m a to g ra p h y ,  0 .7 0  2 /3  V 
(NILCl) and 0 .2 0  2 /3  V (B u/A c) ,  no p u re  compound c o u ld  be 
i s o l a t e d  and i t  s lo w ly  changed i n  a i r  t o  a d a rk  r e s i n .  
T rea tm en t  o f  the  c rude  p r o d u c t  w i t h  u r e a  (1 9 0 ° ,  45 m i n . ) ,  
u r e t h a n e  ( l 8 0 ° ,  1 h r . )  o r  e t h y l  c h l o r o f o r m a t e  ( r e f l u x  f o r  
3 h r . )  gave  no p r o d u c t  c o r r e s p o n d i n g  t o  3 , 4 - d i h y d r o - 2 -  
h y d r o x y p t e r i d i n e .
n e e d l e s  which c r y s t a l l i z e d  f rom  e t h a n o l ,  m .p .  198-200°  
(Bound: C, 4 9 .1 5 ;  H, 7 . 4 ;  N, 2 2 . 7 .  C10H ,  o N . O - .  r e q u i r^10Kl8 ^ 4 ° 3  reclu i r e s
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Table 19
He duct ion of 2-aminopyrazine-3-aldehyde oxime
Deductant Desuit
I'la2S2°4 Many spots on paper chromatography.
Na-Hg Ammonia evolved.
LiAlH4 Many spots on paper chromatography.
HgltOj in HC1 Y/ent brown, half of theoretical H^ abosrbed.
K^/PtOp in aqueous
NIL OH No reduction.
Hg/PtOg in 0. Ill-
acetic acid 5 H were absorbed (4 H for theoretical) and
one main spot on paper chromatography.
Deduction of 2-amino-3-cyanopyrazine over Adams' catalyst
gave results similar to the reduction of the oxime described above.
2-Amino-3-carboxypyrazine was prepared (79Ä yield) by 
heating the ammonium salt of 2,4-dihydroxypteridine with 2.5N- 
sodium hydroxide according to Y/eijlard, Tishler and Erickson 
(1945). It decomposed at 203° (lit. 201°).
2-Amino-3-methoxycarbony1pyrazine was prepared (70^ yield) 
from 2-amino-3-carboxypyrazine by the action of methanolic 
sulphuric acid according to Ellingson, Henry and McDonald (1945).
It had m.p. 172-173° (lit. 172°).
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2-Amino-3~h,ycroxymethylpyrazine. Lithium aluminium hydride 
(80 mg.) was added to a solution of 2-amino-3-carboxymethyl- 
pyrazine (1.53 g.) in tet rally dr ofuran (200 ml.) and kept at room 
temperature for 2 hr. The complex was decomposed with water 
(3 ml.) and the inorganic salt was filtered off. The filtrate 
was evaporated to dryness and extracted with ether. After removal 
of the ether, crystallization of the residue from amyl acetate 
gave 2-amino-3-hydroxymethylpyrazine as colourless needles 
(574 mg., 46/), m.p. 118-119.5° (found, after drying at 65°/lO “mm. 
0, 47.65; H, 5.7; N, 33.1. C.IL^O requires 0, 48.0; H, 5.65;
N, 33.6/0.
Attempts at the synthesis of 3.4-dihydro-2-hydroxypteridine 
from 2-amino-8-hydroxymethy1pyrazine (a) The pyrazine (100 mg.) 
in hydrobromic acid (sp. gr. 1.48, 1 ml.) was kept overnight at 
room temperature. Only the starting material was detected by 
paper chromatography.
(b) The pyrazine (TOO mg.) was refluxed with hydrobromic acid 
(sp. gr. 1.48, 2.5 ml.). Soon after boiling the mixture became 
a brown resin and no jux»duel was obtained from it.
(c) The pyrazine (100 mg.) was mixed with urea, and heated at 
170°C for 45 min. Paper chromatography of the product 
indicated that no reaction had occurred.
(d) The pyrazine (100 mg.) and urethane (0.5 g.) was heated at 
190° for 1 hr. Paper chromatography of the product indicated
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that no reaction had occurred.
(e) The pyrazine (63 mg.) and potassium cyanate (31 mg.) 
in N-hydrochloric acid (6.5 ml.) were refluxed for 45 min. 
Paper chromatography of the reaction mixture indicated that 
no reaction had occurred.
Hydrogenat ion of 4 t 5-diamino-2-hydroxypyrimidine. When 
4,5-diamino-2-hydroxypyrimidine (1*26 g., 10 mmole) in 0.5N- 
hydrochloric acid (40 ml., 2 eq.) was hydrogenated over 10)q 
palladium on carbon, 250 ml. of hydrogen (2 H) was absorbed. 
After removal of the catalyst, the filtrate was concentrated 
to 3 ml. and the product v/as precipitated with methanol 
(3 ml.). Recrystallization from 90/6 methanol (50 ml.) 
gave the product as colourless needles, m.p. 242-248° 
(decomp.) (Pound, after drying at 62°/lO ^ mm.: G, 27.7;
H, 5.2; N, 23.85. C ^ N . O ^ H C l . ^ O  requires G, 27.5;
H, 5.15; N, 24.1?0. The analysis and properties indicate 
the product is an amino-dihydro-dihydroxy-pyrimidine 
hydrochloride hemihydrate.
5.6,7.8-T et rally dro-4-hydro xypt eridine.
Be nzylami no ethanol was prepared from benzylchloride 
and ethanolamine according to hr. D.J. Brown (personal 
communication) with slight modification. Benzylchloride 
(250 g., 2 mole) and ethanolamine (500 g., 8 mole) was 
heated on a steam bath for 2 hr. with gentle stirring.
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After cooling, 2N-sodium hydroxide (l 1.) was added to the 
mixture and extracted with ether. The extract was washed 
with water and dried over potassium carbonate. After removal 
of the ether, the residue was fractionated under vacuum, 
benzylaminoethanol distilled at 94-96J/0.02 mm. (121 g.,
41/) (lit. 148-149/13 mm.).
5-A,:iino-4- (benzyl-ß-hydroxyethylamino) -o-chloropyrimidine 
hydrochloride. A solution of benzylaminoethanol (15 g., 0.1 
mole) in chloroform (40 ml.) was added dropwise with shaking 
to a mixture of 4,6-dichloro-5-nitropyrimidine (19.5 g., 0.1 
mole) in chloroform (150 ml.) and sodium bicarbonate (8.4 g., 
0.1 mole) in water (30 ml.). Shaking was continued until the 
evolution of carbon dioxide ceased. The chloroform layer was 
washed with water (50 ml.) dried over sodium sulphate, and 
evaporated under reduced pressure to give an oil (37 g. ).
The oil, on hydrogenation over Raney-nickel, absorbed 6.6 1. 
of hydrogen (6 '.), After removal of the catalyst the filtrate
was concentrated to 100 ml. , adjusted to about pH 1 with 
ethanolic hydrogen chloride. Refrigeration of the solution 
gave 5~anino-4"(benzy1-ß-hydroxyethylamino) -6-chloroijyrimidine 
hydrochloride as colourless prisms (9.3 g., 34/). for 
analysis it was rapidly recrystallized from ethanol below 70° 
giving colourless prisms, m.p. 130u (Pound, after drying at
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62°/ IO-1 mm. : 0, 49.S; H, 5.2; 01, 22.5; N, 17.8.
C13H1SC12N4° re1uires °» 49.5; H, 5.1; CI, 22.5; N, 17.8;0.
Ef.: 0.62 2D/3X (ITH.Cl), 0.94 2D/3X (Bu/a o ). '.Then Boiled in 
ethanol for 5 min. the above pyrimidine rearranged to an 
isomer, m.p. 202-203' (Pound, after drying at 62°/lO~'1' mm. :
C, 49.65; H, 5.2; 01, 22.6; N, 13.0. g C l ^ O  requires
0, 49.5; H, 5.1; Cl, 22.5; N, 17.8#). Rf.: 0.77 2D/3X 
(xTH^Cl), 0.66 2D/3X (Bu/Ac). This compound on treatment with 
phosphorus trichloride did not give a tetrahydropteridine.
8-Benzyl-4-ohloro-5.6,7.8-tetrahydronteridine . 5-
Amino-4-(benzyl-p-hydroxyethylamino)-S-chloropyrimidine 
(1.5 g.) was added at 10° G.to phosphorus trichloride and kept 
at room temperature overnight. The excess of phosphorus 
trichloride was distilled off at room temperature and the 
residue was dissolved in water (30 ml.). The aqueous 
solution was extracted with chloroform and then adjusted to 
pH 7 with sodium bicarbonate. The solution was extracted 
with chloroform. Removal of the chloroform gave S-benzyl- 
4-chloro-5.5.7,S-tetrahydroptertdine (975 mg., 79a) which was 
recrystallized from ethanol (4.5 ml.) as colourless needles, 
m.p. 127-128° (Pound, after drying at 74°/lO ~ mm.: 0, 59.9; 
H, 5.0; Cl, 13.95; N, 21.3. C - ^ H ^ d N ^  requires C, 59.9;
II, 5.0; Cl, 13.6; IT, 21.45#).
IGO
5.6,7,6-2etraiiydropteridine. Metallic sodium was added 
in small portions to a solution of 8-benzyl-4-chloro- 
5,6,7,8-tet rally dropteri dine in liquid ammonia (130 ml.) 
until a permanent H u e  colour remained, and the colour was 
retained for 50 min. by addition of sodium. Ammonium chloride 
was added until the blue colour disappeared and the ammonia 
was evaporated, Water (3 ml.) was added to the residue which 
was then extracted with chloroform (5 x 10 ml.). The 
chloroform extract was evaporated to dryness and the residue 
was purified by sublimation. 5,6,7,8-Tetrahydropteridine
(66 rag,, 14/ ) had m.p. 147° (Brook and Ramage (1957) give 
m.p. 146-7°).
Attempted hydrolysis of 8-benzyl-4~chloro-5.6,7.8- 
tetrahydropteridine. A typical method is shown below: 
8-Benzyl-4-chloro-5f6,7,8-tetrahydropteridine (120 mg.) was 
refluxed with IT-sodium hydroxide (50 ml.) and ethanol (10 ml.) 
under nitrogen for 3 hr. The mixture was adjusted to pH 7 and 
evaporated to dryness. The residue was dissolved in ethanol 
(50 ml.), and water (50 ml.) was added dropwise to the 
boiling ethanol solution. This gave colourless needles 
(100 mg., m.p. 126.5-127*5 which had the same Rf. values as the 
starting material and showed no melting point depression 
with it. The results of the reactions under various 
conditions are summarized below.
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Reaction conditions 
(refluxed for 3 hr.)
Starting 
material (mg.)
Recovery of the 
starting material (mg.)
Acetate buffer (pH 5) 
glacial acetic acid
95 86
+ sodium acetate 120 100
SK-HCl 120 95
12N-HC1 120 95
N-NaOH 120 100
2>t sodium methoxide 
4$ sodium hydroxide
120 96
in tri-(ethylenglycol)A 120 *
*No product was isolated. No spot corresponding to the 
4-hydroxy derivative was detected.
5-Amino-4-(benzyl-ß-hydroxyethylamino)-6-benzyloxy- 
pyrimidine . 4,6-Dichloro-5-nitropyrimidine (10 g.) and
henzylaminoethanol (7.8 g.) was condensed by the method
described before, and the chloroform layer was washed with
water, dried over sodium sulphate, and the chloroform removed.
benzene (15 ml#) was added to the residual oil and then
distilled off under vacuum at 30°C, this treatment was repeated
to remove the water and chloroform completely. Sodium
benzyloxide (sodium, 2.5 g. in benzylalcohol, 70 ml.) was added
to the residue and heated on a steam bath for 10 min. I)ry-ice
was added to the cooled mixture to decompose the alcoholate and
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then water (50 ml.) was added. The mixture was adjusted to 
pH 6 with acetic acid and then the benzyl alcohol was removed 
by steam distillation (4- hr.). The residual solution was 
extracted with benzene, and the benzene layer was dried over 
sodium sulphate. After removal of the benzene a light brown 
oil (21 g.) remained. The oil (21 g.) in ethanol over Raney- 
nickel absorbed 2.6 1. of hydrogen (this corresponds to 13.3 g. 
of the product). After removal of the catalyst, the filtrate 
was concentrated to about 40 ml. 10$-Ethanolic hydrogen 
chloride (10 ml.) was added to the concentrate and refrigerated 
for two days, giving needles (604 mg., 3/^ ). The product after 
crystallization from ethanol gave 5-amino-4-(benzyl-;- 
hydroxyethylamino)-b-benzyloxypyrimidine as colourless needles, 
m.p. 203° (Found: G, 62.5; H, 6.0; N, 14.35. a20H221W HG1 
requires 0, 62.1; H, 6.0; N, 14.5$).
Attempted cyclization of 5-amino-4-(benzyl-: - 
hydroxyethylamino)-6-benzyloxypyrimidine. 5-Amino-6- 
benzyloxy-4-(benzy1-ß-hydroxyethylamino)-pyrimidine (600 mg.) 
was added to phosphorus trichloride (10 ml.) and kept at room 
temperature.overnight. Hxcess phosphorus trichloride was 
distilled off under reduced pressure at room temperature and 
crushed ice (5 g.) was added to the residue. The solution was 
extracted with benzene and adjustment of the aqueous solution
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to pH 6 gave 5-amino--4- (‘benzyl-; -hydroxy ethyl ami no)-6- 
hydroxypyrimidine hydrochloricle (218 mg., 48p) which was 
recrystallized from water, m.p. 246-247° (decomp.). The 
free base was obtained by recrystallizarion of the hydrochloride 
at pH 9.7, m.p. 140-142° (Found: C, 59.7; H, 6.3; N, 21.0.
G.13K16N4^2 reiuires 6 ) 60.0; H, 6.2; N, 21.55«).
4-0hloro-6-8thoxy-5-nitropyrimidine was prepared (88$) 
from 4,6-dichloro-5--nit ropyrimi dine and sodium ethoxide according 
to Boon and Jones (1951). The product had b.p. 74°/l mm. and 
m.p. 45.5-46.5° (lit. m.p. 42°).
8-Benzyl-5.6.7.8-tetrahydro-4-hydroxypteridine. 
Benzylaminoethanol (3.8 g. in 10 ml. methanol, 26 m. mole) was 
added to 4-chloro-6-ethoxy-5-nitropyrimidine (2.47 g. in 15 ml, 
methanol, 12 m mole) at 0°, and kept at room temperature over­
night. Excess methanol was removed and water (50 ml.) was 
added to the residual oil. The mixture was extracted with 
benzene (2 x 25 ml.) and the benzene layer was washed with 
water (5 x 50 ml.) to remove benzylaminoethanol,
After removal of the benzene under reduced pressure 
the residual oil was hydrogenated in ethanol over Raney-nickel, 
and 890 ml. of hydrogen was absorbed. After removal of the 
catalyst, the filtrate was concentrated and the excess ethanol 
was completely removed by distillation with benzene.
Phosphorus trichloride (15 g. in 30 ml. benzene) was 
added to the residual oil (in 30 ml. benzene) at 0°, and the
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mixture kept at room temperature for 2.5 days. Paper 
chromatography indicated that cyciization and simultaneous 
hydrolysis occurred during this period. The benzene lay^r was 
discarded, and crushed ice (50 g.) was added to the residue.
The mixture was extracted with benzene, and the aqueous 
solution was adjusted to pH 7 with sodium bicarbonate. 
Crystallization of the product from ethanol gave 8-benzyl- 
5.6.7.9-tetrahydro-4-hydrox.ypteridine as colourless needles 
(747 mg., 26/0, m.p. 170-171° (Pound: C, 64.15; H, 5.75;
I'T, 23.1. C13Hu 1Ta0 requires 0, 64.45; H, 5.8; N, 23.1/0.
5.6.7.8-Tetrahydro-i-hydroxy~oteridine . Finely grounded 
5-benzyl-5,6,7,0-tetrahydro-4-hydroxypteridine (1.0 g.) was 
added to liquid ammonia (130 ml.) followed by sodium until the 
solution became deep blue, and this blue colour was retained 
for 30 min. by the addition of sodium (about 350 mg. was 
necessary). Ammonium chloride was added until the blue colour 
disappeared, and the excess of ammonia was evaporated under 
nitrogen. Water was added to the residue and the solution was 
adjusted to pH 6 with IT-hydro chloric acid. The solution was 
extracted with chloroform and the aqueous layer was evaporated 
to dryness under reduced pressure. The residue was extracted 
with hot ethanol and the extract was evaporated to dryness. 
Crystallization of the residue from water gave 5,6,7,8- 
tetrahydro-4-hydroxypteridine as pale buff needles (348 mg.,
54><?), m.p. 234-238° (decomp.) (Pound, after drying at 135°AO amm.:
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C, 47.25; H, 5.6; IT, 36.35 Calc, for CgHgl^O : C, 47.35;
H, 5.3; N, 36.3#).
516-Sihydro-4-h.ydrox.ypt eridine
4-Amino-5~f-diethoxyethylamino-6-hydroxypyrimidine.
4,5-Siamino-6-hydroxypyrimidine (1.26 g., 10 m mole) and 
glyoxal monoaoetal (1.7 g., 13 m mole) in 90# ethanol 
(200 ml.) were hydrogenated over Raney-nickel. After removal 
of the catalyst, the filtrate was evaporatedjto dryness. 
Crystallization of the residue from acetone gave 4-amino-5-,' - 
diethoxyethylamino-6-hyd ro xypyrimidine (837 mg., 35#) as 
colourless needles. It decomposed at 142° (Pound, after 
drying at 65°/lO ^ mm.: C, 49.1; H, 7.6; IT, 23.15.
°10H13N4°- re<luires 49.55; K, 7.5; N, 23.15#).
5.6-Dihydro-l-hydroxypteridine. 4-Amino-5-ß-
diethoxyethylamino-6-hydroxypyrimidine (839 mg.) was boiled 
with 0.5h-hydrochloric acid (10 ml.) for 1 min. and cooled 
immediately. The solution was adjusted to pH 5 with sodium 
bicarbonate and refrigerated overnight. The precipitate on 
crystallization from water gave 5.6-dihydro-j-hydroxygteridine 
as colourless needles 486 mg., 88#. It decomposed at 230° 
(Pound, after drying at 20°/l0 ^ mm.: C, 46.4; , 4.35; , 36.
C,rHgON^.l/4 Hp0 requires C, 46.6; , 4.25; N, 36.2#). Although 
the product retained l/4 molecule of water when dried at 
20°/l0~^ mm., no isolated carbonyl group could be detected by 
an infrared spectrum. This indicates that the product has 
entirely the ring-closed structure.
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Attempted syntheses for 7,6--dihyclro-4-hydroxypteridlne.
4-, •-Diethoxyethylamino-6-hydroxy-5~nitrQp,yrimidine.
Amino acetal (5.4 g.) in water (50 ml.) was adjusted to pH 8 
with acetic acid and then sodium bicarbonate (6.0 g.) was 
added to the solution. The solution was added dropwise with 
shaking to a cold solution of 4,o-dichloro-5-nitropyrimidine 
(7.9 g.) in chloroform (50 ml.). Shaking was continued for a 
further 2 hr. at room temperature. The chloroform layer was 
distilled with N-sodium hydroxide (200 ml.) on a steam bath 
while bubblin nitrogen through the solution for about 20 min. 
(During this time the 4-chloro-substituent was replaced by a 
hydroxy group). The residual solution was extracted with 
benzene and the aqueous solution was adjusted to pH 6 with 
acetic acid. The precipitate on crystallization from 
ethanol gave 4-[ -diethoxyethylamino-6-hydroxy-5-nitropyrimidine 
(2.99 g., 27?»), m.p. 118-120°. (Pound: 0, 42.35; H, 6.1.
C10H16N4 ° 5 - H2° re9.uires °> 42.75; H, 6.1 °ß>).
Deduction of 4-f-diethoxyethylamino-6--hydroxy-5-
nitropyrimidine (a) When 4-ß-diethoxyethylamino-6-hydroxy- 
5-nitropyrimidine (140 mg., 0.5 m mole) was hydrogenated over 
Haney-nickel, 120 ml. of hydrogen (=10 H, 6 H for NO^ group) 
was absorbed, and the reduction mixture turned brown. 
Concentration of the filtrate gave a brown oil which on 
heating with 0.1 IT-hydrochloric acid for 15 min. gave a dark 
resin, and no product could be isolated. (b) The 
nitropyrimidine (700 mg.) in acetic acid was reduced with zinc
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dust (2.1 g.). After removal of the excess zinc the filtrate 
was concentrated to dryness, and the residue extracted with 
methanol. The extract gave a spot similar to the above 
reduction product (a) on paper chromatography, but no product 
could be isolated.
Hydrolysis of 4-, -diethoxyethylamino-G-hydroxy-^- 
nit ro pyrimidine. 4-p-Biethoxyethylamino-6-hydroxy~5- 
nitropyrimidine (1.5 g., 5 m  mole) in N-hydrochloric acid 
(25 ml.) was refluxed for 10 min. The crystals were 
filtered off and recrystallized from water giving colourless 
needles (967 mg., 89/»). The substance decomposed slowly at 
230° without melting (Found: 0, 39.25; H, 2.6.
0-j ^ HgNpO^.lH^O requires G, 39.05; H, 2.45/0. The product 
absorbed 5 molecules of hydrogen over Raney-nickel and gave 
a dark resinous product.
Attempted syntheses for 7.8-dihydro-4-hydroxy-6-methylpteridine.
4 - Ac e t o nylamino- 6- c hi o r o - 5 -n i t ro ; ;y r irni di ne was prepared 
(47/* yield) from 4,6-dichloro-5-nitropyrimidine and aminoacetone 
hydrochloride according to Boon and Jones (1951). It had 
m.p. 84° (lit. 86°).
4-Acetony 1 amino-6-hydroxy-5-nit ropyrimidine . 4-
Acetonylamino-G-chloro-5-nitropyrimidine (3.6 g . ) was dissolved 
in 50io aqueous ethanol and kept at room temperature overnight. 
The precipitate, crystallized from ethanol, gave 4- 
ac et onylamino-6-hydroxy ■-5-nitro pyrimidine as needles, m.p.
168
207 (decomp.) (Pound: C, 39.1; R, 4.3. C„HgN^0^ requires 
0, 39.6, H, 3.8$). Repeated crystallization of the product 
caused loss of one molecule of water from the molecule and 
gave a product which decomposed at 230° without melting 
(Pound: G, 43.2; H, 3.5. requires G, 43.4;
H, 3.1$).
Hydrogenation of 4~acetonylamino-6-h.ydrox.y~5- 
nitropyrimidine. The nitropyrimidine absorbed 3 mole of 
hydrogen over Raney-nickel, but the reduction mixture turned 
brown. No pure product could be isolated from the mixture, and 
no spot similar to that of x,y-diliydro-4-hydroxypteridine was 
detected on paper chromatography.
Attempted synthesis for 1,2-dihydro-4-h.ydroxypteridine 
(a) 2-Amino-3-oarbamoylpyrazine (30 mg.) in (5 ml.) water was 
heated with 30$ formaldehyde (0.2 ml.) on a steam bath for 20 
min. No product other than the starting material was detected 
in the reaction mixture. (b) The pyrazine (50 mg.) in ethanol 
(10 ml.) was refluxed for 45 min. with 30$ formaldehyde (0.1 ml.). 
No product other than the starting material was detected by 
paper chromat ography.
Attempted syntheses of 5,o-dihydro-T-hydroxypteridine.
Attempted preparation of the Schiffs base of 4.5- 
diaminopyrimidine and ethyl glyoxylate. (a) Ethyl glyoxylate 
hemiacetal (Rigby, 1950) (145 mg., 1 m mole) was added to a 
solution of 4,5-diaminopyrimidine (110 mg., 1 m mole) and
169
kept at room temperature for 10 min. Only 7-hydroxypteridine 
was detected in the reaction mixture, and no sijot corresponding 
to the Schiffs base was detected. (b) Ethyl glyoxylate 
hemiacetal (15 mg., 0.1 m mole) was added to 4,5-diamino- 
pyrimidine (10 mg., 0.1 m mole) in methanol (10 ml.). The 
solution had the same ultraviolet spectrum as 4,5-diamino- 
pyrimidine. Yfrien the solution was diluted with water, it gave 
the same ultraviolet spectrum as 7-hydroxypteridine, and no 
Schiffs base formation was detected.
4 - Ami n o-p-c y an ome t hy 1 ami n o i ry r imi dine. Potassium cyanide 
(70 mg., in 2 ml. water) was added to 4,5-diaminopyrimidine 
(l.l g.) in methanol (10 ml.) and the mixture was adjusted to 
pH 7.5 with hydrochloric acid. 30^-Pormaldehyde solution 
(0.9 ml.) was added to the solution and the mixture was kept 
at 40-45° for 45 min. The crystals were filtered off and 
washed with cold water. The 4-amino-5-cyanomethylamino- 
pyrimidine decomposed at 223° (Pound , after drying at 2 0 /lO 
mm.: G, 47.05; H, 5.4; N, 46.55. G^H^N^ requires G 48.3; , 4.7
N, 46.95/C. This compound gave 4,5-diaminopyrimidine on 
hydrolysis in acidic or alkaline condition.
Hit halo y lgly cine was prepared (87 fo yield) by heating a 
mixture of glycine and Tlithalic anhydride at 200° for 20 min.
» r . r « r -
This compound was unstable to hydrolysis and partially 
decomposed on recrystallization from water; hence the poor 
analytic al figures.
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It had m.p. 189-193° (Heese (1887) gives m.p. 192°).
Phthaloy1glycy1 chloride was prepared (80^> yield) from 
phthaloyl glycine, hy the action of thionyl chloride, It 
boiled at 143-150°/2 - 3 mm, and had m.p, 85-36" (G-abriel 
(1907) gives m.p. 84-85°).
5-3r0mo-4-hydr0xypyrimidine was prepared (8 Op yield) by 
bromination of 4-hydroxy^.teridine according to Chesterfield, 
McOmie and Saver (1955). It had m.p. 198-200° (lit. 199- 
200°). 4-Amino-5-bromopyrimidine was prepared (57p yield) 
from 5-bromo-4-hydroxypyrimidine by the action of phosphorus 
oxychloride and then ammonia according to Chesterfield, McOmie 
and Gayer (1955). It had m.p. 209-211° (lit. 208-210°).
5 -1 ro mo - 4 - pht halo y 1 g ly c y 1 ami n o py r i mi d i n e . 4-Amino-5- 
bromopyrimidine (1,0 g . ) and phthaloylglycyl chloride (1.3 g . ) 
in pyridine (5 ml.) was refluxed for 1 hr. After removal of the 
pyridine, water (20 ml.) was added to the residue. The 
precipitate was triturated with sodium bicarbonate solution 
(1 g. NaHCOß in 10 ml. water) and then crystallized from 
ethanol giving 5-bromo-4-phthaloylglycylaminopyrimidine as 
colourless needles, m.p. 223-225" (Pound: C, 46.2; II, 2.6;
N, 15.3. C1,Hoi3rN/10, requires C, 46.55; K, 2.5; N, 15.5^).
Hydrazinolysis of 5-bromo-4-phtlialoylglycylaminopyrimidine, 
Hydrazine hydrate (0.12 ml.) was added to 5-bromo-4- 
phthaloylgiycylaminopyrimidine (723 mg.) in methanol (30 ml.), 
and the solution was kept at room temperature overnight. After
171
removal of the crystals" (224 mg.), the filtrate was 
evaporated to dryness and the residue recrystallized from 
50y ethanol. 'The colourless needles (252 mg., 73/^ ), m.p. 
212-213 , were identified as 4-amino-5-bromopyrimidine from 
the R . value (0.56 2D/3X), and mixed melting point with an 
authe nt ic s amp1e.
4~Amino-5~methoxycarbonylmeth.7laminopyrimidine was 
prepared from 4-amino-5-carboxymethylaminopyrimidine (see p.130) 
by the action of meth nolic hydrogen chloride according to 
Albert, brown and Cheeseman (1952). It decomposed at 188-189° 
(Pound: N, 21.8; Cl, 27.5. Calc, for 2HC1 :
N, 21.95; Cl, 27.8$»).
Attempts at syntheses for 4-amino~5-carbamoylmethylamino- 
pyrimidine (a) 4-Amino~5-methoxycarbonylmethylaminopyrimidine 
dihydrochloride (100 mg.) was added to methanolic ammonia 
(5jb, 2 ml.) and kept at room temperature overnight. Only 
5,6-dihydro-7-hydroxypteridine was detected in the reaction 
mixture by paper chromatography. (b) 4-Amino-5-carboxymethyl-
aminopyrimidine (163 mg.) was dissolved in aqueous ammonia and 
evaporated to dryness. The residual ammonium salt was heated 
at 170° for 10 ain. The product was identified as 5,6-dihydro- 
7-hydroxypteridine and none of the desired amide was produced.
This compound had a low nitrogen content (6.9^) and corresponds 
to £-carboxybenzoylglycine (C-, qEc.0^ N; N, 6.3/-)*
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AtJcerupted synthesis of 7,8-dihydro-2,4-dihydrox;y- 
pt eridine. 2,4,6-Trichloro-5-nitropyrimidine was condensed with
aminoacetal by the same method as described before (see p.149). 
Paper chromatography of the reaction mixture showed many spots, 
nd no product was isol ted from the reaction mixture after 
hydrolysis with I:-sodium hydroxide.
7 t8-Dihydro-2t 6-dih.ydroxypteridine.
2-0l.iloro -4 - ethoxy carbonylmethyl jjaino - 5-nit ropy r imi dine 
was prepared (7V  yield) from 2,4-dichloro-5-nitropyrimidine 
and ethyl aminoacetate hydrochloride according to Boon, Jones 
and Ramage (1951). It had m.p. 101-103° (lit. 101-102°). 
4-2thoxycarbonylmethyla iino-2-hydroxy-5-nitropyrimidine was 
prepared (67^ yield) by hydrolysis of 2-chloro-4-ethoxy- 
carbonylmethylamino-5-nitropyrimidine according to Eoon, Jones 
and Railage (1951). It decomposed at 232° (lit. 230-232°). 
7,8-Dihydro-2,6-dihydroxypteridine was prepared (6lp yield) from 
4-ethoxycarbonylamino-2-hydroxy-5-nit ropyrimidine by re duetion 
followed by hydrolysis according to Boon, Jones and damage, 
(1951). It had m.p. > 3 0 0 °  (Pound: 0, 43.0; H, 3.83; N, 33.55. 
Calc, for C sH 5N,02 : 0, 43.35; H, 3.65; N, 33.7/»).
7,S-Bihydro-4.6-dihydroxypteridine.
6-0 hi o r o - 4 - ethoxy c ar b o ny line t hy 1 ami no- 5 -ni t r o py r imi dine 
was prepared (62>t yield) from 4,o-dichloro-5-nitropyrimidine 
and ethyl aminoacetate hydrochloride according to Boon, Jones 
and Ramage (1951). It had m.p. 90-92° (lit. 93-94°).
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4-3thoxycarbonylmethylamino-6-hydroxy-5-nitropyrimidine was 
prepared (41b yield) by hydrolysis of 6-chloro-4-ethoxy- 
carbonylmethylamino-5-nitropyrimidine according to Boon,
Jones and damage (1951). It had m.p. 213-214° (lit. 214"').
7,8-Bihydro-4,6-dihydroxypteridine was prepared from 4- 
et hoxycarbonyl-6-hydroxy-5-nitropyrimidine by re duetion 
followed by hydrolysis according to Boon, Jones and damage 
(1951). It decomposed >* 300° without melting (Bound: 0, 43.3;
H, 3.8; N, 33.6. Calc, for C ^ - U T ^  : 0, 43.4; H, 3.65;
N, 33.7y).
Attempted syntheses for 5.6-dihydro-2,7-dih,ydroxypteridine . 
(a) Ethyl glyoxylate hemiacetal (2.2 g.) was added to 4,5- 
äiamino-2-hyäroxypteridine in water (20 ml.) and the solution 
was kept at room temperature for 1 hr. and then refrigerated.
The precipitate crystallized from ethanol as leaflets (2.2 g.,
90y) which gave the same Rf. values as 2,7-dihydroxypteridine 
on paper chromatography. (b) Ethyl glyoxylate hemiacetal 
(140 mg.) was added to 4,5-diamino-2-hydroxypteridine in 
ethanol (10 ml.) and the mixture was examined spectroscopically.
No reaction took place under anhydrous condition. When water 
(10 ml.) was added to the mixture, 2,7-dihydroxypteridine was 
produced, but no evidence of Schiff*s base formation was 
obtained. (c) 4,5-Diamino-2-hydroxypteridine (631 mg.) was 
dissolved in R-hydrochloric acid (10 ml.) and then adjusted to 
pH 7.5 with N-sodium hydroxide (5 ml.). Potassium cyanide
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(350  m:;.) nnd 37'/ fo rm a ld eh y d e  s o l u t i o n  (0 .4 5  m l . )  was added 
to  t h e  s o l u t i o n  and t h e  s o l u t i o n  was k e p t  a t  room t e m p e r a tu r e  
f o r  2 h r .  and r e f r i g e r a t e d .  The c r y s t a l s  (252 rag.) had t h e  
same Rf • v a l u e s  a s  4 ,5 - d ia m in o - 2 - h y d r o x y p y r im id in e *  Only
4 . 5 -  d ia m in o -2 -h y d ro x y p y r im id in e  was d e t e c t e d  "by p a y e r  
ch ro m a to g rap h y  i n  th e  f i l t r a t e .
5 . 6 -  I ) ih .y d ro ~ 4 .7 - d ih y d r o x y p te r id in e  .
4 -A m in o -5 -e th o x v  c a rb o n y  l ia e th y  le n e a m in o -6 -h y d ro x y -
pyr~midi__ is p r e p a r e d  (68$  y i e l d )  from  4 , 5 - d ia m in o -6 -
h y d ro x y p y r im id in e  and e t h y l  g l y o x y l a t e  h e m i a c e t a l  a c c o rd in g  
t o  P f l e i d e r e r  (1 9 5 9 ) .  I t  decomposed a t  195-190°  ( l i t .  m .p .
1 9 6 ° ) .
1 - k  i  . -• -  h.. • ■ yd. 1 , 1 , 7  no-G-hydrox;,. , y r i n l d i n e .
4 -A m in o -5 -e th c x y e a rb o n y lm e th y le n # a m in o -6 -h y d ro  x y p y r im id in e  
( 1 .0 5  g* 5 m m ole)  i n  e t h a n o l  (250 m l . )  was h y d ro g e n a te d  ov r  
R a n e y - n i c k e l ,  and 130 m l, o f  h y d ro g en  ( 211) was a b so rb e d
d u r in g  70 m in . A f t e r  rem ova l of t h e  c a t a l y s t  t h e  f i l t r a t e  was 
c o n c e n t r a t e d  t o  d r y n e s s .  The r e s i d u e ,  c r y s t a l l i z e d  from
4 - j n o -d -o t . io x . i  rl o n y lm e th y l  .. h io -6 -  
h y d ro x y p y r im id in e  a s  c o l o u r l e s s  n e e d l e s  (555 mg. 5 2 / ) .  I t  
decomposed a t  130-139° ( fo u n d ,  a f t e r  d r y in g  a t  6 5 ° / l0  ^ mm:
0, 4 5 .2 ;  IT, 5 .8 ;  N, 2 6 .3 5 .  C o T h ^h C , r e q u i r e s  0 , 4 5 .3 ;  H, 5 .7 ;  
IT, 26.4/')).
5, 5 -13 ihyd ro -4 , 7 - d ih y d r o x y p t  e r i  d ine  . 4 -A m ino-5-
e th o x y c a rb o n y lm e th y ]  i in o - 6 - h y d r o x y p y r im id in e  (307 m g.) i n
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1- hydrochloric acid (4 ml.) was heated on a steam bath for 
1 hr. under nitrogen. The starting material dissolved, 
and then colourless needles separated. The product on 
recrystallization from water gave 5,6-dihydro-4,7- 
dihydroxypteridine as pale yellow needles (192 mg., 80$),
Itt.p. >  300° (Found: 0, 43.2: H, 3.7; N, 33.7. Calc, for 
C6H6N402 : 0, 43.4; H, 3.65; N, 33-755).
7, -lihydro-4,o-diaethylot eridine.
4-Ac et onylamino-2-chlo ro-d-methyl-5-nit ropyrimidine 
was prepared (43/* yield) from 2,4-dichloro-6-methyl-5- 
nitropyrimidine and aminoacetone hydrochloride according to 
loon and Jones (1951). It had m.p. 106-108° (lit. 108°).
2- ChLoro-7,8-dihydro-4,6-dimethylpteridine was prepared (59$) 
by reduction of 4-acetonylamino-2-chloro-6-methyl-5-nitro- 
pyrimidine according to Lister and Ramage (1953). It 
decomposed at 195° (lit. 215°) (Found: C, 48.4; H, 4.75;
J, 28.05 calo. for CgHp01N. : C, 48.85; H, 4.6; N, 28.5/0.
7, S--Lihydro-4, 6-dimethylpteridine . (a) 2-Chloro-7,8- 
dihydro-4,6-dimethylpteridine and red phosphorus (100 mg.) 
was refluxed with hydriodic acid (d 1.7, 2 ml.) for 1 hr.
After removal of the red phosphorus, the filtrate was 
evaporated to dryness in a vacuum desiccator over potassium 
hydroxide. The residual oil was dissolved in water, adjusted 
to pH 10 with N-potassium hydroxide and extracted with 
chloroform, do product was obtained from the chloroform extract.
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(b) 2-Chloro-7,6-dihydro-4,6-dimethylpteri dine (920 mg.) 
was hydrogenated in 50# ethanol over palladium on carbon 
catalyst, in the presence of magnesium oxide (800 mg.); 
and 125 ml. of hydrogen (122 ml., 2 H) was absorbed. After 
removal of the catalyst the filtrate was evaporated to 
dryness. The residue was dissolved in water (15 ml.) and 
extracted with chloroform (15 x 8 ml.). The chloroform 
layer, after drying over calcium chloride, was evaporated 
to dryness. The crystalline residue (63l mg., 90#) was 
recrystallized twice from benzene and then sublimed at 
90-100°/l0~’~ mm. The 7, -dihydro-4. b-dimethylpt eridine 
had m.p. 135-140° (Pound, for substance purified by 
sublimation: 0, 59.2; II, 6.15; N, 34.0. ^3^10^4 reluires
0, 59.25: K, 6.2; N, 34.55#).
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o . Ionization Constants,
Two good general methods are available for the
determination of ionization constants, one is by potentiometric
titration and the other is by the spectroscopic method (Albert
and Phillips, 1956). Potentiometric titration is far less
laborious than the latter, but has two limitations: (a) the
solubility of the substance should be higher than 10 \ l ,
because 1 x 10~%I is usually the lower limit of accuracy.
(b) The pK values of the substance should lie between 2.7 a
and 11 (at least in the present work where a 0.005 M solution 
had mostly to be used because of poor solubility) because 
potentiometry is inaccurate when the pK, is less than the 
logarithm of the dilution; also it is not very accurate in 
the high alkaline region). The spectroscopic method can 
be used when the solubility of the substance is less than 
10  ^LI, or the pK_ values were lower than 2.7 or higher than 
11, Howeverin this method any small errors, in determining 
the extinction values of each pure species, can cause a large 
effect on the pK values. This method can only be used for a
cl
substance whose two species have different ultraviolet 
absorption spectra. Both methods need special apparatus and 
technicues if they have to be used for a substance which has 
an unstable species, 
i ) Potentiometric Titration.
The dried specimen (0.00005 mole) was dissolved in 00^- 
free water (10 ml., the concentration of this solution was Ll/200)
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and titrated under nitrogen. A Cambridge Bench pH Meter was
used with glass and calomel electrodes (standardized to pH 4.00
with 0.05 Li-potassium hydrogen phthalate and 9.23 with 0.05 M-
borax at 20°). Only when agreement on restandardization was
within + 0.02 pH unit, without further adjustment, this
instrument was considered ready for titration. After the
solution was titrated, the meter was checked against that one
of the two buffers whose pH was nearer to the pK. Failure to
agree within + 0.02 pH unit, made it necessary to reject the
titration. 0.9 Equivalent of 0.1 N-hydrochloric acid (or
carbon dioxide-free 0.1 1 -potassium hydroxide) was added in
nine equal portions and the pH was recorded after each
addition. The nine plC values, one for each pH reading, werea
calculated fro i the formula (l) when a base was titrated. 
pK = pH - log ([B] + [H+j / [BH+] - [H+]) (l)d
where [BH+] and [B] are the stoicheiometric concentrations
of the cation and neutral molecule respectively. Y/hen an
acid was titrated, formula (2) was used for the calculation
of plC values.- a
pKa = pH + log ([AH] + [OK"] / [A"] - [OH"]) (2)
where [AH] and [A"] re the stoicheiometric concentrations of 
the neutral molecule and anion respectively. The results are 
negative logarthms of concentration ionization constants 
(pK (cone.)) and are valid for the concentration and 
temperature given. At the concentration used, they would
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differ little fro i the thermodynamic ionization constants
( jlZ (therm.))* The two constants are related, approximatelya
by equations (3) and (4):
pICa (therm.) = pH (cone.) + 0.5a y jI (for acids), (3)
-oK* a (therm.) = pi: (cone.) - 0.5St y j l (for bases), (4)
where I is the ionic strength at half-neutralization. Por
example at 0.005 M, the values of pK (cone.) would be only 
0.02 too high for bases and 0.02 too low for acids compared to
pK (therm.). In the present Thesis all ionization constantsa
were recorded as pIC (cone.). Por a few substances havinga
unstable species, the pKr values were determined by a rapid~ a
titration method using a self-recorder in which the whole 
titration was carried out within 3 min. 
ii) Spectroscopic Determin itions of pK .
Solutions were made in a series of buffers, standardized 
gl ss electrode. This series was decreased in pH down 
to values where the change in spectrum, corresponding to the 
step of ionization under study, ceased; and conversely it was 
increased towards the alkaline direction, until the change in 
spectrum ceased. The buffers ( ,01 M) used were of low ultra­
violet absorption: glycine (pH 2.1 - 2.7), formate ( pH 3 - 4. •,
acetate (pH 4.2 - 5.7), phosphate (pH 6.0 - 7*9), borate 
(pH 8.3 - 10.2), and ethylamine (pH 10.2 - 11.0). Por the low
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pH region, t ie acidity function solutions (sulphuric acid of 
various strengths) of Hammett (194-0) and Has combe and Bell 
(1959) were used. For the high pH region, potassium 
hydroxide solutions of known concentration were used. 
Lleasurements were made in the Hilger "Uvispec" „u rtz 
Spectrophotometer using 1 or 4 cm. cells. Buffer solutions 
of the same' strengths were used in the compensating cell.
‘ike wavelength was chosen where a marked difference in spectra 
were observed between the two species. Extinction coefficients 
at the selected wavelength were then determined for different 
oil values corresponding to the range fro a 15 to 857« protonation 
in 8 equal steps. The pK values were determined from formulact
(5):
S£„ -£)/( £ - £ „ ) ]  ( 0
Ec
neutral ect r Z
the extinction coefficient of the sum of the two species at 
the pH value where measurement was carried out. A similar 
method and formula (6) was used for the equilibrium involving 
the neutral molecule and anion:
:(£„ - £) / ( £ £. )] (6)M A
ire , £ £ of the neutral
lolecule, the anion and of the equilibrium mixture of the two 
species respectively. ITo hydrolysis correction for [H+ ] or
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[OH”] is required in this method. . The pIC^  values obtained 
from the above formulae, (5) and (6), are pK (oono.) values,
because, although no corrections for ionic strength of the
see rj t the low dilutions, some correction
would be required for the 0.01 M buffer solutions if pK
(therm.) were required. The nature of these corrections would
he to make both acid and bases about 0.03 pK unit weaker.a
Approximate pK. values of substances very unstable to air a
oxidation (i.e. b >-2,4-dihydroxypteridine) were
determined as follows: 2,4-Dihydroxypteridine (164 mg., 1 m 
nole) was hydrogenated in 0.1 N-sodium hydroxide (10 ml.) over 
Id-catalyst as described before (p. 130). 2,3-Dimercapto-
propanol solution (H/lCOO; 1 ml.) was added to the reduction 
bui the catalyst filtered off. The filtrate was
adjusted to pH 4 and diluted to 100 ml. in a measuring flask 
with M/10000 - 2,3-dimercaptopropanol. The absorption 
coefficd= bs of the solutions, buffered for 3.0, 4.2, 5.0 and 
7.6, ./ere determined at wavelength 300 mp. Prom these values, 
the cationic pH value :/as calculated by formula (5).
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d. opöctra
flrraviolet absorption spectra of the various species were 
obtained using the self-recording Perkin Ulmer ”Spectracord" 
4000A and the extinction coefficients at the maximum wave­
length were rechecked manually on a Hilger "Uvispek" Quartz
Spectrophotometer. The solutions were "buffered (with the
o
same series of "buff s as used in spectrophtometricA
let r lin ti ns of ph ), sun at least 2 pH units away from the 
previously determined pK value, thus ensuring that at least 
SSg of the required species (and. that no more than If of any 
unwanted species) were present.
2) I;irared_1_■ • .■ 1.._-cotra of ' e various sped re
detvrLined by the Perkin Dimer Model 21 instrument fitted with 
a NaOl prism. As all hydroxypieridines are insoluble in most 
organic solvents,the potassium bromide disc ethod had to be 
used for the deter ination of these spectra. Of the dried 
le, 1 mg. ell, mixed with potassium bromide
:g.) and .pressed to ==a a disc.
183
APPENDIX
fig. Ultraviolet absorption spectra used for structure 
determi na t ion.
page
1 x,y-Dihydro-2-hydroxypteridine (neutral molecule) 
and 2-hydroxypteridine (hydrated neutral molecule) 186
2 7, -Dihydro-6-hydroxypteridine (neutral molecule) 
and 6-hydroxypteridine (hydrated neutral molecule) 186
4 Neutral molecule of tetrahydro-2-hydroxypteridine 
and 4,5-diamino-2-hydroxypyrimidine 188
5 Cation of tetrahydro-2-hydroxypteridine and 
4,5-diamino-2-hydroxypyrimidine 188
6 Anion of tetrahydro-2-hydroxypteridine and 4,5- 
di ami no - 2 -hyd r o xy py r i mi dine isg
7 Neutral molecule of 5,6,7,8-tetrahydro-4- 
hydroxypteridine and 4,5-diamino-S-hydroxy- 
pyrimidine 189
8 Cation of 5,6,7,8-tetrahydro-4-hydroxypteridine 
and 4,5-diamino-6-hydroxypyrimidine 190
9 Anion of 5,6,7,8-tetrahydro-4-hydroxypteridine 
and 4,5-diamino-6-hydroxypyrimidine 190
10 Hydrolysis-product of dihydro-7-hydroxypteridine 
with alkali (neutral molecule) and 4,5-diamino- 
pyrimidine (cation) 191
11 Hydrolysis-product of dihydro-7-hydroxypteridine 
with alkali (anion) and 4,5-diaminopyrimidine 
(neutral molecule) 191
%
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12 7, 8-Dihydro-2, 6-dihydroxypteridine (neutral 
molecule) and 2,6-dihydroxypteridine (hy rated 
n eutral mo1e cu1e)
13 7,ö-Dihydro-4,6-dihydroxypt eridine (neutral 
molecule) and 4,6-dihydroxypteridine (hydrated 
neutral molecule)
192
192
Fig. Ultraviolet absorption spectra of pteridines and 
pyrimidines.
page
14 2-Kydroxy-6-methylpteridine 193
15 7,8-Dihy ro-4,5-dimethylpteridine 194
16 3,4-Dihydro-2-hydroxypteridine 194
17 7,8-Dihydro-2-hydroxypteridine 195
18 3,4-Dihydro-2-hydroxy-6-methylpteridine 195
19 7,8-Dihydro-2-hydroxy-6-methylpteridine 196
20 5,6-Dihydro-4-hydroxypteridine 196
21 x, y-Dihyciro-4-hyuroxypt eri dine 197
22 7,8-Dihy. ro-6-hydroxypteridine 198
23 5,6-Dihydro-7-hydroxyT)t eridine 198
24 7,8-Dihydro~2,6-dihydroxyj)teridine 199
25 x,y-Dihydro-2,7-dihydroxypteridine 199
26 7,8-Dihydro-4,6-dihydroxypteridine 200
27 5,6-Dihydro-4,7-dihydroxypteridine 200
28 7,8-Dihydro-2,4,6-trihydroxypteridine 201
29 5,6,7,8-1 et rally dro-2-hydroxy pt eri dine 201
30 5,6,7,8-1 et rally dro-4-hydroxypt eridine 202
21 4,5-Diaminopyrimidine 302
32 4-Ai ii no - 5- c ar h oxyme t hy lami n o pyri mi d i ne 203
33 4,5-Diamino-2-hydroxypyri:aidine 203
34 4,5-Diamino-6-hydroxypyrimidine 204
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Fig. Infrared absorption spectra of pteridines page
35 5,6,7,8-Tetrahydro-4-hydroxypteridine obtained 
by synthesis 205
36 Tetrahydro-4-hydroxypteridine obtained by 
reduction 205
37 5,6-Dihydro-4-hydroxypteridine 206
38 x ,y-Dihydro-4-hydroxypteridine 20S
39 7, -Dihydro-2,6-dihydroxypteridine obtained by 
synthesis 207
40 Dihydro-2,6-dihydroxypteridine obtained by 
reduction 207
41 7,8-Dihydro-4,6-dihydroxypteridine obtained by 
synthesis 203
42 D i hy dr o -4,6- dil iy d r o xy pt eri dine obtained by 
reduction 208
43 5,6-Dihydro-4,7-dihydroxypt eridine obtained by 
synthesis 209
44 Dihydro-4,7-dihydroxypteridine obtained by 
reduction 209
Fig. page
3 Absorption of oxygen by tetrahydro-2,4- 
dihydroxypteridine 187
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Wave length (mp)
Fig.1. x,y-Dihydro-2-hydroxypteridine (neutral molecule)  
2-Hydroxypteridine (hydrated neutral molecule)
(
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Fig.2.
7,8-Dihydro-6-hydroxypteridine ( neutral molecule ) 
6-Hydroxypteridine ( hydrat-edneutral molecule)
(m
ol
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Fig.3.
absorption of oxygen by tetrahydro-2,4-dihydroxypteridine
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-------------  4,5-Diamin 0-2-hydroxy pyrimidine
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Fig.6. anion
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4.5 - Diamino -2-hydroxy pyri mi dine
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Fig.7. neutral molecule
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4,5-Diomino-6- hydroxy pyrimidine
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Fig.11. Hydrolysis-product of dihydro-7-hydroxypteridine 
with alkali (anion)
4.5-Diaminopyrimidine ( neutral molecule )
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Fig-12. 7, 8-Dihydro-2,6-dihydroxypteridine (neutral  molecule ) 
2 ,6-Dihydroxypteridine (hydrated neutral mo lecule)
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4,6-Dihydroxypteridine ( hydrated neutral molecule)
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Fig. 15 . 7,8-Dihydro-4(6- dimethylpteridine
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F i g . 1 6. 3,4-Dihydro-2-hydroxypter id ine
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Fig. 17. 7 , 8 - Dihydro-2 -hydroxy pt er idine
_________  n e u t r a l  m o l e c u l e
c a t i o n
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3,4 -  Dihydro -2-hydroxy-6-methylpteridineF ig .18.
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Fig.1 9. 7,8-Dihydro-2-hydroxy-6-methylpter idine
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Fig .20. 5,6-Dihydro-4-hydroxypteridine
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Fig. 23. 5,6-D:nydro-7-hydroxypteridine
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Fig.24. 7, 8-Dihydro-2,6-dihydroxypteridine
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Fig. 25. x,y-Dihydro -2,7-dihydroxy pteridine
-------------  neutral molecule
-------------  anion
200
200 240 280 320 350
Wavelength ( mjj )
Fig .2 6. 7,8-Dihydro-4,6 -dihydroxypteridine
-------------  neutral molecule
-------------  anion
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Fig.2 7. 5,6-Dihydro-4,7-dihydroxypteridine
-------------- neutral molecule
-------------  anion
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Fig .28. 7,8-Dihydro-2,4,6-trihydroxypteridine
---------------  n eut ra l  mol ecul e
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Fig 30. 5,6,7, 8-Tetrahydro-4-hydroxypteridine
---------------  neutral  mo le c ul e
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---------------  anion
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Fig.31. 4,5-Diaminopyrimidine
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...................  cat ion
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Fig .3 2. 4-Amino-5-carboxymethylaminopyrimidine
------------  neutral molecule
------------  anion
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Fig. 33. 4,5-Diamino-2-hydroxypyrimidine
neutral molecule
cat ion
anion
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Fig. 34. 4,5-Diamino-6-hydroxypyrimidine
--------------  neutral molecule
.................  cation
-------------  anion
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